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Abstract 
THE ASSESSMENT OF GOOD PRACTICE IN PAIN MANAGEMENT IN SEVERE 
DEMENTIA: A PILOT STUDY 
Introduction: Dementia constitutes a major problem for sufferers, carers and society as a 
whole. In common with other progressive life threatening conditions, it has been 
increasingly recognised that the principles of palliative care should apply to patients with 
dementia [1]. One important aspect of care is management of pain, which may contribute 
to agitated behaviour in dementia. Studies suggest that pain is under-recognised and 
under-treated in those with severe dementia [2]. Identifying pain is the first step in its 
effective management. However, research has not been carried out in the UK regarding 
the utility of behavioural pain and distress assessment tools in those with advanced 
dementia. The aim of the research was to demonstrate the importance of assessing and 
managing pain as part of good quality palliative care in people with severe dementia. The 
research objectives were to investigate the utility of a pain assessment tool (Pain 
Assessment in Advanced Dementia scale, PAIN AD [3]) and a distress assessment tool 
(Disability Distress Assessment Tool, DisDAT [4]) in a UK population with severe 
dementia; to demonstrate the ability of the tools to measure change in pain following a 
change to the management regime; to assess the nature of distress that may produce a 
false positive result on a pain scale and to examine the use of analgesia within the nursing 
homes and in those identified as experiencing pain. The PAINAD was chosen for use as 
it is based on a well-validated scale and changes in scores have been demonstrated on 
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analgesic administration. The DisDA T was chosen for use as it identifies distress rather 
than just pain and allows unique behaviours to be documented. The two assessment 
scales were chosen, therefore, because they offered a related but contrasting approach. 
Whereas PAINAD stipulates the behaviours to be observed, DisDAT allows unique 
behaviours to be described for individuals. 
Methods: A pilot study was undertaken involving nursing home residents with advanced 
dementia, defined as a Clinical Dementia Rating (CDR) score of three. Proxy assent was 
gained from relatives. Demographic data was collected and background neuropsychiatric 
scales were completed by nursing home staff. These were the Cornell Scale for 
Depression in Dementia (CSDD), Clifton Assessment Procedure for the Elderly-
Behaviour Rating Scale (CAPE-BRS), Neuropsychiatric Inventory (NPI) and the Cohen-
Mansfield Agitation Inventory (CMAI), completed to assess the levels of depression, 
dependency, psychopathology and agitation of the study participants. The participants 
were observed at rest, during a meal and at a time of intervention by the researcher and a 
nurse. The pain assessment tool and distress assessment tool [3] [4], were completed 
following the observation. The participants who were felt to be in pain were assessed 
regarding the cause of their pain. This was achieved by reviewing medical and nursing 
notes, by discussion with nursing staff and GPs, and by physical examination if 
necessary. Appropriate management was then suggested, utilising non-pharmacological 
and pharmacological strategies. Those who scored above two on the PAINAD scale 
(indicating possible pain) but were felt not to be in pain formed the false positive group. 
Both the participants with pain and the false positive group were reassessed at one month 
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and again at three months using PAINAD and DisDAT. The background 
neuropsychiatric scales were also repeated at the one month stage. A second researcher 
also carried out the observations using the same assessment tool as the researcher to 
provide evidence of inter-rater reliability. All statistical methods were undertaken using 
SPSS-14. Associations between categorical data were analysed using Fisher's exact test, 
associations between numerical and categorical data were analysed using the Kruskal-
Wallis test. Paired observations were analysed using the Wilcoxon signed ranks test. 
Results: 79 participants completed the study, 72% were female and the mean age of the 
sample was 82. 13 participants found to be in pain. A further 26 participants had a 
PAINAD score of above two, but were not felt to be in pain. These results gave PAINAD 
a sensitivity of 92% and a specificity of 61 %. The pain identified had a variety of causes 
with both acute and chronic pain being identified. The majority of the pain identified was 
musculoskeletal in origin. Many of those found to be in pain were already taking 
analgesics, suggesting that pain in this group may be under-treated. The pain identified 
was managed both by non-pharmacological and pharmacological techniques. A 
significant difference was demonstrated in both PAINAD and DisDAT scores on 
intervention following treatment for pain (both significant to p = 0.008). A significant 
difference in the background neuropsychiatric scores was not demonstrated. The majority 
of the behaviour observed in the false positive group seemed to be caused by the 
participant not understanding what was happening, leading either to fear and anxiety or to 
anger and frustration. The inter-rater reliability of the tools varied from fair to worse than 
by chance. 
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Conclusions: Pain was not as common as had been assumed from previous research. The 
behavioural pain assessment tool (PAINAD) identified behaviours that were not caused 
by pain, thereby questioning its use as a tool solely to identify pain. As a significant 
difference was demonstrated in both PAINAD and DisDA T scores once treatment for 
pain was implemented, these tools can be used to assess effectiveness of interventions to 
treat pain. As worsening of chronic pain conditions or new slow onset pain complaints 
had not been identified, regular use of behavioural assessment tools in all of those with 
severe dementia is recommended. This should form part of a thorough overall 
assessment, in order to help to raise a question concerning a person's behaviour, and in 
particular, whether that behaviour signifies pain. This work was a pilot study; further 
studies need to be carried out to assess the potential impact on pain by the regular use of 
behavioural assessment tools, to address issues regarding inter-rater reliability and to 
define an optimum time period for behavioural observation in this patient group. 
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- General Practitioner 
- Human Immunodeficiency Virus 
- Liverpool Care Pathway 
- Minimum Data Set 
- Milligrams 
- Mini-Mental State Examination 
- Mobilization-Observation-Behaviour-Intensity-Dementia pain scale 
- Mini Suffering State Examination 
- National Health Service 
-Non-Communicative Patients Pain Assessment Instrument 
- Neuropsychiatric Inventory 
- Nurse reported pain score 
- Non Steroidal Anti Inflammatory Drug 
- Palliative Care Assessment Tool 
- Pain Assessment Checklist for Seniors with Limited Ability to 
Communicate 
- Pain Assessment for the Dementing Elderly 
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PAINAD 
PEG 
PLPH 
PPC 
PRN 
SRPS 
TENS 
VAS 
VaD 
WHO 
- Pain Assessment in Advanced Dementia 
- Percutaneous Endoscopic Gastrostomy 
- Post Lumbar Puncture Headache 
- Preferred Place of Care 
- Pro Re Nata (as required) 
- Self-reported pain score 
- Transcutaneous Electrical Nerve Stimulation 
- Visual Analogue Scale 
- Vascular dementia 
- World Health Organisation 
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Chapter 1 - INTRODUCTION 
This thesis records a pilot study; the main aim of which was to demonstrate the 
importance of managing pain as part of good quality palliative care in people with severe 
dementia. There were four objectives of the research namely: to investigate the utility ofa 
pain assessment tool and a distress assessment tool in a UK population with severe 
dementia; to demonstrate the ability of the tools to measure change in pain following 
change to management regime; to assess the nature of distress that may produce a false 
positive result on a pain scale; and to examine the use of analgesia within the nursing 
homes and in those identified as experiencing pain. 
In the remainder of the introduction, I shall initially provide brief background information 
on dementia; secondly, describe the issues that arise in connection with palliative care in 
dementia; thirdly, discuss pain as a symptom arising in dementia; before, fourthly, 
considering the assessment of pain in dementia; and finally, reviewing the possible 
management of pain in people with dementia. The background and introductory remarks 
will serve to underpin the aims and objectives of my study, which are reiterated in the 
conclusion of the chapter. 
1.1 Background 
Life expectancy is increasing in European and other developed countries with greater 
numbers of people living beyond 65 years of age. The reduction in deaths from infectious 
diseases in infancy and childhood over the past century has lead to many surviving into 
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old age and dying from a different spectrum of diseases. As more people die as a result of 
serious chronic diseases, a different range of physical, psychological and social problems 
is encountered [5]. Currently, 16.1% of the UK population is over 65, this is set to rise to 
24.1% by 2050 [6]. 
Dementia currently affects approximately 37 million people worldwide, with an 
estimated 775 000 cases in the UK [7]. It affects 5% of those over 65 and 20% of those 
over 80 [8]. The prevalence of dementia rises exponentially with age, doubling in rate 
every five years. Hence the number of those with dementia is expected to rise with an 
ageing population, with cases in the UK predicted to rise to 1.7 million by 2051 [8]. 
Dementia is a chronic progressive condition where there is a disturbance of multiple 
higher cortical functions including memory, orientation, comprehension, language and 
judgement. The impairments of cognitive function are commonly accompanied by a 
deterioration in emotional control, social behaviour and motivation [9]. Although the 
median length of survival from dementia diagnosis has been suggested to be eight years 
[10], recently published data based on a cohort study described median survival from 
estimated onset of dementia to be 4.6 years for women and 4.1 years for men [II]. 
Over 60% of dementia patients have Alzheimer's disease [8]. The condition was first 
described by AloYs Alzheimer in 1906. It is characterised pathologically by 
neurofibrillary tangles and amyloid plaques as well as cholinergic neurotransmission 
dysfunction. Length of survival in Alzheimer's disease is highly variable, ranging from 
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two years to more than sixteen years, with a median survival of between 4.2 and 5.7 years 
[12]. 
Vascular dementias are the second most common type of dementia accounting for a 
further 10 to 20% of dementias. Cerebrovascular disease and ischaemic brain injury are 
the primary cause of deficits in vascular dementia. Morbidity and mortality are usually 
worse for vascular dementia than Alzheimer's disease, with survival around five years 
[13]. It is felt that up to 40% of dementia patients have an overlap of vascular and 
neurodegenerative pathologies. 
Dementia with Lewy bodies accounts for a further 10-20% of dementia. This is a primary 
degenerative dementia with pathological features of both Alzheimer's disease and 
Parkinson's disease (Lewy body formation). Other less common types of dementia in 
older people include frontal lobe dementias, dementia in Pick's disease, Creutzfeld-lacob 
disease, Huntingdon's disease and HIV related dementia [13]. Alzheimer's disease is 
more common in women, while vascular and mixed dementias are more common in men 
[8]. 
1.2 Palliative Care in dementia 
Progressive dementia is an incurable illness and until recently, was viewed as a "living 
death" about which little could be done other than custodial care [14]. In common with 
other progressive life threatening conditions, it has been recognised that the principles of 
palliative care may apply to patients with dementia [I, 15, 16]. Palliative Care is defined 
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by the WHO as, "the active total care of patients whose disease is not responsive to 
curative treatment" [17]. Control of pain, of other symptoms, and of psychological, social 
and spiritual problems is paramount. The goal of palliative care is to achieve the best 
quality of life for patients and their families. 
The hospice movement was initially developed in response to the perceived needs of 
terminally ill cancer patients [15]. During the 1990s it was increasingly recognised that 
cancer patients were not alone in needing palliative care; a report to the Department of 
Health in 1992 argued that "all patients needing them should have access to palliative 
care services" [18]. It is now a key principle in the guidance on the commissioning of 
palliative care services for adults that it is a right of every person with a life-threatening 
illness to receive appropriate palliative care wherever they are. This principle has been 
endorsed by several influential institutions including the National Institute for Health and 
Clinical Excellence, the Royal College of Physicians and the National Council for 
Palliative Care [7, 19, 20]. Despite this important shift in emphasis, the reality is that 
most patients who access hospice and specialist palliative care in the UK have cancer. 
Between 1-2 % of patients admitted to hospice have dementia as their primary diagnosis 
[10, 15] and dementia patients are infrequently referred to hospital or community 
palliative care teams [21, 22]. In addition, palliative care teams may not regard such 
patients as having specialist needs or be appropriate for their service [23]. 
One aspect of palliative care is the management of symptoms including pain. Pain can be 
defined as an unpleasant sensory and emotional experience [24]. It is a complex 
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phenomenon derived from sensory stimuli or neurological injury and modified by 
individual memory, expectations and emotions [25]. Although there are no reliable (or 
specific) biological markers of pain, an individual's description and self report usually 
provides accurate, reliable and sufficient evidence for the presence and intensity of pain 
[26]. In summary, pain is whatever the experiencing person says it is and it exists 
whenever they say it does [27]. If the person is in the terminal stages of dementia with 
corresponding communication difficulties, then the ability to self-report and describe pain 
is diminished. This could therefore lead to the under-recognition of pain in this group. 
These concerns regarding pain management in those with dementia have been borne out 
in multiple studies. Research simply involving elderly nursing home residents with 
varying levels of cognitive impairment have demonstrated that between 45-80% will 
describe substantial pain [28-30] which is often under-treated [2]. It is therefore a major 
concern that there may be considerable numbers of patients with severe dementia with 
undetected and untreated pain. The development of effective means of recognising and 
evaluating pain in this vulnerable population is hence of great importance [31]. 
1.2.1 The palliative needs of patients with dementia 
As dementia is a chronic, progressive, often incurable condition it would therefore seem 
reasonable that palliative care principles should be applied when managing the condition. 
Although there is a wide variation in the course of the illness among individual patients, 
there are groups of signs and symptoms that herald the final stages of dementia. There is 
a progressive worsening of memory, with increasing confusion and disorientation. 
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Behavioural changes are seen in addition to a progressive deterioration of speech with the 
patient eventually becoming mute. There is also a loss of mobility, with the patient 
becoming bed-bound and totally dependant. Appetite and ability to swallow are lost and 
hence aspiration becomes a risk. As a consequence of these neurocognitive, functional 
and nutritional deficits, bladder and bowel incontinence develop, infections become 
increasingly common and decubitus ulcers may also occur [10, 16,32,33]. 
Some of these issues have been demonstrated by work carried out by interviewing those 
caring for someone with dementia in the last year of their life. This work also provided 
information about the needs of those dying from dementia and contrasted this with those 
dying from cancer. McCarthy et al carried out a retrospective survey of carers or family 
members who knew about the last year of life of those dying from cancer or dementia (as 
identified by death certification) [34]. They identified 170 dementia patients and 1513 
cancer patients and gathered information from the carers or relatives. None of the 
dementia patients had died in a hospice; however, 13% of the cancer patients had died in 
a hospice. This was a statistically significant finding. The dementia patients suffered from 
multiple symptoms in the last year of life; most common were mental confusion, urinary 
incontinence, pain, low mood, constipation and loss of appetite. Similar frequencies were 
reported for cancer patients, but dementia patients experienced these symptoms for a 
longer period of time. Dementia patients saw their GPs less often than the cancer patients 
and the levels of assistance needed at home were greater for the dementia patients. 
Although the study was retrospective in nature, which may make the findings less valid, 
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it clearly highlights the symptom burden experienced by those with terminal dementia 
and contrasts this with the supportive care experienced by those with cancer. 
Similar work was carried out by Mitchell et al in New York State [35]. They used the 
Minimum Data Set (MDS) to compare 883 nursing home residents with terminal cancer 
(less than 6 months life expectancy) with 1609 residents with advanced dementia 
(Cognitive Performance Scale 5 or 6) who died within a year of admission to the nursing 
home. They compared the data derived from the admission MDS with the last MDS that 
was completed for the resident before death for the two groups. Six months after 
admission, 92% of the cancer cohort had died and 71 % of the dementia group had died, 
however only 1.1 % of the dementia group were perceived as having a life expectancy of 
less than 6 months on admission. This may reflect the difficulty in identifYing the 
terminal phase of dementia or, alternatively, that advanced dementia is not considered to 
be a terminal illness. These issues were probably also a factor leading to fewer "do not 
resuscitate" (DNR) orders being made for those with dementia as opposed to those with 
terminal cancer. 
In addition, those with dementia were less likely to have had "do not hospitalise" and 
"not for tube feeding" orders made. Various "non palliative" interventions were more 
common for those with dementia compared with those with cancer, such as phlebotomy 
and intravenous therapy. The study also looked at symptom levels and although pain, 
shortness of breath and constipation were documented, the levels were significantly lower 
than experienced by those with cancer. This may be a consequence of the inability of 
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those with dementia to self-report their symptoms. Pressure ulcers and fever were much 
more common in those with dementia, possibly owing to the level of prolonged debility 
experienced by those residents. Although there may be inaccuracies in how MDS data is 
collected, this study highlights the range of symptoms that those with dementia may 
experience and the difficulty in recognising the terminal stage of dementia. 
These studies demonstrate not only a role for palliative care surrounding symptom relief, 
but other aspects of end stage dementia care that may benefit from palliative input. As the 
disease progresses and more functions are lost, decisions have to be made regarding 
levels of medical intervention. This may involve placement of PEG tubes, whether to 
treat recurrent infections or whether to resuscitate in the event of cardio respiratory arrest. 
Providing psychological, social and spiritual care, an essential part of palliative care, is 
also important in dementia care, as is supporting the families of those with dementia. 
Finally providing good quality end of life care, wherever that may need to take place, is 
an important challenge for all those involved in dementia care. 
1.2.1.1 Feeding difficulties 
As dementia progresses, a large proportion of patients will develop feeding difficulties. 
Maintaining independent feeding requires a variety of skills, with a functional swallow 
being only one of the necessary components [36]. Research using video-fluoroscopic 
techniques has suggested that up to 93% of those with advanced dementia will have some 
degree of dysphagia [37]. These feeding difficulties can cause multiple problems 
including aspiration pneumonia, weight loss and malnutrition, with subsequent inability 
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to fight off infection. Conservative strategies for managing this common problem can be 
successful. A voiding drugs that cause xerostomia, careful attention to dental care, use of 
finger food and nutritionally enhanced food as well as increasing personal assistance with 
meals, may all be beneficial [38]. 
As with many other conditions that can lead to dysphagia, PEG feeding can be considered 
to provide nutritional support [39]. The intention of feeding tube placement is to prevent 
aspiration pneumonia, forestall malnutrition and its sequelae and to provide comfort [38]. 
There is little evidence to suggest that tube feeding prevents aspiration pneumonia in 
those with severe dementia as aspiration of oral secretions or regurgitated gastric contents 
is not necessarily avoided [40]. In addition there is relatively sparse data to demonstrate 
that malnutrition is prevented. There is evidence that tube placement itself can cause 
death with peri-operative mortality rates for PEG placement of between 6 to 24% and a 
poorer prognosis for those with dementia who have PEG placement compared to other 
age matched groups [39]. Other work, examining survival rates in patients with dementia 
referred for PEG tube placement, demonstrated that those who did not undergo the 
procedure had a median survival similar to those who did [41]. Additional research has 
also demonstrated little impact on long-term survival by the use of feeding tubes in those 
with advanced dementia [42], although prolonging survival may not necessarily be the 
long-term goal in those with advanced dementia. It is possible that, by the time many of 
those with severe dementia are referred for tube placement, they are already 
malnourished [43]. This may therefore put them at a greater operative risk and make them 
less likely to gain survival benefit from tube placement. 
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1.2.1.2 Treatment of recurrent infections 
Recurrent infections occur in those with dementia for a variety of reasons. There is 
evidence to suggest immune responses are reduced in advanced dementia [44], 
decreasing the ability to resist development of infection. Incontinence and urinary 
retention may lead to an increased risk of urinary tract infections. There is an increased 
risk of developing pneumonia caused by swallowing difficulties and decreased mobility. 
Other infections may also develop such as infected pressure sores caused by impaired 
ambulation [16]. It may also be more difficult to diagnose infections due to a lack of 
reporting of symptoms, which is seen even in those with early Alzheimer's disease [45]. 
The issue of when to treat pneumonia in those with severe dementia is controversial. 
Bronchopneumonia is the commonest cause of death for those with Alzheimer's disease 
[46] so it could be argued that the development of pneumonia is a terminal event. 
Morrison and Siu [47] compared 80 patients with end stage dementia to 39 cognitively 
intact age matched patients who were admitted to a New York hospital with pneumonia. 
Both groups received similar management for their illness in terms of investigations and 
antibiotics. They found that 53% of the dementia group had died within 6 months of 
admission compared with 13% of the cognitively intact group. 
Van der Steen et al [48] compared outcomes of 374 nursing home residents with 
dementia who developed pneumonia and were treated with antibiotics. They found that 
dementia severity was significantly related to death rate within the first week of 
36 
pneumonia being diagnosed. In addition, dementia severity was significantly related to 
death within three months of the pneumonia diagnosis. It would therefore seem that those 
with dementia, particularly those with severe dementia, have poorer outcomes from 
episodes of pneumonia despite antibiotic treatment. Others have attempted to examine 
whether treating infections provides survival benefit. Fabiszewski et al [49] demonstrated 
that the mortality rate from episodes of fever was significantly higher in those not treated 
with antibiotics (who had their symptoms palliated) than those given antibiotics. By 
controlling for the level of disease, they demonstrated that for the more severely affected 
patients, there was no difference in survival probability between the two groups. It is 
worth highlighting that in this study, a third of fevers documented had no obvious 
infective cause, making it difficult to equate the frequency of fever with infection rate. 
The study discusses the invasive nature of investigation for infections; however, such 
procedures as suctioning to gain a sputum sample are not common practice in the UK. 
The argument therefore that the investigation of infections itself causes suffering is less 
relevant. In addition, conclusions reached regarding the futility of antibiotic treatment for 
those with severe dementia is dependant on whether the methods used for controlling for 
the level of disease were appropriate. 
Whether giving antibiotics provides some symptom relief, even if it does not cure the 
underlying infection, is a contentious issue. Volicier [50] argues that patient comfort can 
be ensured by the liberal use of antipyretics and analgesics even if the infection is not 
treated with antibiotics. Vander Steen et al [51] used the Discomfort scale for patients 
with Dementia of the Alzheimer type [52] to evaluate levels of discomfort in nursing 
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home residents with dementia who developed pneumonia. They demonstrated that the 
level of discomfort was higher in the patients that had had antibiotic treatment withheld; 
however their levels of discomfort were higher generally before the pneumonia was 
diagnosed. Although it is not clear from this study what palliative interventions the 
nursing home residents received, it demonstrates the difficulties in deciding whether 
prescribing antibiotics in pneumonia concurs some symptomatic benefit. This leads to 
wide variation in practice, for example, between Dutch and US nursing homes [53]. 
Similar issues arise with treating other infections: do antibiotics provide some 
symptomatic benefit or do they simply cause increased discomfort and prolong the 
terminal phase? Although there can be difficult decisions to make regarding the treatment 
of infections in those with end stage dementia, careful discussion to weigh up the benefits 
and burdens of any treatment is always important. 
1.2.1.3 Resuscitation 
Difficulties may also be encountered in making resuscitation decisions for those with 
advanced dementia. The previous UK guidelines regarding resuscitation for patients were 
frequently a source of confusion amongst clinicians [54] as they contained many 
contradictory statements and lacked a framework for decisions to be made. A recent joint 
statement from the British Medical Association, Resuscitation Council and Royal College 
of Nursing has been published to clarify decisions relating to resuscitation [55]. Hence if 
the clinical team believe that resuscitation will not restart the heart and maintain 
breathing, it should not be offered or attempted. If, however, resuscitation in the event of 
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an arrest might be successful, then the benefits of prolonging life must be weighed 
against the potential burdens. In these circumstances, discussion with the patient is an 
essential part of the decision-making process, but is not feasible with a patient with 
advanced dementia lacking the capacity to consent to resuscitation. In England and Wales 
the decision should be based on a proper and careful estimation of what might be in the 
person's best interests in accordance with the provisions of the Mental Capacity Act 2005 
[55,56]. 
The outcomes for cardiac arrest in a nursing home are poor. Zweig [57] reported that 
survival to discharge from an acute care hospital after cardiac arrest in a nursing home 
ranged from 0 to 5% and was lower if the arrest was un-witnessed. This is based on work 
carried out in the US where resuscitation practices in nursing homes are better developed 
[58]. In hospitals, resuscitation is three times less likely to be successful in patients who 
are cognitively impaired and the success rate is almost as low as in metastatic cancer 
[59]. It has been demonstrated that most cognitively intact older adults (95%) would not 
want cardiopulmonary resuscitation if they had severe dementia [60]. Even if 
resuscitation is successful, two thirds of survivors from community arrests have new 
neurological or functional deficits [58]. 
There are, therefore, several very difficult treatment decisions that often have to be made 
during the course of a patient's illness. Distress can occur surrounding these decisions 
because of the long course of the illness, the patient's reduced capacity to have input into 
them, stress of the caregivers and underestimation of the terminal nature of advanced 
dementia [16]. As similar issues occur in those with other terminal illnesses such as 
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cancer and motor neurone disease, palliative care teams may be able to offer advice and 
support regarding difficult decision-making processes [5]. The treatment decisions that 
may need to be made all involve balancing benefits and burdens to the person and 
therefore all need to be made on an individualised basis. The person's wishes, if known, 
are central to the decision-making process. Advance care planning is increasingly 
promoted to allow such wishes to be documented [20]. Around 11 % of those dying of 
dementia in a US study have made a living will [35]. Research evaluating advance care 
planning in nursing homes has demonstrated a decrease in hospital admissions and the 
mortality of nursing home residents [61], as well as increased satisfaction of patients' 
families [62]. Early discussion of diagnosis could enable those with dementia to express 
their wishes when mentally capable [63], thus allowing more person centred care to be 
delivered in the terminal stages. 
1.2.1.4 Family support 
Providing support to family members during a terminal illness forms an integral part of 
palliative care philosophy. Caring for someone with advanced dementia can be 
emotionally and physically exhausting. Often marked stress is caused by a diminishing 
capacity to participate in relationships as the carers lose the person they knew [10, 16]. 
This stress may be exacerbated if the dementia produces difficult behavioural symptoms. 
As a patient deteriorates, nursing home placement may become necessary. Despite this 
clearly being appropriate for the patient's needs, it can induce feelings of guilt and 
ambivalence. Once the person with dementia dies, their caregivers may need bereavement 
support particularly ifthe grief is complicated. 
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Albinsson and Strang asked dementia care and palliative care nursing staff what the most 
important measures for supporting families were [64]. Both groups highlighted giving 
infonnation and listening to families. Owing to the longer disease trajectory in dementia, 
the rate that the infonnation needed to be given was different. A lack of infonnation 
about the natural course of the disease can make it difficult for families to anticipate 
future events, hence families may insist on hospital admission for acute illnesses in their 
relative with dementia [65]. Research carried out by Engel et al [62] demonstrated that 
few families of those with dementia recognised when their relative was in the final six 
months of the illness. Other issues highlighted by dementia care staff in the research by 
Albinsson and Strang included the provision of respite care, forming support groups for 
families and trying to relieve families' feelings of guilt. Although there were many 
similarities between the needs of the two groups, this research emphasises that supportive 
care for families needs to be specifically designed based on the trajectory and nature of 
dementia. Admiral Nurses may be well placed to give such support, however their 
services are not available country wide [63]. Support for families must, therefore, be 
provided from other sources, both professional and voluntary. 
1.2.1.5 Psychological, social and spiritual needs 
As those with dementia become increasingly dependant, aphasic and immobile, it is 
sometimes said that they only require physical care [33]. Palliative care involves not only 
attending to physical needs but also psychological, social and spiritual aspects to enhance 
quality of life as part of holistic care. In the study by McCarthy et al [34], two of the 
commonest symptoms described by carers caring for individuals with dementia were 
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mental confusion and low mood. Behavioural symptoms such as aggression, delusions, 
wandering, agitation and sleep disturbance are common in dementia, with over 90% of 
patients experiencing "behaviour disturbance" [66]. These non-cognitive symptoms seen 
in dementia are often described under the umbrella term of behavioural and psychological 
symptoms of dementia (BPSD). 
Many of these symptoms form a syndrome that occurs after the onset of symptoms of 
dementia and vary over time [67, 68]. Evidence suggests that these symptoms are 
important determinants of patients' distress, quality of life [69], carer burden and 
outcome in dementia. The symptoms are also important in leading to prescription of 
psychotropic drugs and nursing home placement [66, 68]. The recognition of particular 
symptoms can help to determine the underlying cause of the dementia. Multiple factors 
cause these symptoms, including the underlying brain disease, host factors and the 
environment. Thorough investigation of all the contributing dimensions is required in 
order to plan logical intervention [70], with treatment designed to address the underlying 
cause where possible [71]. Also important is the question as to why the behaviour is 
perceived as a problem, and therefore, treatment may need to encompass family and 
carers as well as the person with dementia [67]. 
Non-pharmacological interventions can be helpful, including behavioural therapies, 
exercise, music therapy and changes to the care environment. Providing quiet spaces and 
privacy within a home has been shown to reduce negative behaviours [72]. 
Antipsychotics, mood stabilisers, antidepressants and anxiolytics are commonly 
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prescribed for patients with dementia to address some of these symptoms; however there 
have been few clinical trials to support the use of these drugs in this patient group. Recent 
systematic reviews found that the evidence supporting the effectiveness of these drugs 
when managing BPSD is limited [70], although advising against them completely creates 
problems when managing those with severe behavioural disorders. 
The recent document produced by the Alzheimer's Society, Kings College London and 
the London School of Economics [8] estimated that 63.5% of those with dementia lived 
in private households and 36.5% in care homes. The proportion of those in residing in 
care homes increases as the condition progresses. In one study around 76% of those with 
dementia were institutionalised before death [73]. The Preferred Place of Care (PPC) 
document is a patient held record designed to record patient choices for all terminally ill 
patients [74]. To use such a document fully for those with dementia would require 
advanced planning, adequate resources and determination from all involved in caring for 
that person [33]. It is not clear to what extent the wishes of those with dementia are 
elicited when currently planning social support. 
Spiritual care helps people in their search for hope and meaning, particularly as they face 
issues of grief, loss and uncertainty [75]. Although religion can form part of spirituality, it 
is possible for those without religious belief to explore the cause of illness and distress 
[76]. Essential elements of spirituality revolve around a relationship with self, others and 
God, a sense of meaning and purpose, hope, connectedness and beliefs. These issues 
become more urgent when people face crises of life [75, 77]; however, because of 
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cognitive changes, those with dementia may become dependant on others to maintain 
their spirituality [78]. In order to do this, those providing spiritual care need to see the 
whole person and join in that person's journey through the challenges they face [79]. 
Supporting the spiritual needs of families and carers is also important, as the suffering 
caused by dementia can last for many years with several losses experienced during that 
time. Despite the importance of spiritual care, the study by Sampson el af [21] 
demonstrated that very few patients with dementia admitted to hospital have their 
spiritual needs assessed or addressed. Although addressing such needs in those with 
severe dementia may be challenging, the spiritual needs do not stop with the onset of 
dementia [75]. 
The work of Kitwood has highlighted the importance of a person centred approach to 
caring for people with dementia. This approach emphasises the importance of those with 
dementia being viewed as a valued human and social being with moral worth and 
entitlement to human rights [80]. Those with dementia have the same needs as other 
people whether it is for physical comfort and care or for emotional, social and spiritual 
wellbeing [81]. Identifying and addressing the psychological, social and spiritual needs of 
those with advanced dementia will further the goal of improving care and hence quality 
of life. 
1.2.1.6 End oflife care 
It has been suggested that people with dementia die in three different ways. They may die 
due to a medical condition unrelated to their dementia; others may die with a complex 
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mix of mental and physical problems consequent upon to the interaction between 
dementia and other conditions; or they may die from complications arising from end 
stage dementia [82]. Although the modes of dying may vary, ensuring excellent end of 
life care is of great importance. 
Several studies have looked at issues surrounding end of life care for those with 
dementia. Professor Lloyd-Williams [83] carried out a retrospective case note audit of 17 
patients with end-stage dementia on a psychogeriatric ward in 1996 to determine the most 
prevalent symptoms in terminal dementia (the last two weeks) and assess the palliation 
given. Pain and breathlessness were the most common symptoms that were documented 
in the notes and the palliation of these symptoms was variable. In particular, syringe 
drivers were not used even though patients were unable to take anything orally in the 
final 48-72 hours. 
As many of those with dementia die in nursing homes, it is important to assess end of life 
care provided by such homes. This work has been carried out in Holland by Brandt et al 
in 2005 [84]. They used a Palliative care Outcome Scale, developed as an outcome 
measure for use with dying patients with advanced cancer and with their families, to 
assess end of life care. The nursing home staff completed the scale on a weekly basis for 
all those whose prognosis was felt to be six weeks or less. They demonstrated that the 
spiritual and psychosocial aspects of care were often not addressed when patients die in 
nursing homes. This seems likely to hold true for those dying in UK nursing homes. 
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Sampson et al compared the differences in care of those with and without dementia who 
died during an acute hospital admission in the UK [21]. They retrospectively reviewed 
100 case notes and found that those with dementia were less likely to be referred to 
specialist palliative care teams and less likely to have had spiritual issues addressed. 
Similar work has also been carried out in the US by Ahronheim et al [85]. They reviewed 
164 notes of patients with advanced dementia or metastatic solid tumour malignancy who 
died in a large teaching hospital. They found that those with dementia were more likely to 
have enteral tube feeding (51 % had the tube in place when they died), the majority of 
both groups received empirical antibiotics in the last days or weeks of life and very few 
of those with dementia had made advance directives. Although there are clear differences 
in practise between the US and UK, particularly concerning tube feeding, these studies 
demonstrate the variety of issues surrounding end of life care for those with dementia 
which may be amenable to palliative input. 
Attempts have been made to improve end of life care for those with dementia. Following 
the 1996 audit, Lloyd-Williams and Payne repeated the audit after the implementation of 
guidelines on management of common symptoms at the end of life [86]. The case notes 
of 27 patients who died on the unit were reviewed. There was an increase in the number 
of patients prescribed analgesics and fewer courses of antibiotics were prescribed in the 
last week of life following guideline implementation. The NHS End of Life Care 
Programme has been set up to improve the quality of care for people at the end of life 
(www.endoflifecare.nhs.uk). Three tools have been suggested by the programme. The 
Preferred Place of Care plan [74], as discussed earlier, is a patient held document 
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outlining the patients' thoughts about their care, choices they would like to make and 
where they would want to die. The Gold Standards Framework in Care Homes 
Programme [87] aims to identify, assess and plan care by promoting integrated 
collaborative working with primary care and specialist teams. The Liverpool Care 
Pathway [88] for the dying aims to take the best of hospice care for the last days of life 
into different care settings. It addresses issues surrounding communication, symptom 
control and psychological support at the end of life [7]. The use of the LCP for the dying 
is gradually increasing not only in hospitals and in the community but also in nursing 
homes where many with dementia die. Hockley et al looked at the benefits of 
implementing the tool in eight independent nursing homes in Scotland [89]. From 
interviews with nursing staff they found that the use of the LCP created a greater 
openness around death and dying, with dying being recognised more often. The staff also 
felt that teamwork and communication had improved and that they were using palliative 
care knowledge to influence practice. The study identified barriers to implement the LCP 
including high staff turnover and multiple GPs being involved in patients in the home. 
In summary, as palliative care should be integral to all clinical practice involving chronic 
terminal disease, it is suited to the care of people with severe dementia [79]. Several 
studies have highlighted the needs of those with dementia [34, 35] including assessment 
and management of symptoms and issues regarding feeding, treatment of infections and 
resuscitation. Early discussion of such issues, when patients are mentally capable, could 
allow their wishes to be incorporated into the decision-making process [63]. Support for 
the family and friends of those with dementia is an integral part of a holistic approach to 
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care, as is addressing psychological, social and spiritual needs. All of these areas are 
fundamental to care at the very end of life, and recent care programmes have been 
designed to address these issues. 
1.2.2 The timing of palliative care input 
As the palliative needs of those with dementia can be described, the question arises of 
when it is appropriate for palliative involvement for those with dementia to commence. It 
has been recognised that different conditions have differing theoretical trajectories of 
dying. Glaser and Strauss described three patterns of dying - abrupt and sudden death, 
expected death of varying duration (short term and lingering) and entry-reentry deaths 
(slow decline with frequent acute deteriorations) [90]. More recently these ideas have 
been expressed as a set of functional trajectories in which short term expected deaths 
(terminal illness such as cancer) are portrayed differently from lingering expected deaths 
(frailty) [91]. 
Work by Lunney et al [92] looking at activities of daily living (ADLs) of people in their 
last year of life demonstrated similar patterns to these theoretical trajectories, with those 
with cancer having a more predictable terminal period. Defining a terminal phase for 
cancer, however, can be problematic. One study looking at determining a terminal phase 
demonstrated that it can vary from between 1 to 1340 days [93]. Hence the period of 
active treatment and palliative care often overlaps [94]. The difficulty with a disease 
process such as dementia, which is often characterised by a gradual decline in functional 
ability, is to identify when a switch from active to palliative care is appropriate. Neither 
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approach is mutually exclusive but obtaining a timely balance between the two 
approaches may be difficult to judge [95]. A model where both curative and palliative 
treatments occur simultaneously could enhance quality of life and better manage end of 
life care [96]. 
Coventry et al carried out a systemic review in 2005 to try and identify tools and 
predictor variables that might aid clinicians to estimate survival and assess palliative 
status in non-cancer patients, including those with dementia [97]. Three studies were 
reviewed to determine prognosis in hospice based patients with dementia. One study used 
Functional Assessment Staging (FAST) using level 7C as a cut off point for hospice 
enrolment; equating to being virtually mute, dependant for all activities of daily living 
and unable to walk without assistance [98]. This was found to be a strong predictor of 
survival with a mean survival time of 6.9 months. However 41 % of those studied could 
not be scored on this scale as their disease progression was not ordinal. Further work by 
this team [99] demonstrated that the non-ordinal patients survived significantly longer 
than those who deteriorated in a more predictable manner. Research published by Zvi 
Aminoff and Adunsky looked at identifying levels of suffering using a Mini-Suffering 
State Examination (MSSE) [100]. This research demonstrated that end stage dementia 
patients with higher MSSE scores had a shorter survival when compared to dementia 
patients with lower MSSE scores. The authors suggest that this group might benefit more 
from a palliative approach to their care. Defining what constitutes suffering is 
problematic and what is not clear is whether survival is improved if the causes of 
suffering as identified by the MSSE are alleviated. These studies demonstrate the 
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difficulties faced in trying to identify markers of a terminal phase for dementia that is 
applicable to all patients and when a more palliative approach is most appropriate. 
Although it is important to recognise the terminal phase of dementia, it is clear that 
palliative care does not solely apply to those facing imminent death [101]. As those with 
dementia do not necessarily deteriorate in an ordinal manner, many of the palliative care 
issues discussed could potentially occur at any stage in the illness, not just in the last few 
weeks of life. Enabling those caring for people with dementia to recognise these issues as 
well as giving appropriate support from the relevant specialist teams will further the goal 
of providing adequate palliative care for all of those who suffer from dementia. 
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1.3 Pain in dementia 
To understand the issues surrounding pain in those suffering from dementia, it is 
beneficial to start by examining the issues surrounding pain management in an age-
matched population with normal cognition or mild cognitive impairments. Several studies 
have attempted to quantify levels of pain amongst elderly populations and how well pain 
is managed. 
1.3.1 Pain in the elderly 
Ferrell et al [2] carried out a pilot epidemiology study of 92 nursing home residents with 
an average age of 88 and an average Mini Mental State Examination [102] of 20.7. They 
carried out semi-structured interviews, reviewed medical records and used two pain 
instruments, the Pain Experience Measure and the McGill Present Pain Intensity Scale. 
Interviews were carried out avoiding times within an hour of analgesia being given and 
focussing on the worst pain complaint and its character over the previous seven days. 
Sixty-five subjects (71%) indicated the presence of pain at least some of the time, 47% 
reporting intermittent pain and 24% constant pain. Twenty-two subjects (24% of sample) 
reported daily pain. The commonest source of pain was low back pain, followed by 
previous fractures, neuropathies, leg cramps and arthritic knees. Of those with pain, 54% 
reported that their pain impaired their ability to enjoy activities in the facility, as well as 
impairing ambulation and disturbing sleep. Only 15% of those with pain had received any 
analgesic medication in the previous 24 hours. 
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Won el al [103] carried out a cross sectional study of almost 50,000 nursing home 
residents who were over 65 with a MMSE of less than 19. Subjects were asked simple 
direct questions about pain. Daily pain was defined as any type of physical pain or 
discomfort in any part of the body occurring daily over the 7 days preceding the 
assessment. Over a quarter experienced daily pain and a quarter of those with daily pain 
received no analgesics. Residents who were over 85, male, black or mildly cognitively 
impaired were at the greatest risk of under-treatment. 
An additional cross sectional study was carried out by Won et al [104] to understand 
analgesic prescribing patterns in nursing home residents by assessing 21,380 residents 
aged 65+ with persistent pain. They defined persistent pain as any pain recorded at least 
twice within 6 months by simple direct questioning of the residents. Almost 50% of the 
residents had persistent pain and the prevalence of persistent pain was very high in those 
with musculoskeletal pain and those with a history of falls, fractures or surgery in the past 
6 months. Of those with persistent pain, 38.4% received opioids, 37.1% received non 
opioids and 24.5% received no analgesics. Additional studies [29, 32, 105-109] have 
identified similar levels of pain in both nursing home and community dwelling elderly 
patients. 
1.3.1.1 The problems associated with managing pain in the elderly 
It would seem, therefore, that pain is a common problem in the elderly and is under-
diagnosed and under-treated. There are multiple reasons why this might occur. Yates et al 
[110] used qualitative methods to investigate views of pain and pain management 
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practices held by elderly people living in long-tenn residential care settings in Australia. 
They found that many elderly people believed that it was common to experience pain and 
was a nonnal consequence of growing old. There was a perception that little could be 
done for their pain and they believed that pain is something that they should "put up" 
with. There were also concerns regarding worrying busy staff and being labelled as a 
"complainer". Similar widespread stoicism in the presence of chronic pain was described 
in work carried out in UK nursing homes by Cairncross et al [108]. 
There may also be a perception amongst medical staff that pain is a nonnal consequence 
of aging and, hence, does not receive the attention that it should. There are 
misconceptions that older patients tolerate pain better or the perception of pain declines 
with age [Ill]. In addition, there may be concerns that medications suitable for younger 
patients cannot be used safely in the elderly. Until more recently, nursing homes have not 
prioritised pain assessment and management in the manner that occurs within acute care 
settings [112]. A study by Sengstaken and King [105] identified that often the non-
detection of pain occurred owing to a failure of the treating physicians to inquire directly 
about the problem. There are also challenges regarding prescribing analgesics for the 
elderly. Older people are particularly susceptible to drug side effects with adverse drug 
reactions occurring twice as frequently in older than in younger patients. This effect 
increases with the number of drugs taken. On average older people take three times as 
many drugs as younger patients [113]. Alterations in phannacokinetics in older patients 
can lead to varying oral bioavailability and differing drug distribution, owing to altered 
body composition and protein binding. Changes in metabolic clearance are also seen 
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owing to decreasing glomerular filtration rates and changes in the ability to induce liver 
enzymes [114]. In addition, changes to the number and affinity of receptors and impaired 
neurotransmitter production can lead to altered drug pharmacodynamics giving differing 
end organ responses to drugs [114]. The combination of lack of reporting by elderly 
patients, misconceptions by medical staff and difficulties regarding analgesic prescribing 
contribute to the under-recognition and under-treatment of pain in the elderly. 
1.3.2 Pain in cognitively impaired elderly 
Although several studies have been carried out to ascertain levels of pain in elderly 
cognitively intact patients, there is a relative lack of evidence surrounding pain in those 
with cognitive impairment. This is more marked for those with severe dementia as this 
group is invariably excluded from studies into pain in those with cognitive impairment 
[115]. 
Ferrell's study of pain in nursing home residents excluded those with severe cognitive 
impairment [2]; hence this study is unable to provide information about their pain levels. 
A further study carried out by Ferrell et al [116] involved 217 nursing home residents 
with a mean MMSE of 12.1. The participants were interviewed about their pain, medical 
notes and charts were reviewed and the subjects were shown five scales to rate the 
intensity of their pain. In this study, 62% of the participants complained of pain, however 
17% were unable to complete any of the scales presented. Although this study does 
involve those with a more marked cognitive impairment, 70 subjects were excluded from 
the initial sample as they were essentially mute and unresponsive and no meaningful 
54 
infonnation could be obtained from the patient interview. Presumably many in this group 
were severely demented and again infonnation regarding there pain experience is not 
provided. 
A study carried out by Shega et 0/ [117] of geriatric out patients involved a sample of 
patients with a mean MMSE of 16.6 who were interviewed regarding the levels of pain. 
From those interviewed, 32% reported experiencing pain at that point in time. Although 
this study provides infonnation regarding levels of pain in those with moderate cognitive 
impainnent, those unable to attend an outpatient clinic or who were unable to 
communicate were excluded. The study carried out by Won et al from 2004, of over 
21000 nursing home residents with persistent pain, also excluded those with low MMSE 
scores and those unable to communicate [104]. Work carried out by Schuler et a/ [118] 
investigating the psychometric properties of the Gennan PAINAD tool involved a sample 
of 99 nursing home residents with a mean MMSE of 12.9. They asked nursing staff to 
judge whether the participants were in pain during an observation period whilst the pain 
tool was also completed. The nursing staff concluded that 39.4% of the sample was in 
pain. 
If those with severe dementia are being excluded from studies around pain caused by an 
inability to answer questions about their pain, then other methods of assessment need to 
be found. Horgas and Tsai [119] compared the analgesics prescribed for 155 nursing 
home residents with cognitive impainnent with 184 residents without dementia 
diagnoses. They demonstrated that after controlling for the presence of painful 
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conditions, those with cognitive impairment were prescribed and administered 
significantly fewer analgesics than their cognitively intact peers. They also attempted to 
identify the factors linked to analgesic prescription and administration, highlighting that 
the more withdrawn and disorientated residents were prescribed significantly less 
analgesia. Unfortunately the two groups in this study were described in terms of having 
or not having a dementia diagnosis, rather than the level of their cognitive impairment. In 
addition simply having a potentially painful diagnosis does not always equate with 
having pain, hence it is difficult to draw firm conclusions from this work. 
An alternative method might be to look at analgesics required by those with and without 
cognitive impairment following an event known to be painful and use this as a marker for 
levels of pain. Morrison and Siu carried out a prospective cohort study of elderly patients 
following a hip fracture [120]. Fifty-nine of the patients were cognitively intact and 38 
had advanced dementia. They found that half the cognitively intact patients who 
experienced moderate to very severe pain were arguably prescribed inadequate analgesia 
for their level of pain. Less than 25% of this group had regular analgesia prescribed 
during their hospital stay. They also demonstrated that the cognitively intact group 
received on average three times as much opioid analgesia as those with advanced 
dementia (despite three patients of the advanced dementia group being managed without 
surgery.) A similar proportion of the advanced dementia group also did not have regular 
analgesia prescribed and had to rely on "as required" analgesia being administered for 
pain relief. The authors concluded that the inability of those with advanced dementia to 
self-report their experience of pain led to less analgesia being administered. They also 
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suggested that this group would have similar pain levels to the cognitively intact group, 
hence demonstrating under-treatment of pain in those with advanced dementia. One other 
possible explanation might be that pain is experienced differently in those with dementia, 
potentially accounting for some reduced levels of analgesic usage. 
A similar study conducted by Feldt et al [121] used three measures to look at potential 
levels of pain in elderly patients following hip fracture surgery. They monitored opioid 
usage, a verbal descriptor scale to rate intensity of pain and the Checklist of Nonverbal 
Pain Indicators [122] to look at pain behaviours. A group of cognitively intact patients 
(35) and a group of cognitively impaired patients (53 with a mean MMSE of 12.1) were 
reviewed following surgery. Their levels of analgesic administration, pain intensity and 
pain behaviours at rest and during activity were recorded in both groups. A similar 
proportion of both groups were able to rate their pain intensity levels and this did not 
differ significantly between the groups. The cognitively impaired subjects again were 
administered significantly less opioid analgesia in the first four days post operatively than 
the cognitively intact group, despite prescribed amounts of opioid being similar for both 
groups. In addition, those with cognitive impairment scored significantly higher on the 
CNPI when being moved than did the cognitively intact patients. This suggests that the 
conclusions reached by Morrison and Siu [120] may well be correct, namely that pain is 
under-treated in cognitively impaired patients because of the inability of patients to report 
pain and the inability of those caring for them to recognise pain successfully. They 
suggest that this may be compounded by nursing staff being reluctant to administer 
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opioids owing to a fear of exacerbating or precipitating delirium In a patient with 
cognitive impairment. 
There have been many studies published demonstrating the levels of pain in elderly 
patients and how this pain is often not recognised and not adequately treated. There are 
far fewer studies looking specifically at levels of pain in those with cognitive impairment 
and these studies do not include those with severe dementia. As those with severe 
dementia are often unable to communicate their level of pain, alternative methods of 
assessing levels of pain are required. The work looking at analgesic prescription in 
painful conditions has highlighted that prescribing differs depending on levels of 
cognitive ability. This may be caused by under-recognition of pain in this group of 
patients, but could also be caused by a change in pain perception. 
1.3.2.1 How pain is experienced in those with dementia 
As discussed previously there is evidence that pain is under-reported and under-treated in 
cognitively impaired elderly patients. There is little known about the effect of age alone 
on how pain is perceived. There may be age associated changes in transmission along A-
delta and C nerve fibres; however it is not clear how this might affect an individual's 
experience of pain [123, 124]. The findings from experimentally controlled laboratory 
investigations are equivocal and variations seem to occur according to the type and 
intensity of noxious stimulation [125]. Work carried out by Gagliese and Melzack [126] 
by asking young and elderly chronic pain sufferers to complete the McGill Pain 
Questionnaire [127], demonstrated that there may be a difference in the quality but not 
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intensity of chronic pain. In general, age related changes in pain perception are probably 
not clinically significant [123]. 
Although it is clear that the ability to report pain is impaired for many patients with 
dementia, it may also be possible that there is an alteration in the perception of pain due 
to the effects of the dementing process on the brain. Pain is a construct incorporating 
sensory/discriminative components (identifying the injury in time and space), 
cognitive/evaluative components (how a response to a stimulus is influenced by culture, 
anxiety, attention and other factors) and affective/motivational components (protective 
processes to avoid injury) [128, 129]. The sensory/discriminative component of pain is 
chiefly mediated through the lateral pain system. The lateral pain system consists of 
spinothalamic tract neurons that project to the primary somatosensory area, parietal 
operculum and the insula via the lateral thalamus [130]. The cognitive/evaluative 
component of pain is mediated via the medial pain system, in particular the locus 
coeruleus and anterior cingulate cortex (ACC). The affective/motivational component is 
mediated through the medial pain system via the intraluminal and medial thalamic nuclei. 
Hence, relating neuropathological changes seen in dementia to the pathways of the 
constructs involved the pain experience may help in understanding how pain is 
experienced in dementia. 
1.3.2.1.1 Neuropathological changes in Alzheimer's disease 
In Alzheimer's disease the lateral thalamic nuclei are not significantly affected [131] and 
it is felt that the sensory/discriminative quality of pain perception may therefore be 
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preserved. Neuronal loss has been found in the locus coeruleus in Alzheimer's disease, as 
well as severe atrophy in the anterior cingulate cortex, potentially affecting the 
cognitive/evaluative component of pain. The affective/motivational component may also 
be affected as the intraluminal and medial thalamic nuclei, as well as the insula, have 
been found to be atrophied in the brains of those with Alzheimer's disease. The prefrontal 
cortex plays a role in the anticipation of affective painful stimuli and neuronal loss has 
been found in this area. In addition, the hippocampus and amygdala, both involved in 
memory for pain, have been found to severely atrophied in Alzheimer's disease. In 
summary most ofthe areas of the medial pain system seem to be affected in Alzheimer's 
disease [130]. This also includes memory as well as autonomic responses. Therefore, 
owing to the condition's effects on the medial pain system, a decrease in some of the 
components of pain might be expected. 
1.3.2.1.2 Neuropathological changes in Vascular Dementia 
In vascular dementia, infarcts can occur at many locations and hence could influence both 
the lateral and medial pain systems. These infarcts could alternatively provoke or 
ameliorate the suffering associated with pain [131]. Disruption of connections within the 
cortex and between cortex and sub-cortex by white matter lesions seen in vascular 
dementia can cause increased pain, termed central post-stroke pain. Hence it is possible 
that those suffering from vascular dementia suffer from an increase in pain. 
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1.3.2.1.3 Neuropathological changes in other dementias 
Less work has been done on other types of dementia. In dementia with Lewy bodies, 
atrophy and Lewy bodies particularly affect areas related to the medial pain system 
suggesting that many components of pain experience may be altered. [n frontotemporal 
dementia more severe atrophy is seen in the frontal, lateral temporal and parietal regions. 
It is speculated, therefore, that the cognitive/evaluative and motivationaVaffective aspects 
are prone to deterioration in frontotemporal dementia [130]. 
1.3.2.1.4 Clinical evidence for neuropathological findings in Alzheimer's disease 
There is some research evidence in people with dementia that correlates with 
neuropathological findings. Fisher-Morris and Gellatly published two case reports of 
patients with Alzheimer's disease who had experienced physical trauma of various kinds 
[132]. Neither of the patients exhibited normal pain behaviour or gave verbal reports of 
pain commensurate with the tissue damage they had incurred. They then carried out a 
small scale national survey of abnormal pain experience in Alzheimer's sufferers by 
requesting reports via the Alzheimer Disease Society newsletter. They received 38 
additional reports of patients failing to exhibit a normal pain experience in response to 
acute accidents, infections, acute surgical conditions and chronic conditions. A further 
nine reports were of the apparent disappearance of symptoms from diagnosed medical 
conditions. Although these reports were not verified, the authors felt that there was a sub-
set of Alzheimer's patients who do not experience pain. 
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Porter et al examined the effects of venepuncture on several variables in 44 subjects with 
dementia (recruited from the Alzheimer's disease research centre) compared with 51 age-
matched cognitively intact individuals [133]. They monitored heart rate at rest, whilst 
preparing for venepuncture, during venepuncture and in recovery. In addition they 
recorded levels of self-reported anxiety and pain by using a visual analogue scale before 
and after the procedure. They also video taped facial expressions and coded them using 
the facial coding system. The dementia group exhibited less of a heart rate increase 
during the preparation phase and a slight heart rate increase during venepuncture, 
whereas the cognitively intact group had a heart rate decrease during venepuncture. 
Facial expression was increased in demented individuals but could not be classified by 
specific emotions. The ability to respond to questions about anxiety and pain dropped 
markedly as the severity of the dementia increased. Only ten patients out of the total had 
Clinical Dementia Rating score [134, 135] of two or three and hence this may have 
altered the magnitude of the responses seen. The authors felt in conclusion that dementia 
influences both the experience and reporting of pain among elderly individuals. 
Work carried out by a group in Italy demonstrated blunted autonomic responses to 
electrical stimuli in those with Alzheimer's disease [136]. In addition, Benedetti et al 
[137] demonstrated that pain anticipation and reactivity depended on both cognitive 
status and frequency bands of the EEG, whereas stimulus detection and pain threshold 
were not affected by the progression of Alzheimer's disease. They concluded that these 
findings demonstrated that the sensory-discriminative components of pain are preserved 
even in advanced Alzheimer's disease and that the cognitive and affective functions 
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(related to anticipation and autonomic reactivity) are severely affected. Further work by 
this group also suggested that owing to impairment in frontal lobe function seen in some 
with Alzheimer's disease, the expectation/placebo related mechanism of therapies for 
pain may be reduced [138]. 
Pickering et al [139] examined the differences in analgesic prescribing for acute and 
chronic pain in those with Alzheimer's disease compared with age match controls. They 
prospectively followed two groups of a 150 patients (with and without Alzheimer's 
disease) and documented analgesics administered for chronic pain conditions and acute 
pain episodes over a two year period. The frequency of acute pain episodes were similar 
for both groups, as was the amount of analgesia given to treat these episodes. The nature 
and number of chronic pain conditions in both groups were also similar, however the 
amount of analgesia administered was significantly less in the group with Alzheimer's 
disease. The authors postulate three possible causes for what was seen, that the group 
with Alzheimer's were unable to communicate their pain effectively, that the disease 
entities causing pain were less severe or that this demonstrates that the progressive effects 
of the dementia alters the pain experience of chronic pain. They point to the fact that the 
treatment of acute pain did not differ in the two groups, which suggests that perhaps there 
is a difference in how chronic pain is perceived in those with Alzheimer's. It is also 
possible, however, that the acute painful episodes that were described were much more 
easily identified as these may provoke an acute change in someone even if that person is 
unable to communicate. This would explain why the acute pain treatment levels were 
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similar. It is also possible that gradual worsening of chronic conditions may not provoke 
such noticeable differences and therefore explain why this was treated less. 
Blennow et al [140] carried out a study of patients having a lumbar puncture as a 
diagnostic procedure for their dementia and looked at the incidence of post lumbar 
puncture headache (PLPH). All the patients were actively asked for symptoms of 
complications, including 86 with severe dementia. Only eight (2%) complained of PLPH 
compared with a published incidence in non-demented individuals of 24-38%. 
Unfortunately, information regarding the type of dementia these patients had is not 
described in the paper and there is a lack of information surrounding whether any of the 
patients were unable to respond appropriately to questions about their pain. It seems 
surprising that the 86 severely demented patients were all able to provide information 
about PLPH. The study would have benefited from having age-matched control patients 
as the incidence given in the paper for PLPH was derived from a variety of studies 
conducted by different groups several years previously, whose techniques may not have 
been comparable. 
Despite these papers demonstrating some evidence that the experience of pain being less 
in those with dementia, recent work by Cole et al [141] using tMRI techniques to analyse 
responses to pain in patients with Alzheimer's disease showed that activity in both medial 
and lateral pathways was preserved. They also demonstrated increased activity in the 
dorsolateral prefrontal cortex compared with normal controls in response to pain. The 
authors felt that this may indicate an increased threat value of the pain for the patients on 
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account of their reduced ability to appraise the consequences of the experimental pain 
stimulus. The work was carried out with those in the early stages of their illness, but does 
call into question the evidence suggesting that the neuropathological changes affect the 
pain experience. 
1.3.2.1.5 Clinical evidence for neuropathological findings in vascular dementia 
Several studies have been published looking more specifically at pain levels in vascular 
dementia. A study carried out by Scherder et al [142] suggested that patients with 
possible vascular dementia suffered more pain than age-matched controls without 
cognitive impairment. The study involved 20 patients with ''possible'' vascular dementia 
and a control group matched for chronic pain conditions. They were asked to complete 
several different self-report scales based on current levels of pain and the CNPI [122] was 
also completed. There was a significant increase in scores on two of the self report scales 
in the group with vascular dementia, suggesting that those with vascular dementia suffer 
from more pain than those without cognitive impairment. It is worth noting however that 
as well as the numbers of participants being small, not all participants had had CT or MRI 
to confirm the diagnosis of vascular dementia. 
Further work by Achterberg et al [143] examined the relationship between 
cardiovascular risk factors (hypertension and diabetes mellitus) and pain in those with 
cognitive impairment. They compared two groups of patients, all with cognitive 
impairment and at least one chronic condition likely to be painful and asked them to rate 
their pain over the last seven days. Those who had cardiovascular risk factors reported 
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more severe pain. It is vel)' difficult to draw conclusions from this work as it is not clear 
what proportion of participants had vascular dementia, what the nature of the pain was 
(i.e. whether related to stroke disease, such as central post stroke pain, or caused by the 
painful condition originally identified) and which risk factor was more significant. It 
would therefore seem that despite theoretical reasons why those with vascular dementia 
may experience more pain, the current clinical evidence to confirm this is far from 
adequate. 
Although it is useful to extrapolate information from cognitively intact elderly subjects 
regarding levels of pain, there is some evidence from neuropathological findings, case 
reports and experimental data that the pain experience for demented patients may be 
altered. More recent research has challenged some of these findings making it unwise to 
draw firm conclusions for all those suffering from dementia. Pain is a unique individual 
experience, as is the manner in which the disease progresses. It is, therefore, impossible 
to be certain whether a particular person with dementia will experience pain differently 
from someone without dementia. An important (and at times unappreciated) consequence 
of pain in those with dementia is fear. The memol)' of the social context and beliefs that 
would have modified the experience of pain may be lost causing those with cognitive 
impairment to be excessively frightened by pain episodes [131, 141, 144]. Therefore, 
even if some people with dementia may not appear to exhibit a normal pain response to a 
known painful stimulus, as described by Fisher and Gellatly [132], others may not only 
experience pain but also fear, greater than would be expected, in response to pain. 
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1.3.2.2 The link between pain and other variables in patients with dementia 
Quality of life for elderly people with dementia has been defined as involving cognitive 
functioning, activities of daily living, social interaction and psychological well being 
[145]. If one is aiming to improve quality of life by treating pain, then those factors that 
define quality of life should be improved by alleviating pain. A number of studies have 
been carried out looking at the links between pain and variables that relate to quality of 
life. 
Cipher and Clifford carried out a study of234 residents in nursing care who were referred 
to a geropsychologist because of a change in cognitive functioning, emotional distress or 
behavioural dysfunction associated with dementia [146]. By using scales to measure 
levels of pain, illness, depression, cognitive status, dysfunctional behaviours and 
resistance to activities of daily living (ADL), the authors found that cognitive, emotional 
and behavioural variables interact with one another to predict patients' activities of daily 
living. Pain levels were found to influence behavioural disturbances and depression 
which in turn influenced ADL, rather than being a direct influence. The authors 
concluded that decreasing pain is likely to yield the greatest overall improvements in 
ADL. 
The study carried out by Won et al [103] in almost 50,000 nursing home residents used 
data from the MDS not only to assess pain levels but also the relationship between pain 
and mood, involvement in activities and ADL impairment. Pain was evaluated using 
observation and direct questioning and those with daily pain were included in the study. 
67 
Subjects suffering from daily pain were more likely to have mood disorders, ADL 
impairment and decreased involvement in activities. The authors do point out that this is 
purely an association and does not demonstrate direct causation. 
Other studies look more at a specific variable and its relation to pain. Buffum et al [147] 
carried out a pilot study looking at the relationship between agitation and discomfort. 
They used scales to assess agitation, cognitive impairment, dementia severity and 
discomfort with a moderate positive correlation being found between discomfort and 
agitation scores. This might suggest that agitated behaviours indicate painful sensations. 
However, there is some overlap between the two scales (for example fidgeting on the 
discomfort scale is similar to restlessness on the Cohen-Mansfield Agitation Inventory 
[148]) which increases the chances of a positive correlation. There were also positive 
correlations between both discomfort scores and severity of dementia and agitation scores 
and severity of dementia. The authors felt that this implied that agitated behaviours 
should not be solely attributed to dementia as some of the behaviour might be due to 
discomfort. Further evidence of the relationship between discomfort and agitation was 
provided by a study carried out Pelletier and Landreville [149], which confirmed the 
findings of the pilot study by Buffum et al. 
Parmalee et al [150] carried out a study of 598 nursing home residents to look at the 
relationship between pain and depression. They demonstrated a significant association 
between pain and depression, with those having criteria for major depression reporting 
more intense pain and a greater number of localised pain complaints than those with 
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minor depression or non depressives. The data also suggested that physical infirmity was 
not the sole factor underlying the correlation of pain and depression. The relation of 
depression to localised pain complaints was strongest where there was a physical disorder 
to which pain might be logically attributed. 
Although there may be an association between pain and other variables, such as 
depression, agitation and levels of activity, relatively few of these studies look at this 
association with respect to those with severe dementia. Those which did were smaller in 
subject size or did not come to any definite conclusions. These studies all fail to 
demonstrate what happens when the pain is actively treated and whether this affects 
levels of depression and agitation. Ultimately if the goal of treating pain is to improve 
quality of life then observing a reduction in agitation and depression with an 
improvement in activity levels would be a valuable research outcome. 
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1.4 The assessment of pain in dementia 
Several different approaches have been employed to assess pain in those with cognitive 
problems. One approach is simply to use self report pain assessment tools as might be 
used in the general population. Pain assessment tools such as Visual Analogue Scales, 
Verbal Rating Scales and Pain Faces Scales have been used in a variety of studies [116, 
151-159] in elderly patients with varying levels of cognitive impairment. Some of these 
studies excluded those who were severely demented [155] or found that many scales 
could not be completed with worsening cognitive ability [116, 153, 156, 158, 159]. Other 
studies have demonstrated that at least one of the scales could be completed, but this 
differed from person to person, making it difficult to recommend one scale for all [IS 1]. 
In addition it has been suggested that, owing to memory difficulties, those with cognitive 
impairment can only rate their pain at that moment rather than say how the pain has been 
over a period of time [157]. 
Similar conclusions were reached by Stolee et al in their systematic review of pain 
assessment tools for use in older persons with cognitive impairment [160]. They reviewed 
30 self-report instruments and found completion in those with cognitive impairment 
varied between 20% and 100%. The higher completion of the self-report tools was found 
for those with mild to moderate cognitive impairments. There were no self-report 
instruments for which all major forms of reliability and validity testing were reported. 
These studies and reviews demonstrate that although some patients with severe dementia 
are able to complete certain self-report scales, this can vary tremendously. The validity 
and reliability of these scales for assessing pain in this population has not been 
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conclusively demonstrated. It would, therefore, seem logical to use a different method to 
assess pain than scales reliant on self-report. Behavioural assessment tools offer an 
alternative approach and have consequently been evaluated in this population. 
1.4.1 Behavioural pain assessment tools 
Pain has been characterised as "whatever the patient says it is and occurs whenever the 
patient says it does" [27]. This characterisation of pain is based on the premise that the 
sufferer can subjectively feel, cognitively interpret and clearly report the experience 
[161]. If this definition were to be followed to the letter, then it would follow that if 
patients could not express themselves, they would not be in pain. This definition is 
clearly unacceptable for use with confused or non-verbal elderly, but may explain why 
pain is frequently undetected in this group [162]. The loss of the ability to process, 
understand and describe internal experiences regularly leads to behavioural expressions 
of distress [163]. It would seem logical, therefore, to use behaviour to assess pain for 
those who are unable to express verbally what they are experiencing. 
The use of such tools forms part of a framework of techniques to assess pain alongside 
self-report, a search for potential causes of pain, surrogate reporting and analgesic trial 
[164]. The American Geriatrics Society Panel on persistent pain in older persons 
recommended assessing pain in those with severe dementia by direct observation for pain 
behaviours [123]. This forms the first step of their algorithm for assessing pain, followed 
by meeting comfort needs, looking for underlying causes and considering an empirical 
trial of analgesia. 
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The idea of using observed behaviour for assessing pain is not new. Behavioural tools 
and observational procedures have been identified in the literature as methods of 
assessing pain in various populations from neonates to older adults [165, 166]. Such tools 
have a wide array of behaviours that can indicate pain including behaviours related to 
posture, facial expressions and change in functional ability. Although such tools could be 
used in patients with dementia, this assumes that the signs that are normally indicative of 
pain in a general population are also representative of pain in elderly patients with 
dementia. This assumption is doubtful given the identification of less obvious or atypical 
behavioural presentations in some people with dementia [167]. As a result, numerous 
tools to be used specifically in those with dementia have been developed over the past 15 
years. Two assumptions underlie the development of such tools: firstly, that discomfort 
can be observed although it may not be verbally expressed; secondly, that those with 
dementia cannot voluntarily control their expressions or demeanour. Thus, observed 
behaviours can be considered external markers of internal states [52]. 
1.4.2 Using behaviour to assess pain 
The work on developing behaviour-related pain tools for use with cognitively intact 
patients was greatly aided by the fact that these patients can report when they are in pain. 
Keefe and Block demonstrated that certain behaviours were correlated with reports of 
pain in cognitively intact adults with chronic low back pain [166]. With cognitively 
impaired patients who are unable to report their pain, there is no reliable method of 
knowing if what is being observed represents pain. If a certain procedure is known 
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usually to cause pain, it is therefore assumed that the behaviours observed during the 
procedure denote pain. 
This principle was used in work carried out by Manfredi et aI, who recorded the facial 
expressions and vocalisations that occurred during a dressing change of decubitus ulcers 
for nine severely demented patients [168]. This was then shown to medical students and 
nurses who had to infer the presence or absence of pain based on the vocalisations and 
facial expressions. Eight of the nine patients demonstrated facial expressions that were 
identified by observers as indicative of pain. The patient who was felt not to be in pain 
during the dressing change was the only patient receiving regular opioids. This study 
proposes that the facial expressions and vocalisations of demented patients suggestive of 
pain correlate with a procedure presumed to be painful. However, it is not possible to be 
absolutely certain that what was experienced by the patients' was pain as oppose to fear 
or anxiety. There is no evidence that behaviours resulting from pain are exclusive to that 
experience or are different to the behaviours that result from psychological causes such as 
anxiety [4]. Hence many tools designed to identify pain in patients with dementia may 
simply identify a negative emotion, one cause of which might be pain. 
There is tremendous variability in the behavioural manifestations of dementia and the 
expected pain expressions that occur as a function of each person's unique damage to the 
brain [131, 169, 170]. This was demonstrated by Borod et al [171] who videotaped the 
facial expressions of patients with unilateral brain damage in response to emotionally 
laden slides. They showed that those with right sided brain damage used facial expression 
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in response to the slides less frequently than those with left sided damage and normal 
controls. Hence the variety of anatomical distribution of deficits in those with 
Alzheimer's and vascular dementia may lead to variation in many behavioural traits, as 
well as facial expression. 
This variability in behaviour has been described by several authors, such as a patient 
becoming quiet and not eating when in pain [162]; and a patient laughing intermittently 
when in pain [172]. Pain assessment, therefore, needs to be uniquely tailored and 
individualised [169]. During the development of DisDAT by Regnard et al [4] it was 
identified that although some distress cues were common between patients, each patient 
had a distinct pattern of distress cues. This was also seen in the work by Parke [165] who 
interviewed gerontological nurses about how they recognised pain in cognitively 
impaired older adults. They described pain cues which were specific to the individual and 
were recognisable to nursing staff who knew them well. Using predetermined lists of 
potential pain behaviours runs the risk of missing important individualised cues and, as a 
consequence, the risk of not recognising when that person is in pain. 
The use of behaviour related pain tools requires those working with demented patients to 
be able to identify behaviours that might indicate pain. Weiner et a/ [173] looked at the 
ability of nursing home staff and patients' families to identify pain behaviours reported 
by the patients themselves. The patients in the study all had chronic pain and were able to 
respond to pain questionnaires. They showed that the nurses' and the families' 
assessments of the residents' pain behaviours differed from the residents' assessments of 
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themselves. Agreement on pain behaviours between family and nurses was also poor. The 
authors felt that this might have a variety of causes. The staff might not be observing the 
patients at the moment the behaviour was occurring or they might have become 
desensitised to the behaviours if they occur chronically. In addition some of the pain 
behaviours might be displayed in patients who are pain free and hence might not be 
recognised appropriately in those who have pain. Other papers looking at pain behaviours 
in demented patients have discussed how nurses can accurately describe most of the 
residents' pain behaviours [162]. It has also been demonstrated, in a population of people 
with learning disabilities, that different carers will recognise different behaviours, with 
most able to recognise a core of behaviours for each patient [4]. 
1.4.3 Challenges associated with using behavioural pain assessment tools 
A recent paper by Pautex et al [174] has questioned the routine use of behavioural scales 
in those with severe dementia. They asked 129 patients, with a Clinical Dementia Rating 
Scale of 3, randomly to complete a verbal rating scale, visual analogue scale and faces 
pain scale, whilst the nursing team completed the Doloplus-2 [175] behavioural rating 
scale. They demonstrated that 61 % of the participants could complete at least one of the 
self report scales and the Doloplus-2 correlated moderately with the self-assessment 
scale. The Doloplus-2 underestimated severity when compared with self-assessment. This 
study can only really provide evidence around the utility of the Doloplus-2 scale, not all 
behavioural scales. It is, however, worth noting that studies comparing self report and 
behaviour assessment in those without cognitive impairment have found a low to 
moderate correlation between the techniques [176-178]. It has been suggested that self-
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reporting pain intensity and pain behaviour comprise different aspects of the complex 
pain experience [177]. Others have discussed how behavioural expressions of pain, 
expected by clinicians, are often absent [179]. Both these factors may explain why 
behavioural scales do not always correlate well with self-report. 
Although it is clear that behavioural tools are a sensible approach in identify pain in those 
with severe dementia, there are mUltiple pitfalls to this approach. There is no evidence for 
any behaviour that solely indicates pain [4], which could lead to an over-diagnosis of pain 
when the behaviour is due to a different cause. Pain behaviours are not unique from those 
that might indicate other problems such as boredom or depression [180]. The uniqueness 
of individuals and their disease means that a behaviour indicating pain in one patient may 
indicate contentment in another. Hence, there is a danger that important cues are 
overlooked or misinterpreted. The behaviours seen can be complex and difficult to 
capture adequately by behavioural tools not tailored to that individual [181]. Having 
behaviours on a scale that the person would not ever display runs the risk of their pain 
behaviours not scoring highly on a scale and therefore not being taken as seriously. 
Therefore, any scoring system attached to a behavioural scale is merely a representation 
of the number of behaviours seen, not an intensity rating [182]. Behaviouml scales may 
measure a different aspect of the pain experience to self report [177] and may not be an 
accurate representation of the pain experienced, particularly if the person tries not to 
"show their pain"[179]. As some responses to chronic pain can be decreased activity, 
rather than an increase in certain types of behaviour, this may not be adequately identified 
on a un i-directional pain behaviour measure [170]. Finally, the tools rely on the abilities 
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of nursing staff to identify and interpret the behaviour correctly, which may be difficult 
owing to constraints on time or desensitisation [181]. 
Despite these potential problems, the concerns raised regarding the under-recognition 
and under-treatment of pain in this population have increased the drive to develop 
suitable assessment tools to identify pain [183]. Without the promotion of pain 
assessment tools, it is possible that many behaviours, caused by pain, may simply be 
ascribed to that persons dementia. Several reviews, although critical of aspects of current 
assessment tools, have emphasised that the use of behavioural tools in this population 
form an important part of assessing pain [31, 183]. Around 25% of nursing homes in a 
recent study were using a pain assessment tool to assess the pain of their residents [109]. 
Understanding how best to use such tools, as well as appreciating their limitations, is vital 
in developing strategies for assessing and managing pain in severe dementia. 
Behavioural tools differ greatly in terms of evidence of validity, reliability and clinical 
utility. One review of 10 assessment tools concluded that currently there is no 
standardised tool that may be recommended for broad adoption in clinical practice [31]. 
Another review of 12 papers concluded that none of the scales was convincingly the most 
appropriate scale for assessing pain in elderly people with dementia [184]. A further 
review published recently [170] was again unable to recommend one tool for use across 
popUlation and settings. From these reviews it is clear that more research is required to 
evaluate current tools. The difficulty lies in which tools to choose for further evaluation. 
Important factors influencing this choice are the strength of current psychometric 
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evaluation data, clinical feasibility of instruments and the support for use with the 
population of interest in specific settings [31]. Eleven published pain and distress 
assessment tools are summarised in the table overleaf. 
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Table 1.1 Comparison of behavioural pain and distress assessment tools 
Behavioural Authon Development Subjects, setting AdministratioD, Reliability Validity Other issues 
AUe5sment tool s&:oring, 
Feasibility 
Abbey pain scale Abbey etal Used work by on Evaluated in 61 Nurses asked to Internal Measured using Uses 
Australia pain behaviours participants in use tool when consistency scale score and physiological 
2004 [185] by other authors long term care pain suspected (Cronbach's a = nurse's holistic indicators (no 
Modified by with late stage Tool claimed to 0.74) was assessment, evidence for use 
Delphi study and dementia take 1 minute to satisfactory found to be in chronic pain) 
focus groups score Modest inter- "satisfactory" Equates 
rater reliability behaviours with 
pain intensity 
Assessment of Kovach et al Protocol using Evaluated in 2 Concerns that Internal Use of protocol Unclear how 
Discomfort in USA work on pain studies (104 & may be too consistency not lead to long taken to 
Dementia (ADD) 1999 [186] behaviours by 143 participants) complex for established. significant complete 
other authors with severe routine use [31] Varying levels of decrease in protocol 
dementia inter-rater discomfort and 
reliability increase in 
treatment 
Checklist of Feldtetal Developed from Evaluated 53 in Score whether Moderate Tool possibly Not evaluated in 
Nonverbal Pain USA existing pain patients with hip behaviour is or is internal only valid for long-term care 
Indicators 2000 [122] behaviour scale fracture (mean not present consistency , assessment of facilities 
(CNPI) MMSE= 12.2) good inter-rater pain on 
reliability movement 
Doloplus-2 Wray, Lefebvre- Adapted from Evaluated in a Need to know Good internal Significant Unclear if 
Chapiro et al pain scale for variety of patients well to consistency , convergent English version i 
France young children settings but little complete satisfactory retest validity psychometrically I 
1992 [175] info on subjects reliability tested 
Disability Regnard et 01 Developed from Evaluated in Caren recognised Research Research Found to be 
Distress UK distress and subjects with different cues currently being currently being simple to use and 
Assessment Tool 2007 [4] contentment cues severe Behaviour undertaken to undertaken to useful 
(DisDAT) identified in intellectual monitored using establish establish 
subjects disability. some score sheets psychometric psychometric 
with dementia 
-
pn>perties properties 
-
Behavioural Authors Development Subjects, setting Administration, Re6ability Va6dity Other issues 
Assessment tool scoring, 
Feasibility 
Discomfort Scale Hurleyetal Behaviours Evaluated in 2 Each item scored in Moderate retest Significant Well established in 
for patients with USA identified by studies (97+ I 04 terms of frequency, reliability, correlations research setting but 
Dementia of the 1992 [52] nursing staff subjects) with duration and satisfactory internal between DS-DAT complex to use 
Alzheimer Type working in advanced AD intensity consistency and CMAl, VDS & 
(OS-DAT) dementia centre (Cronbachs a = discomfort 
I 0.79) thermometer 
Mobilization- Husebo etel Developed from Evaluated in 26 Subject observed High internal More pain Small sample size ' 
Observation- Norway existing pain subjects with and then gentle consistency once identified using Difficulty in 
Behaviour- 2007 [187] assessment tools MMSE~ II and standardised items deleted. MOBID scoring certain 
Intensity-Dementia and literature with chronic pain movements Variable inter-rater Higher pain domains for pain 
pain scale review performed Also reliability intensity scores Concern that tool 
(MOBID) videoed from watching provokes pain 
video 
Non- Snowetal Developed by Evaluated in Used at rest and Strong inter -r.tter Low specificity Criticised for 
Communicative USA expert panel of nursing assistants movement reliability scores having limited 
Patients Pain 2004 [188] clinical and & in 83 subjects in Unclear how to Low to moderate Excellent comprehensiveness 
Assessment research experts in nursing homes with interpret scores retest reliability agreement between of non verbal pain 
Instrument pain and severe dementia videoedand behaviours 
I (NOPPAlN) psychometrics recorded scores [31] 
Pain Assessment Fuchs-Lacelle and Behaviours Evaluated by 40 Checklist of 60 High levels of Moderate Reliability testing 
Checklist for Hadjistavropoulos identified by nurses recalling a behaviours but no internal correlation between subject to recall 
Seniors with Canada nursing staff to be specific patient indication of bow consistency but scores and nurses bias 
Limited Ability to 2004 [189] indicative ifpain with limited ability to interpret score used nursing staff global rating LowinternaI 
Communicate to communicate recall Rated as useful by consistency for 
(PACSLAC) staff in later study some items in later 
[183] study [183], item 
DO. reduced [190] 
Pain Assessment Vi11anueva et al Items developed Evaluated in 2 Three areas Variable retest Correlated Complex using 
for the Dementing USA after literature studies (25+40 assessed, physical reliability significantly with different scoring 
Elderly 2003 (191) review, interviews subjects) with behaviour, global and internal CMA1 methods and time 
(PADE) and observations advanced dementia assessment and consistency Differentiated needed to complete 
ADLs between pain and 
no~ain 
Pain Assessment in Warden et al Developed from Evaluated in 2 Five items scored Moderate to good Evidence of Simple and easy to 
Advanced USA existing pain tools studies (19+25 from 0 to 2, giving internal construct validity use 
Dementia 2003 [3] including DS-DAT subjects) with a score out of 10 consistency Pain scores lower Change in scores 
(PAINAD) severe dementia High inter-r.tter during pleasant seen on treating 
reliability activity pain 
-_.-
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1.4.4 Behavioural assessment tools used in this study 
The published behavioural assessment tools were reviewed before deciding which tools 
to use in the current research. The Abbey pain scale [185] was not chosen as it includes 
physiological change as a pain indicator. The autonomic nervous system responses have 
been shown to be altered in those with Alzheimer's disease [136, 137]; hence the 
inclusion of physiological change in the Abbey scale has to be questioned. In addition, 
physiological change is more commonly associated with acute pain rather than chronic 
pain [31). The tool also equates the number of behaviours seen with pain intensity, 
despite the lack of published research demonstrating a correlation between pain intensity 
and number of behaviours [182]. The ADD [186] was not chosen as it is a protocol rather 
a pain assessment tool, creating difficulties in comparing it to other tools. An important 
part of the research was exploring the use of tools at different times of the day, hence the 
CNPI [122], which may only be valid for movement related pain, was not chosen. 
Other tools were excluded for different reasons. The Doloplus-2 tool [175] requires 
knowledge of the patients to be completed, thereby creating difficulties for the researcher 
to complete the tool. Research carried out in Norway [192] questioned the validity of 
Doloplus-2 in its present version. The PADE [191] was felt to be too complex and time 
consuming to use during every day care. The NOPPAIN [188] has been criticised for 
have limited comprehensiveness of behaviours [31], addressing only obvious pain cues. 
The PACSLAC tool [189] had not been used directly to observe patients at the time when 
the research was commenced and the MOBID tool [187] had not been published. This 
study uses two assessment tools, the Pain Assessment in Advanced Dementia scale 
(PAINAD) [3] and the Disability Distress Assessment Tool (DisDAT) [4], the reasons for 
using these tools is discussed below. 
1.4.4.1 PAINAD 
PAINAD was developed by Warden et al in 2003 and is based on categories and 
behaviours from the Discomfort Scale for patients with Dementia of the Alzheimer Type 
(OS-OAT) [52] and the Face, Legs, Activity, Cry, Consolability scale (FLACC) [193] as 
well as on a literature review and consultation by experts in the field. OS-OAT was 
developed by Hurley et al and was first published in 1992. Several studies have 
demonstrated that it has good internal consistency, construct validity and test-retest 
reliability [194]. It is a well established tool [31], is often used in dementia research [48] 
and is the standard by which nearly all additional observational assessment tools in 
dementia have been evaluated [163]. 
However, it has some shortcomings. It has been found to be complex and difficult to use 
[194]. The tool requires extensive training to achieve acceptable inter-rater reliability, 
thus limiting its use as a clinical assessment tool in routine care. It only includes the most 
common behaviours thus potentially excluding more subtle indicators [31]. Despite these 
drawbacks it attained the highest score on a review of 10 behavioural assessment tools 
because of its reliability, validity, conceptual clarity and the subjects in which it has been 
evaluated [31]. It would, therefore, seem sensible to use assessment tools that are based 
on OS-OAT but are more easily administered, hence PAINAD was chosen. 
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PAINAD consists of five items including breathing, negative vocalisation and facial 
expression (see Appendix p322). Each item is rated on a three point scale with specific 
descriptions provided for each level of pain. There was a pilot testing phase where the 
terms were modified. The tool was then compared with OS-OAT and a Visual Analogue 
Scale for pain and discomfort by observing each subject for a five minute interval at rest, 
during intervention and during an activity which was pleasurable. In addition the 
PAINAD was used by clinical staff along with clinical judgement to assess participants 
who routinely received pain medication on an "as required" basis. The PAINAD was 
repeated 30 minutes after the pain medication had been given. Pain scores on the 
PAINAD were found to be lower during pleasant compared to adverse activities and the 
scores differed before and after pain modification [3]. The PAINAD has been found to be 
user friendly and requires minimal training time [195]. In the same study the tool 
correlated well with OS-OAT and the visual analogue scales. The internal consistency of 
the scale was found to be only moderate, however high levels of inter-rater reliability 
were attained. Furthermore, the sample size used to develop PAINAD was small and the 
pain scores tended to be clustered around zero [183], possibly because it only measured 
negative behaviours [3]. 
1.4.4.1.1 Published studies utilising PAINAD 
Several studies have been published regarding the psychometric properties and utility of 
the PAINAD tool. In a report by Gibson el al [196], 80 nursing home residents (42 in 
high level care with a mean MMSE of 13.9) were assessed using the Brief Pain Inventory 
[197], PAIN AD and Abbey [185] pain scales. They demonstrated only fair inter-rater 
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reliability, however internal consistency was found to be very good. Concurrent validity 
was assessed by comparing the Abbey and PAINAD scales with each other, however 
many of behaviours on each scale are the same; hence it was not particularly surprising 
that there was a strong concordance. There was a low agreement between BPI scores 
(completed by the participant) and the PAINAD scores, suggesting either that not all pain 
produces recognisable behaviour, or that the behaviours seen could not be found on the 
PAINAD scale. 
Leong et al evaluated PAINAD in 88 nursing home residents with moderate and severe 
dementia [198]. Those who were included in the study needed to be able to answer 
queries about the presence and severity of pain as PAINAD was compared to a self 
reported pain score (SRPS), as well as a nurse reported pain score (NRPS). The PAINAD 
was completed by nurses recalling behaviours that the patient had exhibited in the last 
week. The NRPS was completed if the nurses felt that the patient had experienced pain in 
the previous week and the SPRS was completed if the patient, on asking, had described 
experiencing pain in the past week. The pain was graded using a four point verbal 
descriptor scale. A major correlation was demonstrated between the PAINAD and NRPS 
but this may be compounded by the fact that the same nurses completed both scales. Both 
the PAINAD and NRPS correlated poorly with the SRPS. The authors felt that this could 
be caused by SRPS measuring another aspect of pain, by it being an inaccurate measure 
or by it being confounded by another factor such as depression. It is not clear what other 
aspect of pain the authors feIt self reporting measured. In addition, the work by Parmalee 
[199] has suggested that even those with marked dementia were able accurately to report 
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pain. This study also used the tool in a different way from how it was designed by only 
recording a score based on the nursing staff's ability to recall behaviour at weekly 
intervals, rather than by five minute direct observation. Furthermore, those who were 
recruited for the study were able to describe both presence and severity of pain, whereas 
PAINAD was designed for use with non-communicative patients. Although this study 
evaluates PAINAD in a larger population and demonstrates that PAINAD has an ordinal 
structure, there are concerns raised about the methods used and conclusions reached 
regarding PAINAD. 
Hutchison et al [200] used PAINAD to identify pain in post operative patients. The study 
consisted of a control group of 53 participants and a PAINAD group of 27 participants, 
only 76% of the PAINAD group had a diagnosis of dementia. In addition, despite the 
entire control group having dementia; the control group all had an MMSE above 25. In 
the PAINAD group only a quarter had a MMSE score of less than 25. They demonstrated 
a higher opioid use in the group who had their pain monitored using PAINAD compared 
with the control group. The two groups were not matched in terms of dementia diagnosis 
or cognitive ability and hence any conclusions produced by the research are questionable. 
In addition, the practice of using a behavioural assessment tool in a group of patients 
most of whom, in view of their MMSE scores, were likely to be able to accurately self 
report their pain is dubious from the perspective of interest in people with severe 
dementia. 
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In a larger study carried out by Zwakhalen et al [183], the PAINAD scale was completed 
for elderly people with dementia, during a potentially painful situation (having an 
influenza vaccination) and at rest. They concluded that PAINAD had good psychometric 
qualities in terms of homogeneity, reliability and validity. This was measured either by 
nursing staff completing a Visual Analogue Scale or by a Verbal Rating Scale being 
completed by participants who were able to complete one. The authors acknowledge that 
alternative causes for the indicators that are included in PAINAD scale, such as anxiety 
or resistiveness to care, have to be excluded. This problem was highlighted by the work 
carried out by van Iersel et al [201] who introduced the PAINAD scale (as well as the 
Abbey scale) to nursing homes in Belgium. Many care providers felt that they were 
measuring pain with PAINAD. However, they were unsure ifit was always physical pain 
rather than fear, anger or another cause. The authors questioned the use of consolability 
as an item on the scale as they felt that being able to console was the result of a treatment 
rather than an indication for it. 
The scale has also been recently translated for use in Italian and German [118, 202]. The 
German version of the scale was used in 99 individuals with a mean MMSE of 12.1 at 
times of intervention by two different nurses [118]. Prior to the intervention a different 
rater had made a note of whether the individual was felt to have pain and rated the pain 
on a verbal rating scale. Following data collection, psychometric analysis demonstrated 
good internal consistency (Cronbach's a = 0.85) and inter-rater reliability of 0.8. The 
PAINAD scores were higher in residents who were felt to suffer from pain compared 
with those felt not to have pain, however the scores in those without pain were not zero. 
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In addition, the level of pain as rated prior to the observation did not correlate with the 
PAINAD scores. 
A further concern raised by some authors is that the PAINAD tool has a limited range of 
indicators for pain. It is therefore possible that the PAINAD is unable to pick up subtle 
changes in behaviour which may indicate pain [170]. However, some reviewers of the 
scale felt it showed promise [163] and suggested that it needed further evaluation in a 
larger sample [31,184]. 
In conclusion, PAINAD is itself based on a well-validated scale and is quick and easy to 
use. There is some research evidence for its psychometric properties with high levels of 
inter-rater reliability and moderate internal consistency. It has also been demonstrated 
that PAINAD scores change following analgesic administration. It was therefore chosen 
for further investigation in this study. 
1.4.4.2 J)isJ»)llr 
Some of the problems surrounding the use of behavioural tools (such as a lack of 
behaviours that only indicate pain and the possibility of missing unique behavioural 
responses) are addressed by the Disability Distress Assessment Tool (DisDAT) [4]. 
DisDA T was developed for use in people with intellectual disabilities and identifies 
distress. Once distress is identified then the cause is sought which can include pain as 
well as fear, anxiety and so on. The tool was not specifically developed for use in older 
people with severe dementia; however it has been used successfully with people with 
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Downs-related dementia. The tool is designed to be individualised to the patient, as the 
carers and family create a list of behaviours of distress and contentment specific to the 
patient from a checklist covering facial signs, skin appearance, speech, habits, and 
posture as well as body observations. It is also possible to record behaviours that are not 
listed that the person might display. The list of distress behaviours is then used as the 
assessment tool. In this way the subtle cues unique to the person can be identified by the 
assessment tool. 
The tool has been investigated in practice with 56 carers completing the tool in 25 
patients with profound communication difficulties. It was found that each carer 
recognised different numbers and types of distress cues, with a core of cues recognised by 
all raters. The carers expressed the view that each person had unique ways of showing 
that they were distressed but many cues were shared. Some cues were specific to a certain 
situation but many were non-specific and carers described a process of looking through 
various causes to interpret the cause of the distress. The majority of carers found the tool 
simple to use and useful in practice. Further work was carried out with the carers for ten 
patients exploring the meaning of distress for each of the carers. Some carers described it 
as solely a physical construct however the majority described a spectrum of distress 
including physical and emotional causes. The study by Weiner el 01 [173] demonstrated 
that "pain" means different things to different people when describing pain related 
behaviours. The behaviours of distress and pain as described in the literature were then 
compared in the paper by Regnard et 01 [4]. There is little difference between the two 
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groups of behaviours, demonstrating the difficulty in differentiating between pain and 
distress by solely observing behaviour. 
The patients in the study demonstrated high numbers of identifiable distress cues [4]. 
This was felt to be caused by the way in which important signs of distress were often the 
absence of signs of contentment. Different cues were picked up by different carers, 
probably as a result of the diverse relationships each had with the patient. Hence, 
involving several carers to generate the DisDA T documentation produces a more 
complete picture of the person's behaviours of distress. The tool is not designed to be a 
scoring tool. A change in behaviour, however, can be monitored using monitoring sheets 
based on the PACA scoring system [203]. A specific score is not linked to a level of 
distress as different patients will generate differing numbers of distress cues. The scoring 
system is designed to monitor change once distress has been identified and a treatment 
put in place. Regnard et 01 also emphasise that the context in which the distress occurs is 
critical in identifying its cause. 
Although DisDA T was not designed to be used in elderly patients with severe dementia, 
its flexibility in generating behaviours unique to the individual means that it could be 
used in this group. There is a lack of psychometric data regarding DisDA T; this is being 
addressed by on-going validity studies. The tool is also currently being evaluated in 
general hospital care. The tool allows for subtle unique behaviours to be identified so that 
more unusual presentations of distress are not overlooked. This allows a more 
individualised approach to pain management to be aqopted as recommended by numerous 
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authors [169,204,205]. The importance of knowing the person well and therefore being 
able accurately to interpret behaviours has been recommended by several authors 
including Closs et aJ [205]. The DisDA T tool allows the great experience of the carers of 
the patient to be distilled into a document allowing their knowledge to be used by those 
new to the patient. In these ways the DisDA T tool provides a potential remedy to the 
concerns raised regarding current published pain and discomfort tools and hence is the 
second assessment tool used in the study. 
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1.5 The management of pain in dementia 
Once pain has been identified a variety of pharmacological and non-pharmacological 
methods can be used to treat it. Pharmacotherapy is commonly used to control pain and 
all treatments carry a balance of benefits and risks. As no two patients will respond to the 
same degree or experience side effects to the same drug, any intervention has to be 
individually tailored to the patient's needs [123]. As discussed previously, the elderly are 
particularly susceptible to drug side effects, and adverse drug reactions occur more 
frequently than in younger patients. The alterations in pharmacokinetics and 
pharmacodymamics seen in the elderly lead to varying oral bioavailability, differing drug 
distribution, changes in metabolic clearance and differing end organ responses to drugs 
[206]. These issues can lead to an increased frequency of constipation, confusion and 
orthostatic hypotension owing to drug treatments [112]. 
The majority of trials of pharmacological agents have been carried out in young or 
middle aged adults, not in older people [28]. These factors need to be carefully borne in 
mind when prescribing any drug, not just analgesics, for this group. Hence a sensible 
approach is to start with the lowest anticipated effective dose, monitor frequently on the 
basis of expected absorption and known pharmacokinetics of the agent and then titrate the 
dose on the basis of likely steady state blood levels and clinically demonstrated effects 
[123]. Using drugs with a short half life may be useful initially as the elderly are 
particularly susceptible to drug accumulation [207]. Using a combination of 
pharmacological and non-pharmacological techniques often results in more effective pain 
control and less reliance on medications that have major side effects in elderly patients 
91 
[28].There have been no specific studies on the metabolism of analgesics in older people 
with dementia, so the current knowledge is based on the principles of using analgesics in 
all elderly people [124]. 
Evaluating the underlying nature of the pain is important as this will govern its treatment. 
The mechanisms underlying pain are often divided into the categories of nociceptive and 
neuropathic pain [114]. Nociceptive pain results from direct stimulation of pain receptors 
and arises from inflammation, tissue injury or mechanical deformity. This type of pain 
often responds well to the analgesics that form the WHO analgesic ladder. Neuropathic 
pain results from injury to nerve fibres from compression, infiltration or degeneration of 
neurons. Although neuropathic pain may respond to the analgesics of the WHO ladder, it 
also responds to adjuvant agents such as antidepressants or anticonvulsants. Some pains 
may have both nociceptive and neuropathic elements. 
The principles governing analgesic use have been encapsulated in a series of slogans by 
the WHO [17, 208]. Drugs should be given by mouth where possible, by the clock and by 
the ladder, using a three-step analgesic ladder. Prescribing drugs on an "as required" basis 
partly requires the individuals to request medication. Many people with cognitive 
impairment are often unable to initiate a request for analgesia even if they can report pain 
when asked directly. This may therefore lead to under-treatment of pain in those with 
cognitive impairment [209]. The first step of the analgesic ladder is the prescription of 
non opioid drugs such as paracetamol and NSAIDs, followed by adding weak opioids as 
step 2 and then step 3 is the prescription of strong opioids with non opioids. Adjuvant 
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analgesics (neuropathic agents, psychotropic medication) can be added at any step. Drug 
treatments move up the ladder if an optimal dose of the drug fails to give adequate relief. 
This framework can be applied to the pharmacological treatment of pain in the elderly. 
1.5.1 Pharmacological management of pain 
1.5.1.1 Paracetamol 
Paracetamol is often the first choice for musculoskeletal pain in elderly patients [28, 123, 
210]. The maximum recommended dose for patients with normal renal and hepatic 
function or history of alcohol abuse is 4g a day. In those with renal or hepatic function, 
dose reduction by 50-75% is recommended [123]. Care needs to be taken to avoid the 
concomitant prescription of paracetamol and combination drugs containing paracetamol 
as this can potentially lead to liver toxicity [210]. Paracetamol is available in liquid and 
soluble form which can be easier for those with swallowing difficulties to take. However, 
the lack of a slow release preparation means administering the drug four times a day 
which may be difficult for some patients. The small incidence of drug interactions and 
lack of gastrointestinal side effects [125] lead to paracetamol being frequently prescribed 
for elderly patients with pain. 
1.5.1.2 Non Steroidal Anti-inflammatory Drugs (NSAIDs) 
NSAIDs can also be used for musculoskeletal pain; however the side effect profile of this 
group of drugs means that they are less safe to use. All NSAIDs can cause peptic ulcer 
disease, renal failure and fluid retention [211] and these effects are more pronounced in 
93 
elderly patients owing to the changes in pharmacokinetics and dynamics as outlined 
above. NSAIDs vary in their selectivity for inhibiting different types of cyclo-oxygenase: 
selective inhibition of cyclo-oxygenase-2 improves gastrointestinal tolerance. Cyclo-
oxygenase-2 selective inhibitors (such as celecoxib and rofecoxib) were hoped to have a 
better safety profile [210], however emerging concerns regarding cardiovascular safety 
suggests these drugs should be avoided in those with ischaemic heart disease or 
cerebrovascular disease [211]. Ibuprofen has fewer side effects than other non selective 
NSAIDs; however its anti-inflammatory properties are weaker. Hence paracetamol may 
be the preferred choice of non opioid analgesic, with NSAIDs used with caution and co-
prescribed with a proton pump inhibitor or misoprostol because of the high incidence of 
gastrointestinal toxicity [212]. The American Geriatric Society suggests that NSAIDs 
should be avoided in those needing long term daily analgesic therapy. 
1.5.1.3 Weak opioids 
The main weak opioids prescribed in the UK are codeine, dihydrocodeine and tramadol. 
The division between weak and strong opioids is arbitrary, as by injection most weak 
opioids can provide analgesia approximately equivalent to morphine 10 mg [208]. 
Codeine is partly a prodrug of morphine, hence many of the issues surrounding its 
prescription are similar to other opiates. It is worth noting that 10% of the population 
cannot convert codeine to morphine and hence may not derive analgesic benefit from it. 
Dihydrocodeine can be used alone or with paracetamol; it has an active metabolite 
dihydromorphine. Tramadol forms a bridge between classic weak and the classic strong 
opioids. It has a dual mechanism of action binding to opioid receptors and inhibiting 
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noradrenaline and 5HT reuptake. Its efficacy and safety are reported to be similar to 
equianalgesic doses of codeine including the potential for drowsiness and nausea [123]. 
There is some evidence that it can lower seizure threshold, so should be used with caution 
in those with epilepsy and in those taking other medication that can lower seizure 
threshold [123, 208]. 
1.5.1.40pioids 
Strong opioids form the third step of the WHO pain ladder. There are often 
misconceptions surrounding the use of this group of drugs with beliefs that they are a last 
resort treatment and that patients will become addicted to them. True addiction in older 
patients with persistent pain syndromes is rare in comparison with the known prevalence 
of untreated debilitating pain. Longitudinal studies suggest that tolerance is slow to 
develop in the face of stable disease [123]. There is no ceiling to their analgesic effect but 
dose is often limited by side effects [213]. Caution must be taken when prescribing 
opiates on account of age related changes in renal function leading to accumulation of 
glucuronide metabolites [124]. In addition, J.1-0pioid receptor densities decrease with age; 
this is accompanied by an increase in receptor affinity [113]. Advanced age is also 
associated with a prolonged serum half life for most opiate drugs. Hence, for a variety of 
reasons, pain relief may be achieved with smaller doses than might be expected [28]. 
Serious side effects such as impaired consciousness or respiratory depression are rare, 
especially when doses are started low and escalated slowly, allowing for steady state 
blood levels to be reached at each dose prescribed [123]. This approach allows for the 
variability in drug effects that can be seen in older people treated with opioids because of 
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the factors described above. The potential to develop opiate related side effects such as 
constipation and nausea are increased, hence prescribing appropriate laxatives and anti-
emetics, where needed, is important. 
Morphine remains the first line choice of opiate in the UK; however oxycodone, fentanyl 
and hydromorphone are also prescribed [214]. Many opiates can be given as slow release 
preparations and it is vital that these drugs are not crushed to allow ease of swallowing 
[210]. Fentanyl patches are sometimes used for patients with swallowing difficulties, 
however their use can be problematic in older people owing to the lipophillic nature of 
the drug and changes seen in fat stores compared to younger patients [215]. The drug 
forms a reservoir on account of the transdermal delivery and hence has a long serum half 
life [28]. The drug is therefore not recommended for use in opiate naYve patients and 
should be used with caution if switching from a different opiate to fentanyl patches. 
Opiates can also be given subcutaneously via a syringe driver which can be beneficial if 
pain control is needed in patients unable to take oral preparations. Although some opioids 
are available as suppositories, this is likely to be unacceptable for long term use. 
I.S.1.S Adjuvant analgesia 
Adjuvant analgesics can also be used at any stage of the WHO pain ladder. Neuropathic 
pain is often poorly controlled by opioids alone and the addition of antiepileptic and 
antidepressant drugs is often beneficial. Low dose amitriptyline can be used but 
anticholinergic side effects, orthostatic hypotension and the risk of arrhythmias may limit 
its use [144]. Carbamazepine and gabapentin can be used but starting at lower doses and 
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slowly increasing [210]. Capsaicin cream is a topical agent derived from cayenne pepper 
which acts by depleting nerve terminals of substance P, responsible for pain transmission 
[125]. It can be used for neuropathic pain; however the burning sensation that can occur 
with initial treatments may be intolerable to some patients [28]. Corticosteroids can also 
be used for cancer related nerve injury pain as a short term trial [208]. Antispasmodics 
can also be used for smooth muscle spasm but have anticholinergic side effects and can 
cause confusion in older people [211]. Benzodiazepines can be used to reduce anxiety 
associated with pain as well as relieving painful muscle spasm. The principles for 
prescribing any of these drugs are the same as for analgesics; start at low dose, carefully 
monitor for side effects, and increase the doses slowly allowing for steady state blood 
levels to be attained [123]. 
1.5.2 Non-pharmacological management of pain 
Non-pharmacological pain management strategies are often very effective when used in 
combination with drug strategies [28]. Physical methods, such as heat (stimulating 
production of endogenous opioids) and cold (suppressing the release of products from 
tissue damage), can be effective [210]. Massage has been shown not only to reduce pain 
scores [216], but also to reduce anxiety, agitation and other dysfunctional behaviour [217, 
2 t 8]. Transcutaneous Electrical Nerve stimulation (TENS) and acupuncture are thought 
to cause endogenous opioid release, however it is debatable how well these approaches 
may be tolerated by those with severe dementia. Nerve blocks and tumour site radiation 
can be used for specific indications [210]. Other non-pharmacological approaches such as 
Cognitive Behavioural Therapy (CBT) have been recommended for use with older people 
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[123, 219], but are inappropriate for use with those with very severe cognitive 
impairments. 
1.5.3 Prevention of pain 
It would seem sensible that as well as treating pain as it is recognised, that efforts should 
be made to prevent painful conditions occurring. Gentle exercise may help reduce 
immobility and inactivity that can worsen pain [28, 123, 210], as well as improving 
psychological wellbeing [144]. The frequency of fractures in the elderly can be reduced 
by preventing falls occurring in the first place and by using hip protectors and treating 
osteoporosis [206]. In addition, preventing painful pressure ulcers from developing by the 
use of pressure relieving aids, frequent turning and maintaining adequate nutrition is also 
important [206]. 
1.5.4 Alternative approaches to managing pain 
Although identifying pain using assessment tools would seem a logical approach to 
managing pain in those with severe dementia, several studies have used different 
methods. One such approach is to give all patients an analgesic to see if this improves 
difficult behaviour. 
Chibnall et al [220] hypothesised that routine administration of an analgesic would 
increase social and physical activity, decrease agitation, increase emotional well-being 
and decrease the number of doses of as needed psychotropic medications in nursing home 
residents with moderate to severe dementia. A randomised, double blind placebo 
98 
controlled crossover trial was carried out in 25 residents who had a Functional 
Assessment Staging stage of five or six. Participants were given paracetamol 500mg three 
times a day for four weeks and a placebo three times a for four weeks with a one week 
wash out period. There were multiple exclusion criteria including liver or renal 
compromise, anaemia, bedridden/comatose state, current routine prescription for 
paracetamol or an opioid and unstable medical disease that could interfere with 
participation. It was found that although there were some changes in observed behaviour 
(increased social interaction and activity levels) there was no decrease in agitation, no 
improvement in emotional well-being and no reduction in the number of PRN 
psychotropic medications. The results from this study are not only inconclusive (the 
authors felt that this may be due to their sample having low pre-intervention CMAI 
scores and low as required psychotropic medication use), but because of the multiple 
exclusion criteria it is also difficult to apply these results to a general nursing home 
population. 
Similar work was carried out by Buffum el al [221] who gave 650mg paracetamol four 
times a day with PRN placebo for two weeks followed by placebo four times a day with 
PRN paracetamol to 39 nursing home residents with severe dementia. Levels of 
discomfort were monitored using the OS-OAT. No significant difference was noted in 
discomfort scores during either part of the trial, with few PRN doses being administered 
during the four weeks. It is possible that the behaviours documented using the OS-OAT 
were not due to pain, or that the paracetamol was inadequate to treat the pain. 
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A smaller study was carried out by Douzijan et al [222] who gave 650mg of paracetamol 
three times daily to ten residents with difficult behaviour who were also on psychotropic 
medication. Out of the eight subjects who commenced regular analgesia, five showed a 
decrease in behavioural symptoms. There was also a reduction in psychotropic and 
antidepressant drug prescribing. The number of participants in the study was too small to 
draw any major conclusions and it is not known what constituted a significant decrease in 
the assessment tool. Another problem with these studies is that paracetamol (particularly 
given at what seems to be sub therapeutic doses) may not have been adequate to control 
the participants' pain and hence reduce agitation. 
A different analgesic was used in the study by Manfredi et al [223]. This group carried 
out a double blind placebo controlled cross over trial using placebo for four weeks and a 
long acting opioid (oxycodone 10mg twice daily) for four weeks with laxatives also given 
in the opioid phase. This was given to 47 nursing home patients with a MMSE of < 21 
with persistent agitation (measured as a CMAI score of > 40) who were unable to 
complain of pain or did not suffer from a painful condition. Again there were multiple 
exclusion criteria including liver and renal compromise, constipation, hypoxia, 
hypotension and those already on opioids. Oxygen saturation, respiratory rate and 
sedation (using the Ramsey Sedation scale) were monitored and the CMAI score was 
recorded every two weeks. 
Only 25 participants completed the study (discontinuation reasons included unsteady gait, 
increased agitation and faecal impaction) and there were no significant differences in 
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agitation scores between the placebo and opioid phases. The authors claimed that the 
levels of various adverse events (constipation, falls and nausea) were not statistically 
different in the two treatment phases; however it is possible that these events were 
reasons for withdrawing from the study. In addition it is not clear how nausea was 
monitored as the participants were unable to communicate that they had pain. Agitation 
levels were significantly lower after the opioid phase in 13 of the subjects who were over 
85, after adjusting for sedation level. The actual opioid used varied in the study as 12 of 
the subjects could not swallow tablets. These participants were given 20mg of long acting 
liquid morphine instead, however this is not equivalent to the oxycodone dose (which 
should be 30-40mg morphine). The authors concluded that treatment with low dose, long 
acting opioids is safe in agitated elderly demented patients. This study is clearly flawed 
on many levels with multiple exclusion criteria, a high drop out rate, different and not 
equivalent opioids used and no difference in agitation levels seen in those that completed 
the study, other than when the study group was divided arbitrarily by age. 
None of these studies provides good evidence for the blanket prescribing of analgesics for 
elderly demented patients in an attempt to reduce agitation. Although agitation may well 
be caused by undetected pain, prescribing analgesics to all without any other form of 
assessment can lead to sub therapeutic-treatment of pain in those with pain and 
unnecessary additional medication for those without. 
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1.6 Conclusions 
The review of the current literature has demonstrated that the principles of palliative care 
apply to those with severe dementia. This includes addressing several important issues 
including physical symptoms, end of life care and providing psychological, social and 
spiritual care. The difficulties in assessing pain in dementia have been highlighted, with 
the evidence regarding under-recognition of pain in this group discussed. The use of 
behavioural assessment tools to identify pain has been debated, yet it remains unclear 
how useful such tools are in assessing pain. Concerns have been raised that pain 
assessment tools may not solely identify pain. Understanding how frequently this may 
occur and what the cause of the behaviour observed might be will further the 
understanding surrounding the use of pain assessment tools. Although the principles of 
managing pain in patients with severe dementia have been identified, putting these 
principles into practice is important. 
Hence the aim of the research is: 
To demonstrate the importance of assessing and managing pain as part of good quality 
palliative care in people with severe dementia. 
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And the objectives of the research are: 
1. To investigate the utility of a pain assessment tool and a distress assessment 
tool in a UK population with severe dementia; to test the hypotheses that a) 
pain is common and under-recognised in this population and b) that such tools 
can reliably be used to identify pain; 
2. To demonstrate the ability of the tools to measure change in pain following a 
change to the management regime; to test the hypothesis that the tools are 
sensitive to change; 
3. To assess the nature of distress that may produce a false positive result on a 
pain scale; to test the hypothesis that pain tools will identify behaviour owing 
to a variety of causes; 
4. To examine the use of analgesia within the nursing homes and in those 
identified as experiencing pain; to test the hypotheses that a) analgesics may 
be prescribed inadequately for those with dementia and b) pain can be 
managed using both simple pharmacological and non-pharmacological 
techniques. 
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Chapter 2 - METHODS 
2.1 Protocols and Procedures 
The research has been carried out in one continuing care NHS unit for people with severe 
dementia (i.e. elderly severely mentally impaired (ESMI) unit) and three privately run 
elderly mentally infirm (EMI) nursing homes in the North Tyneside area. Ethical 
committee approval was sought and obtained from the local research ethics committee of 
Newcastle and North Tyneside. Research governance approval was also sought and 
obtained from the Research and Development department of Northumbria NHS Trust. 
Caldicott approval was gained to review medical and psychiatric notes held within the 
trust. 
2.1.1 Inclusion and exclusion criteria 
All people entering the study had an established clinical diagnosis of dementia and had 
advanced disease (i.e. Clinical Dementia Rating score of three [134, 135]). They were 
unable to communicate verbally in a reliable or consistent manner and were residents in 
long-term care facilities. There were no specific exclusion criteria. 
2.1.2 Research stages 
2.1.2.1 Stage 1 
Contact was made with nursing homes, identified by members of the North Tyneside Old 
Age Psychiatry team, known to have large numbers of residents with severe dementia. 
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The project was discussed initially with the home management team and information 
regarding the research project was provided. Once the home manager was agreeable, the 
project was explained to as many staff as possible. If the home had a relatives group then 
the project was presented to this group as well. Two of the homes were run by Southern 
Cross Healthcare, an independent provider of nursing care services, information was sent 
to the ethics committee of this company. 
Potential participants were identified with the help of the home staff by completing a 
Clinical Dementia Rating scale on all residents within the home. All residents with a 
CDR of three were randomly assigned a number with a prefix to identify the home in 
which they lived (TC Tynemouth Court, WC Willow Court, CP Cleveland Park, AP 
Appleby nursing home). This number was used to identify the participant with any data 
held pertaining to them. Information regarding the participants' identity and the assigned 
codes was kept separate from study data. The next of kin of all suitable residents were 
then sent a letter regarding the study with an information sheet. Telephone contact was 
made with the next of kin to arrange a meeting for further discussion of the research and 
to sign an assent form. If there was no next of kin, the solicitor acting as next of kin was 
also contacted to see if assent could be given. The General Practitioners of all those 
participating were also contacted to inform them that the person was included in the 
project. It was made clear on the information sheet and in the assent procedure that the 
next of kin were free to withdraw their assent at any time and for whatever reason. 
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The patient's nursing, medical and psychiatric notes were reviewed prior to the study 
commencing. If there were no medical or psychiatric notes held by North Tyneside 
General Hospital then the participants' GP notes were reviewed. The notes were reviewed 
in order to:-
(a) Confirm the inclusion criteria were satisfied (that the diagnosis of dementia subtype 
fulfilled the DSM IV classification [224] or for DLB, fulfilled the consensus guidelines 
for the diagnosis of dementia with Lewy bodies [225]); 
(b) Note basic demographic details such as age, date of admission to current home and 
ethnicity; 
(c) Record past medical history particularly co-morbidities that could potentially be 
painful; 
(d) Record dementia type and date of diagnosis; 
(e) Record all prescribed medication at the commencement of the study. 
The information from the notes review was documented on a data recording sheet with 
only the assigned number for identification. The data sheet information was transferred to 
a password secured trust computer and the data sheets were stored in a locked filing 
cabinet. 
Several neuropsychological scales were also completed for each participant by the 
nursing staff. These were the Cornell Scale for Depression in Dementia (CSDD) [226], 
Clifton Assessment Procedure for the Elderly - Behaviour Rating Scale (CAPE-BRS) 
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[227], Neuropsychiatric Inventory (NPI) [228] and the Cohen-Mansfield Agitation 
Inventory (CMAI) [148]. The scores for each assessment were entered onto a separate 
score sheet, entered into the database and stored with the data recording sheets. 
In addition, the Disability Distress Assessment Tool (DisDAT) [4] was completed for the 
particular participant in conjunction with both nursing staff and relatives where possible. 
The number of distress behaviours for each participant was noted, as well as the 
frequency of the documented behaviours. Appropriate training was given to the nursing 
staff regarding completion of the PAINAD and DisDA T tools. 
2.1.2.2 Stage 2 
All the participants in the study were observed on three occasions for approximately 5 
minutes by the researcher and a nurse from the home:-
(a) At a time of rest 
(b) At a meal time 
(c) At a time of intervention. 
These three times for observation were chosen as they would occur each day for each 
participant. In addition it was felt that the different observations might provide different 
information about any pain that might be experienced; for example, behaviours caused by 
musculoskeletal pain would be more likely to be observed during intervention than at 
rest. The observation at rest was usually carried out during the afternoon whilst the 
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residents were sitting in the lounge, the meal time used was usually lunchtime and the 
intervention observation was usually carried out when the participant was got out of bed 
in the mornings. Occasionally it was difficult to carry of the observation at these times so 
different observation timings were used, having discussed matters with the nursing staff 
to determine the most suitable time. If this occurred, the same observation timings for 
that participant were used at the repeat observations. At each of these three times, the 
researcher completed one of the tools (Le. PAINAD or DisDA T) and the nurse from the 
home independently completed the other tool. The researcher completed the PAINAD for 
those with even assigned code numbers and the DisDA T for those with odd numbers. The 
nurse completed the PAINAD for those with odd assigned code numbers and the DisDA T 
for those with even numbers. This was to ensure that the person completing the specific 
tool was allocated randomly as the code numbers had been assigned at random. The 
researcher and the nurse did not confer during the completion of the scales. Once the 
tools were completed, the cause of the behaviour seen was discussed to determine 
whether it was felt to be caused by pain or whether it had some other cause. The 
researcher also made notes to assist in deciding whether the behaviours observed were 
caused by pain or were due to another cause. The participant was examined if this was 
appropriate. If it remained difficult to ascertain the cause of the behaviours seen, the 
observation was repeated and other staff members or medical professionals consulted. 
In summary, the decision about whether or not a participant's behaviour indicated the 
presence of pain was determined by:-
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a) A review of medical, psychiatric and nursing notes; 
b) Information gleaned from discussion with relatives during the assent procedure; 
c) Observations by a doctor specialising in palliative medicine and a nurse familiar 
with the patient on three occasions using two different observational tools; 
d) A discussion after the observations between the doctor and the nurse; 
e) A physical examination if necessary and appropriate; 
f) Repeated observations if necessary; 
g) Further discussion with other nursing and medical professionals if necessary. 
All participants who were assessed as being in pain continued into stage 3 of the protocol 
(P group). Those who were not assessed as being in pain but had scored significantly on 
the PAINAD scale (a score greater than 2) also continued into stage 3 (FP group). Those 
who were not felt to be in pain and had not scored significantly on the PAINAD scale (a 
score equal to or less than 2) left the research at this point (NP group). The reasons for 
using two as a cut off score are discussed in section 2.2.4 of this chapter. 
A second researcher also carried out the observations using the same assessment scale as 
the researcher within a week of the original observations to provide evidence of inter-
rater reliability. Two researchers carried out these observations, Dr Sarah Hepburn and 
Dr Mani Bhasin, both experienced Specialist Registrars in Psychiatry of Old Age. 
Appropriate training was given to both second researchers regarding the completion of 
the PAINAD and DisDA T tools. 
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2.1.2.3 Stage 3 
A decision was made for those participants in the P group with regards to management of 
the pain. This was made by the researcher in conjunction with the nursing home staff as 
well as the GP where necessary. If the decision required input outside the experience of 
the researcher, an appropriate opinion was sought. If the decision required a change in 
medication this was made in agreement with the GP and the GP kept informed by letter 
of the results of further observations. A discussion took place with the nursing staff as to 
the likely cause of distress of those in the FP group. Any potential alleviating measures 
for the observed distress were also discussed. 
2.1.2.4 Stage 4 
Clinical re-assessment by the researcher occurred weekly to monitor the effects of any 
treatment suggested. At approximately one month, the participants in the P group and the 
FP group were re-assessed using both the DisDAT and PAINAD, again in three different 
circumstances, and again by a nurse from the home and the researcher scoring the same 
instruments as before. At this stage the CSDD, CAPE, NPI and CMAI scales were 
repeated. 
2.1.2.5 Stage 5 
At three months from the original assessment there was further re-assessment of both the 
P and FP groups using DisDAT and PAINAD. This was again in three different 
circumstances and again by a nurse from the home and the researcher scoring the same 
instruments as before. In addition a further review of notes and medication took place 
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order to account for any changes in the participant's clinical state. If at that time there 
was evidence of on-going pain, this was referred back to the participant's GP. 
2.2 Scales used in the research 
2.2.1 DSM IV Classification 
The DSM IV Classification [224] is a categorical classification that divides mental 
disorders into types based on criteria sets with defining features. It was used to verifY that 
the criteria had been met for the diagnosis of dementia and for the type of dementia 
diagnosed. For DLB, the only common type of dementia which is absent from DSM, the 
consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy 
bodies was used [225]. 
2.2.2 The Clinical Dementia Rating Scale (CDR) 
The CDR [l34, l35] gives a global measure of dementia assessing six domains: memory, 
orientation, judgement and problem solving, community affairs, home and hobbies and 
personal care. The total CDR rating is made from the sum of boxes which represents an 
aggregate score of each individual's areas. CDR ratings are zero for healthy people, 0.5 
for questionable dementia and 1, 2, and 3 for mild, moderate and severe dementia 
(Appendix p315) 
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2.2.3 Background neuropsychiatric scales 
2.2.3.1 The Cornell Scale for Depression in Dementia (CSDD) 
The CSDD [226] (Appendix p321) is specifically designed to assess signs and symptoms 
of major depression in patients with dementia. The 19 item scale is rated on a three point 
score of absent, mild/intermittent and severe. The item scores are added; those above 10 
indicate a probable major depression, above 18 definite major depression and below 6 as 
associated with absence of significant depressive symptoms. The CSDD can be 
completed using both informant interview and patient interview. In the current research, 
informant interview was used. 
2.2.3.2 The Clifton Assessment Procedure for the Elderly - Behaviour Rating Scale 
(CAPE-DRS) 
The CAPE-BRS [227] (Appendix p318) assesses mental and physical functioning in 
elderly people by recording physical disability, apathy, communication difficulties and 
social disturbance. It consists of 18 statements, each with three possible answers scoring 
zero, one or two. The score can be equated to a dependency grade indicating the level of 
care that may be required. 
2.2.3.3 The Neuropsychiatric Inventory (NPI) 
The NPI [228] (Appendix p322) evaluates psychopathology by assessing 12 behavioural 
areas including delusions, hallucinations and anxiety from informant interview. Each 
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domain is rated in terms of frequency (from I to 4) and severity (I to 3). These numbers 
are multiplied to give the score; hence the maximum score is 144. 
2.2.3.4 The Cohen-Mansfield Agitation Inventory (CMAI) 
The CMAI [14S] (Appendix p320) looks at agitated behaviour in patients with cognitive 
impairment. It consists of 29 behaviours, with each rated by an informant using a 7 point 
scale according to frequency in the previous 2 weeks. The minimum score is 29, 
maximum score is 203. 
2.2.4 The Pain Assessment in Advanced Dementia (P AINAD) Scale 
The PAINAD [3] (Appendix p324) has been designed as a simple, valid and reliable 
instrument for the measurement of pain in non-communicative patients. It is a five item 
observational tool that is scored from 0 to 10. As discussed in chapter 1, PAINAD is 
based on categories and behaviours from the Face, Legs, Activity, Cry, Consolability 
scale (FLACC) [193], Discomfort Scale for Dementia of the Alzheimer Type (DS-DA T) 
[52] as well as on a literature review and consultation by experts in the field. Since 
publication, several research studies have used PAINAD to evaluate pain providing 
further information on its psychometric properties and utility in those with severe 
dementia [liS, IS3, 196, 19S, 200-202, 229]. The original research paper [3] does not 
give an indication of how to interpret the scores, but as the scale is designed to score from 
o to 10 to be comparable to severity scores, it was presumed that a higher score was 
designed to reflect more severe pain. Reviews of pain measurement [230] have suggested 
that a score of above 20mm on a 100mm scale is a useful cut ofT for relevant pain. In the 
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initial research, the mean PAINAD scores (+1- Standard Deviation) at a time of no 
stimulation were 1.3 (+/- 1.3), were 1.0 (+/- 1.3) during pleasant activity and 3.1 (+/- 1.7) 
during intervention. In addition, the study by Leong et af using PAINAD determined that 
a score of 0-1 corresponded to no pain, 2-3 to mild pain and a score of 4 and above would 
correspond to moderate and above pain [198]. Based on these results it was decided that a 
PAINAD score above 2 was likely to be significant and this therefore provided the level 
for the false positive (FP) group. 
2.2.5 The Disability Distress Assessment Tool (DisDA T) 
The DisDAT [4] (Appendix p327) is designed to help identify distress cues in people 
with limited communication (owing to cognitive impairment or physical illness). It is 
completed by those caring for the person, who compile lists of behaviours that they 
recognise as signs of contentment and distress. Documenting the behaviours is feIt to 
increase carer confidence in their ability to pick up distress and facilitate the 
identification of underlying causes for the distress observed. The DisDA T is not a scoring 
tool, however change in behaviour can be monitored using monitoring sheets based on 
the PACA system [203] (Appendix p331). If the behaviour was absent during the 
observation it scored 0, if it was present it scored 1, if it moderately affected the 
observation it scored 2 and if it dominated the observation it scored 3. This system was 
used in the study to monitor change after treatment for pain was initiated. 
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2.3 Variables collected 
2.3.1 Analgesia 
All medication that the participants were prescribed was documented on commencement 
of the research by examining the current medication charts in the home. Although many 
participants were prescribed regular Aspirin, this was only included as analgesia if this 
was the reason for which it was prescribed. In fact most Aspirin prescriptions were for 
prevention of cardiovascular events. In a similar way any other drugs, such as 
antidepressants or anticonvulsants, that could be used as analgesics were not included 
unless they had been specifically prescribed for this reason. Three categories of analgesia 
were created, regular (including those prescribed regular analgesia as well as required 
analgesia), as required (for those only prescribed PRN analgesia) and none (for those not 
prescribed analgesia at all). 
2.3.2 Diagnoses 
The participants' dementia diagnoses were documented from review of medical, 
psychiatric and GP records. Most participants had had the dementia diagnosis made by a 
Consultant Psychiatrist. However, if it was difficult to find evidence of review by old age 
psychiatry services, the DSM IV [224] classification was used to check that the diagnosis 
made was appropriate. The last recorded diagnosis was used as the dementia diagnosis 
since the type of dementia may not be apparent at the time of initial presentation. If the 
type of dementia was not documented, then the medical and psychiatric notes were 
reviewed by a consultant psychiatrist to give a likely dementia type on the basis of 
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documented evidence. If this was impossible to do, but the participant clearly had 
dementia, the type of dementia was categorised as not known (NK). 
2.3.3 Length of time since diagnosis made 
This was recorded in months as the time since a formal diagnosis of dementia was made 
by a doctor or member of the old age psychiatric team (and documented in medical, 
psychiatric or OP records) to the date of consent being given. 
2.3.4 Length of stay in home 
This was recorded in months as the time since the participant was admitted to their 
current place of residence (from the notes held in the nursing home) to the date of consent 
being given. 
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2.4 Statistical methods 
All the statistical methods were undertaken using SPSS-14. Normality of data was 
assessed using the Kolmogorov-Smimov tests of normality, as well as examining 
histograms and normality curves. Results were determined to be significant if p < 0.05. 
All significant results are highlighted in red in the results section. 
Owing to small expected frequencies of some of the variables, the associations between 
categorical data were analysed using Fisher's exact test. Where the data was normally 
distributed, the associations between categorical and numerical data were analysed using 
one way analysis of variance (ANOVA). If the numerical data was non-parametric in 
nature, the associations between this data and the categorical data was analysed using the 
Kruskal-Wallis test. Further analysis of statistically significant results from using the 
Kruskal-Wallis test were analysed using the Mann-Whitney Exact test. 
The Wilcoxon signed ranks test was used to look at the paired observations of baseline 
and 1 month observations, I month and 3 month observations and the baseline and 1 
month neuropsychological scores. This test was used as the difference between the scores 
was shown to be not normally distributed. Analysis of the proportion of change in the 
scores for each group was analysed utilising the Mann-Whitney test. 
The correlations between numerical data were analysed using Spearman's Correlation 
Coefficient as the data was non-parametric in nature. The strength of the association was 
graded according to the scores shown below 
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Table 2.1 Spearman's correlation coefficient and association strength 
Correlation Coefficient (r) Strength of association 
0-0.33 Weak 
0.34 - 0.66 Moderate 
0.67 -1 Strong 
(Adapted from Swinscow [231]) 
The degree of agreement between the researcher observation scores and the 2nd observer 
scores was analysed using the kappa statistic. Weighted kappa was used to take into 
account the extent to which the observers disagreed as well as the frequencies of 
agreement. The degree of the agreement was graded as shown below. 
Table 2.2 Kappa score and degree of agreement 
Kappa score (K) Degree of agreement 
1C ~ 0.20 Poor 
0.21 ~ 1C ~ 0.40 Fair 
0.40 ~ 1C ~ 0.61 Moderate 
0.61 ~ 1C ~ 0.80 Substantial 
1C > 0.80 Good 
(Taken from Petne and Sabm [232]) 
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Figure 2.1 Flow chart of participants' experience 
Clinical dementia rating scale completed for all nursing home residents 
1 1 
CDR = 3, information CDR < 3, excluded 
sheet sent to relative from study 
1 
Next of kin contacted Assent not given or 
regarding giving unable to contact, 
assent excluded from study 
1 
Assent signed, GP 
informed. Notes reviewed 
and medication 
documented 
1 
Background neuropsychological tests 
and DisDA T behaviour sheet 
completed by nursing staff 
1 2nd researcher I Observations carried out at rest, eating and intervention observations 
~ 1 
In pain (P group) Not in pain I PAINAD score:5 2 
Cause identified and I (NP group) 
management suggested 1 
PAINAD score> 2 
(FP group) 
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Figure 2.2 Management and assessment o/the pain and/alse positive groups 
Pain group False positive 
group 
Pain management 
decision 
Weekly review of 
pain management 
Background neuropsychological scales repeated 2nd researcher 
-Observations repeated at 1 month observations 
Observations repeated at 3 months 2nd researcher 
Medications documented r-- observations 
Information and feedback given to homes 
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Chapter 3 - RESULTS 
3.1 Background 
The data in this section provides background demographic information regarding the 
study participants. 
3.1.1 Patient selection 
Four homes in the North Tyneside region were approached to participate in the study and 
all agreed. The total number of residents in each home shown in the table below was the 
number of residents at the time of starting the research at each home. The total number of 
nursing home residents screened for the study was 192. From those screened for the 
study, 131 (68%) met the inclusion criteria and were therefore approached regarding the 
study. 61 residents had a CDR of less than 3 and were therefore excluded from the study. 
Assent was gained for 79 of the remaining 131 residents, 60% of those who were 
approached. Whilst assent was being sought, 2 residents were transferred to other nursing 
homes and 9 residents died. Assent was not given for 41 potential participants; this was 
either due to the next of kin deciding against participating in the study (20 potential 
participants) or difficulties in contacting the next of kin (10 potential participants). The 
patients under the care of Dr. Hughes, a supervisor of the project, were excluded (6 
potential participants). This was because of concerns that relatives might be unduly 
influenced to give consent. A further 5 potential participants had to be excluded as they 
did not have a living next of kin. Their appointed next of kin were contacted (all 
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solicitors) but none felt able to give as ent for the re earch. Tho e ne t of kin who did not 
give as ent were not asked spec i li ca lly for the rea ons why they had refu ed as ent. Th 
52 potential participants for whom a en! was not given 58% were female and 42% were 
male. Assent was not withdrawn for any res ident during the tud , howev r a further 10 
participants died between the initial a e sments and the tudy completion . Thi proce 
has been ummarised in the table and fi gure below. 
Table 3. 1 Outcomes of patient selection 
Home Noof CDR3 Died Transferred No 
residents Assent 
in home 
Tynemouth 38 31 2 1 12 
Court 
Willow 39 28 1 1 8 
Court 
Cleveland 62 43 4 0 13 
Park 
Appleby 53 29 2 0 8 
Total 192 131 9 2 41 
Figure 3.1 Pie chart of outcomes of participants suitable for research 
Assent given 
• Died before assent 
given 
o Transferred 
o Assent not given 
Final no 
16 
18 
26 
19 
79 
Figure 3.2 Flow chart of outcomes of patient selection 
Clinical dementia rating scale completed for 192 
nursing home residents 
1 
CDR= 3,131 CDR<3,61 
information sheets sent residents excluded 
to relatives from study 
Next of kin contacted Assent not given or 
regarding giving unable to contact next of 
assent kin of 41 residents 
9 residents died before 
assent given 
2 residents transferred 
Assent given 
79 participants 
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3.1.2 Sex 
The gender of the study participants is outlined in the table below. 
Table 3.2 Gender of the study participants 
Female Male 
No of participants 57 22 
Percentage of participants 72% 28% 
3.1.3 Diagnosis 
The dementia diagnoses, as ascertained by examination of the participants' medical notes, 
are documented in the table and histogram below. 
Table3.3 Participants' dementia diagnoses 
AD VaD Mixed DLB Downs Not 
known 
No of participants 42 23 9 3 1 1 
Percentage of 53.2% 29.1% 11.4% 3.8% 1.3% 1.3% 
participants 
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Figure 3.3 Histogram a/participants ' dementia diagnoses 
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I 
Downs Not known 
3.1.4 Age, time since diagnosis and time since admission to home 
The table below summarises the other background variables co llected on th tudy 
participants. 
Table 3.4 Participants ' age, time since diagnosis and admission 
Mean Standard deviation Median Range 
Age (years) 81.9 8.14 82 64 - 98 
Time since dementia 71.1 35 .2 68 15 - 192 
dia2nosis (months) 
Time since admission to 35.8 26.6 32 2 - 11 5 
home (months) 
3.1.4.1 Age 
The mean age of the study population was 81 .9, with a range from 64 - 98 year . The 
histogram below demonstrates the distribution of age in the study population. Analysis 
using Kolmogorov - Smirnov Test of Normality suggested that this data was normally 
distributed. 
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Figure 3.4 Hi ·togram of age distribution of study population 
60.00 80.00 
Age when consented (years) 
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100.00 
Mean =81 .9241 
Std . Dev. =8.11578 
N =79 
3.1.4.2 Time since dementia diagnosis 
The mean time, in months, since the diagnosis of dementia wa fo rm ally made wa 7 1.1 
with a large range fTOm 15 to 192 month . The hi stogram below d mon trate the 
di tribution of time since dementia diagno is in the tudy population. Analy i U Ing 
Ko lmogorov - Smirnov Test of Normali ty uggested that thi data wa not n rmally 
distributed. 
Figure 3.5 Histogram of time since diagno is distribution of tudy population 
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n 
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Mean " 71 .1081 
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3.1.4.3 Time since admission to home 
The mean time since the participant had been admitted to their current nursing home was 
35 .8 months, again with a wide range of 2 to I 15 month . The hi togram below 
demonstrates the di stribution of time since admi ion to home. The hi togram i kewed 
to the left, with mo t participant having been in their current hom fI r a horter period of 
time. 
Figure 3. 6 Histogram of time since admission to current home 
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I 
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Mean =35.7662 
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3.1.5 Background neuropsychiatric scales 
In addition to the Clinical Dementia rating scale, all study participants had four 
neuropsychiatric tests completed. These were the Cornell Scale for Depression in 
Dementia (CSDD), Clifton Assessment Procedure for the Elderly - Behaviour Rating 
Scale (CAPE-BRS), Neuropsychiatric Inventory (NPI) and the Cohen-Mansfield 
Agitation Inventory (CMAI). 
Table3.5 Background neuropsychiatric data 
Mean Standard Median Range 
deviation 
Baseline CSDD 5.27 4.08 5.0 0-16 
Baseline CAPE- 21.8 3.88 22.0 II - 34 
BRS 
Baseline NPI 14.5 12.25 12.0 0-50 
Baseline CMAI 52.2 18.45 50.0 29 - 96 
130 
3.1.5.1 Baseline CSDD scores 
The baseline median C DO core wa 5, with a rang of 0 - 16. The hi togram below 
demonstrates the distribution of ba eline C DO cores in the tudy population . core 
be low 6 are, as a ru le, associated with ab ence of ignificant depre ive ymptom . 
Scores above 10 ind icate probable major depression. The hi togram be low demon trate 
that the scores are skewed to the left with very few participant having ignificant core 
on the CSDD. 
Figure 3. 7 Histogram of baseline SDD scores 
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3.1.5.2 Baseline CAPE-BRS scores 
The median base line CAPE-BRS core was 22 with a range between II and 34. T he 
histogram be low demon trates that most of the score are c lu te r d between 20 and 28, 
indicat ing max imum dependency [227]. 
Figure 3.8 Histogram of baseline 'APE- BRS scores 
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3.1.5.3 Baseline NPI scores 
The median base line N PI score wa 12, w ith a range of 0 to 50. The hi togram be low 
demonstrates that the scores are skewed to the left . 
Figure 3.9 Histogram a/baseline NPI scores 
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3.1 .5.4 Ba eline CMAI score 
The medi an ba e line C MA I core wa 50, w ith a range of 29 t 96 (wi th 29 b ing the 
minim um core of the sca le). 
Figure 3. 10 Hi IOgram a/baseline CMA J cores 
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3.1.6 Results from baseline assessment 
The results from the baseline assessment test the hypothesis that pain is common and 
under-recognised in this population. Once the three observations forming the baseline 
assessment were completed, a decision was made as to whether the behaviour observed 
was caused by pain. The participants who were not felt to be in pain but had scored 
greater than two on the P AINAD scale at any of the three observations, formed the false 
positive group (FP group). The other participants who were not felt to be in pain and had 
not scored greater than two on the PAINAD scale formed the no pain group (NP group). 
Table 3.6 Resultsfrom the baseline assessment 
Result from baseline Pain group False positive group No pain group 
assessment 
Number of 13 26 40 
participants 
From the baseline assessments, 13 participants were assessed to be in pain (16%), 26 
participants had scored significantly on the PAINAD scale (33%) for reasons other than 
pain and 40 participants (51 %) were assessed as not being in pain nor had scored above 
two on the PAINAD scale. There was one participant who was felt to be in pain but did 
not score greater than two at any assessment. They were included in the pain group but 
could also be considered as the only false negative. 
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Figure 3.11 Pie chart of outcomes of baseline observation 
Fi~t assessment 
result 
• Pain 
• Falae Positive 
o No Pain 
Figure 3.12 Flow chart of outcomes following baseline assessment 
Observations carried out at rest eating and intervention 
-79 participants 
2nd re earcher 
ob ervation 
PAINAD core S 2 
In pain Not in pain NP group of 40 
P group of 13 participants participants (12 with PAfNAD > 2) 
PAJNAD score> 2 
FP group of26 
participants 
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The sensitivity and specificity of PAINAD can also be calculated from the results from 
the baseline assessment. 
Tab/e3. 7 Assessing sensitivity and specificity of P AINAD 
Pain No Pain 
Positive (P AINAD > 2) 12 26 
Negative (PAINAD ~ 2) I 40 
Total 13 66 
12 participants, out of the 13 with pain, scored above 2 on the PAINAD scale. This gives 
PAINAD a sensitivity of 92%. 40 participants, out of the 66 without pain, scored 2 or 
below on the PAINAD scale. This gives PAINAD a specificity of61%. 
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3.2 Results from all three groups 
The factors associated with the groups fonned following the baseline assessment were 
analysed to fulfil several study objectives. These were to assess the nature of distress that 
may produce a false positive result on a pain scale and to examine the use of analgesia in 
those identified as experiencing pain. Analysis of the factors associated with the pain 
group could potentially identify subgroups where pain was more common. Owing to 
some of the expected counts being less than five, the association between the groups and 
gender, dementia diagnosis, place of residence and analgesia prescribed were analysed 
using Fishers exact test. Fishers exact test has been extended so that it can be used for m 
by n tables, as it has been in this research. 
3.2.1 Background information 
3.2.1.1 Participants' gender 
Table 3.8 Association o/participants' gender and results from baseline assessment 
First P group FPgroup NPgroup Total 
assessment 
Female 8 (14%) 19 (33%) 30 (53%) 57 
Male 5 (23%) 7 (32%) 10 (45%) 22 
Totals 13 26 40 79 
Value Exact significance 
(2 sided) 
Pearson Chi-Square 0.90 0.703 
Fisher's exact test 1.010 0.655 
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There were no statistically significant differences seen in gender between the groups 
3.2.1.2 Participants' dementia diagnosis 
Table 3.9 Association of participants' dementia diagnoses and results from baseline 
assessment 
Dementia Pgroup FPgroup NP group Total 
diagnosis 
Alzheimer's 6 (14%) 14 (33%) 22 (52%) 42 
Lewy Body 1 1 1 3 
Vascular 6 (26%) 9 (39%) 8 (35%) 23 
Mixed 0 2 (22%) 7 (78%) 9 
Downs 0 0 I 1 
Not known 0 0 ) ) 
Total 13 26 40 79 
Value Exact significance 
_{l sidecll 
Pearson Chi-Square 8.606 0.610 
Fisher's exact test 9.264 0.487 
Although there appears to be a greater proportion of those with vascular dementia in the 
pain group, these differences are not statistically significant. 
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3.2.1.3 Participants' place of residence 
Table 3.10 Association of participants' place of residence and results from baseline 
assessment 
Place of P group Fpgroup NP group Total 
residence 
Tynemouth 3 6 7 16 
Court 
Willow Court 3 8 7 18 
Cleveland 3 7 16 26 
Park 
Appleby Care 4 5 10 19 
Home 
Totals 13 26 40 79 
Value Exact significance 
(2 sided) 
Pearson Chi-Square 3.308 0.785 
Fisher's exact test 3.498 0.769 
There were no statistically significant differences seen in place of residence between the 
groups 
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3.2.1.4 Analgesia prescribed for participants 
Table 3. J J Association of participants' analgesia and results from baseline assessment 
Analgesia P group FP group NPgroup Total 
Regular 6 3 2 11 
As required 2 11 13 26 
No analgesia 5 12 25 42 
Total 13 26 40 79 
Value Exact signiflcance 
(2 sided) 
Pearson Chi-Square 15.43 0.003 
Fisher's exact test 12.214 0.011 
Owing to some of the counts being less than five, the differences between analgesia 
prescribed and the groups (from the first assessment) have been analysed using Fishers 
exact test. These differences are significant to p = 0.011, with almost half of those found 
to be in pain prescribed regular analgesics compared with 5% of those not in pain. As the 
numbers within each group are small, it is difficult to carry out further statistical analyses 
on this data. 
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3.2.1.5 Participants' age 
The mean and standard deviati on of the age of each of the group ha been repre ented in 
the table below and a a box and whisker plot 
Table 3. 12 Age of participants of groups folio wing ba eline as ess'ment 
Age in years Mean Standard Median Range 
deviation 
P Group 83.2 7.373 82 72 - 98 
FP Group 83 .7 8.385 81.5 70 - 97 
NP Group 80.4 8.047 82 64 - 98 
Figure 3. J 3 Box and whisker plot of participants ' age of roups fo llowing baseline 
assessment 
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The group means for age were further analysed using one-way analysis of variance 
(ANOYA). 
Table 3. J 3 Analysis of group means for age 
Sum of df Mean F Significance 
squares square 
Between 202.598 2 101.299 1.560 0.217 
2roups 
Within 4934.946 76 64.934 
groups 
Total 5137.544 78 
There are therefore no significant differences between the group means for age. 
143 
3.2.1 .6 Time since d iagno i 
The mean and standard deviation of the time ince diagno i for each f the group ha 
been repre ented in the table below and a a box and whi ker plot. 
Table 3. 14 Time since diagnosis of participants of groups following baseline ass ssmenl 
Time since Mean Standa rd Media n Range 
diagnosis (in devia tion 
months) 
P G roup 57 .8 26 .62 1 58 21 - 105 
FP G roup 71.3 36.492 84 15 - 142 
NP G roup 75 .6 36.640 68 16 - 192 
Figure 3.14 Box and whisker pIal of parli ipanl " time sin e diagnosis of roups 
following baseline assessment 
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3.2.1.7 Time since admission 
The mean and standard dev iation of the time since admis ion for ea h f lh gro up ha 
been represented in the table below and a a box and whi ker plot. 
Table 3.15 Time since admission of participants of groupsfollowing ba 'eline assessment 
Time since Mean Standard Median Range 
admission (in deviation 
months) 
P Group 40.5 22.070 42 8 - 73 
FP Group 30.6 28.093 19 4 - 108 
NP Group 37.5 27.120 33 2 - 11 5 
Figure 3. 15 Box and whisker plol of participants I lime since admission of groups 
follow ing baseline assessment 
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As the time since admitted and time since diagnosed are non-parametric distributions the 
group means for time since diagnosed and admitted were analysed using the Kruskal-
Wallis test. 
Table 3.16 Analysis of group means for lime since diagnosis and admission 
Chi-squared (H) df Asymmetrical 
statistic siRnificance 
Time in months 2.718 2 0.257 
since diagnosed 
Time in months 2.277 2 0.320 
since admitted 
Although the time since diagnosis was less for the P group, this difference was not 
statistically significant. In addition the mean time since admission was much less in the 
FP group, but this again did not reach statistical significance. 
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3.2.2 Background neuropsychiatric scale 
The mean and standard dev iation of the background neurop ychologica l te t fi r each of 
the group has been represented in the table below and a a b x and whi ker plot. 
3.2.2.1 Baseline CSDD 
Table 3.17 Baseline SDD of the groups 
Baseline Mean Standard Median Range 
CSDD deviation 
P Group 4.038 3.3 15 3.5 0 - 9 
FP Group 6.154 4.442 5 0 - 16 
NP Group 5.024 4.003 5 0 - 14 
Figure 3.16 Box and whisk.er plot of baseline SDD of the groups 
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3.2.2.2 Baseline CAPE 
Table 3.18 Baseline APE-BRS a/the groups 
Baseline Mean Standard Median 
CAPE-BRS deviation 
P Group 22.333 4.075 23 
FP Group 22.500 4.320 22 
NP Group 21.317 3.517 21 
Figure 3. 17 Box and whisker piot a/baseline APE-B a/the groups 
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Range 
II - 26 
II - 34 
12 - 27 
3.2.2.3 Sa eline NPI 
Table 3.19 Baseline NP 10/ the groups 
Baseline NPI Mean Standard Median 
deviation 
P Group 15.417 14.3 18 14 
FP Group 17.308 11 .623 14 
NP Group 12.073 11 .930 9 
Figure 3. 1 Box and whi ker plOI o/baseline NPJ o/the roup ' 
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3.2.2.4 Baseline CMAJ 
Table 3.20 Sa eline MAl of the groups 
Baseline Mean Standard Median Ran ge 
CMAI deviation 
P Group 44.25 14 .882 42 .5 29 - 74 
FP Group 60.346 20.73 1 60 .5 30 - 96 
NP Group 49. 122 16.427 47.0 29 - 92 
Figure 3. 19 Box and whisker plot of baseline MAl of the roups 
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As the background neuropsychiatric scales are non-parametric distributions (non normal) 
the group means were analysed using the Kruskal-Wallis test. 
Table 3.21 Analysis of group background neuropsychiatric tests 
Chi-squared (H) df Asymp. 
statistic si2nificance 
Baseline CSDD 1.983 2 0.371 
Baseline CAPE 1.805 2 0.405 
Baseline NPI 4.586 2 0.101 
Baseline CMAI 7.790 2 0.020 
This analysis demonstrated a significant difference between some of the mean scores of 
the CMAI. This was explored further by using a Mann-Whitney Exact test. 
Table 3.22 Analysis of mean CMAI scores in P and FP groups 
Baseline CMAI N Mean Rank Sum of ranks 
result 
P group 13 13.77 179.00 
FP group 26 23.12 601.00 
Baseline CMAI Mann Whitney U Z score Exact significance 
result (2 tailed) 
P and FP groups 88.00 -2.415 0.015 
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Table 3.23 Analysis of mean CMAI scores in P and NP groups 
Baseline CMAI N Mean Rank Sum of ranks 
result 
P group 13 23.04 299.50 
NP group 40 28.29 1131.50 
Baseline CMAI Mann Whitney U Zscore Exact significance 
result (2 tailed) 
P and NP groups 208.5 -1.066 0.293 
Table 3.24 Analysis of mean CMAI scores in FP and NP groups 
Baseline CMAI N Mean Rank Sum of ranks 
result 
FP group 26 39.79 1034.50 
NP group 40 29.41 1176.50 
Baseline CMAI Mann Whitney U Zscore Exact significance 
result (2 tailed) 
FP and NP group 356.500 -2.147 0.031 
There are significant differences between the mean CMAI scores in the P and FP groups 
and the NP and FP groups, with mean CMAI scores in the FP group significantly higher 
than those in the other groups. 
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3.2.3 Comparison of the PAINAD scores for the three groups 
This comparison was carried out to test the hypothesis that the pain assessment tool can 
reliably be used to identify pain. 
Table 3.25 Initial PAINAD scores in P group 
Mean Standard Median Range 
deviation 
Rest 1.25 2.301 0.5 0-8 
Eating 0.67 1.073 0 0-3 
Intervention 5 2.629 4 1 - 8 
Table 3.26 Initial PAIN AD scores in FP group 
Mean Standard Median Range 
deviation 
Rest 1.269 1.68 0 0-6 
Eating 1.7 1.43 1.5 0-5 
Intervention 3.192 1.939 3 0-7 
Table 3.27 Initial PAINAD scores in NP group 
Mean Standard Median Range 
deviation 
Rest 0.325 0.526 0 0-2 
Eating 0.375 0.629 0 0-2 
Intervention 0.725 0.784 1 0-2 
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The differences between the mean scores for each group were further analysed using the 
Kruskal-Wallis Test. 
Table 3.28 Analysis of mean initial PAINAD scores of each group 
PAINAD Groups N Mean rank 
assessment 
Initial Rest P 13 43.15 
FP 26 45.65 
NP 40 35.30 
Initial Eating P 13 36.88 
FP 26 54.56 
NP 40 31.55 
Initial intervention P 13 63.62 
FP 26 52.33 
NP 40 24.31 
First rest PAINAD First eat PAINAD First Intervention 
PAIN AD 
Chi-squared 4.675 19.298 41.538 
df 2 2 2 
Asymp. 0.97 < 0.001 < 0.001 
si2nificance 
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There is therefore a statistically significant difference between the initial PAINAD scores 
during the eating and intervention observations and the three groups. This was analysed 
further using the Mann-Whitney exact test. 
3.2.3.1 First Eat PAINAD analysis 
Table 3.29 Analysis ojfirst eat PAINAD scores oj P and FP groups 
First Eat P AINAD N Mean Rank Sum of ranks 
P group I3 14.27 185.5 
FPgroup 26 22.87 594.5 
First Eat PAINAD Mann Whitney U Z score Exact significance 
(2 tailed) 
P and FP groups 94.5 -2.298 0.025 
Table 3.30 Analysis oj first eat PAINAD scores oj P and NP groups 
First Eat PAINAD N Mean Rank Sum of ranks 
P group I3 29.62 385.0 
NP group 40 26.15 1046.0 
First Eat PAINAD Mann Wbitney U Z score Exact significance 
(2 tailed) 
P and NP groups 226.0 -0.854 0.377 
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Table 3.31 Analysis offirst eat PAINAD scores ofNP and FP groups 
First Eat PAINAD N Mean Rank Sum of ranks 
FPgroup 26 45.19 1175.0 
NPgroup 40 25.90 1036.0 
First Eat PAIN AD Mann Wbitney U Z score Exact significance 
(2 tailed) 
FP and NP groups 216.0 -4.335 < 0.001 
The mean FP group PAINAD eating score was greater than those obtained by the P and 
NP groups (table 3.26, page 152). As statistically significant differences have been 
demonstrated between the FP group score and those obtained by the P and NP groups, the 
FP group score for eating is significantly greater than the P and NP scores for this 
observation. 
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3.2.3.2 First Intervention P AINAD analysis 
Table 3.32 Analysis offirst intervention PAINAD scores of P and FP groups 
First Intervention N Mean Rank Sum ofnnks 
PAINAD 
P group 13 24.73 321.5 
FP group 26 17.63 458.5 
First Intervention Mann Whitney U Z score Exact significance 
PAINAD (2 tailed) 
P and FP groups 107.5 -1.869 0.066 
Table 3.33 Analysis offirst intervention PAIN AD scores of P and NP groups 
First Intervention N Mean Rank Sum ofnnks 
PAINAD 
P group 13 45.88 596.50 
NP group 40 20.86 834.5 
First Intervention Mann Whitney U Z score Exact significance 
PAINAD (2 tailed) 
P and NP groups 14.5 -5.260 < 0.001 
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Table 3.34 Analysis of first intervention PAIN AD scores of NP and FP groups 
First Intervention N Mean Rank Sum of ranks 
PAINAD 
FPgroup 26 48.19 1253.0 
NPgroup 40 23.95 958.0 
First Intervention Mann Whitney U Z score Exact significance 
PAINAD (2 tailed) 
FP and NP groups 138.0 -5.164 < 0.001 
The mean NP group PAINAD intervention score was less than those obtained by the P 
and FP groups (table 3.27, p 153). As statistically significant differences have been 
demonstrated between the NP group score and those obtained by the P and FP groups, the 
NP group score for intervention is significantly less than the P and FP scores for this 
observation. Although the mean P group PAINAD score for intervention was greater than 
that obtained by the FP group, this was not statistically significant (p = 0.066) 
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3.2.4 Summary of results from all three groups 
The three groups have been looked at as a whole to examine factors associated with 
having pain or producing a false positive result on the PAINAD scale. There was no 
significant association with the participants' sex, dementia diagnosis or place of residence 
with the results from the first assessment. There was however a significant association 
between analgesia prescribed prior to the assessment and the first assessment result (p = 
0.011). 
There was no significant association demonstrated between age, time since admission and 
time since diagnosis. There was no significant association between the background 
neuropsychiatric tests and the first assessment result, apart from the CMAI scores. This 
association was evaluated further, demonstrating that the CMAI scores for the false 
positive group were significantly different compared to those obtained by participants in 
the P and NP groups. 
There were significant differences between the initial PAINAD scores for the eating and 
intervention assessments (p < 0.00 I). It was demonstrated that the mean PAINAD score 
for the eating observation was significantly greater for the FP group compared with the 
other groups. In addition it was demonstrated that the mean PAINAD scores on 
intervention for the NP group were significantly less than those obtained for the FP and P 
groups. 
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3.3 Results from pain and false positive groups 
3.3.1 Pain group 
The following analyses were carried out to test the hypotheses that the PAIN AD and 
DisDA T tools are sensitive to change and that pain can be managed using both simple 
pharmacological and non-pharmacological techniques. 
Table 3.35 Underlying causes o/pain and treatment changes 
Number Cause of pain Treatment used 
TC2 Contractures Regular Paracetamol 
TC16 Dental Caries Tooth extraction! filling, as 
required Paracetamol 
TC23 Arm tension owing to anxiety Massage 
WC9 Pain on sitting on hard surfaces Pressure area care on washing 
WC20 Rheumatoid arthritis of knee Topical NSAlDs 
WC22 Contractu res Regular Paracetamol 
CPI7 Cellulitis and DVT of leg Antibiotics!Cocodamolffinzaparin 
CP 19 Arthritis! previous hip fracture Slow Release Tramadol 
CP25 Arthritis/ immobility Regular Paracetamol 
AP6 Arthritis Change in time of analgesia 
AP9 Hand contracture Procyclidine (started by 
participant's GP) 
API7 Pain on sitting on hard surfaces Not left sitting on hard surfaces 
AP25 Pain on cleaning nails Acute incident therefore staff 
alerted to it 
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The medication charts were reviewed prior to the 1 month assessment and all the 
suggested drug changes had been made. The medication charts were reviewed prior to the 
3 month assessment; most of the medication was still prescribed at the time of the 3 
month assessment. There were two exceptions, the CPI7 drug changes (as the cellulitis 
had resolved) and CP19 drug changes (problems with supply of slow release tramadol, 
therefore temporarily given short acting tramadol). The changes in patient management 
were documented in care plans and were acted upon during the assessments at 1 and 3 
months. The massage therapy (for WC 23) had just commenced at the time of the 
month assessment and was continuing at the 3 month assessment. 
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3.3.1.1 Background neuropsychiatric scales 
The data from these scales was non parametric, hence the pairs of observations were 
analysed using the Wilcoxon signed-rank test. 
Table 3.36 Analysis of the differences between baseline and / month background 
neuropsychiatric scales of the P group 
Second CAPE Second CMAI Second CSOD Second NPI-
- First CAPE -FirstCMAI -FintCSSD Fint NPI 
Z score -1.811 a -1.337° -0.211° -1.334° 
Asymp. 0.070 0.181 0.833 0.182 
Si2nificance 
a) Based on negative ranks 
b) Based on positive ranks 
There were no significant differences observed between the initial background 
neuropsychiatric scales and those carried out after making a treatment change for pain. 
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3.3.1.2 Assessment results - initial and 1 month scores 
The change in assessment scores following change in treatment was also analysed using 
the Wilcoxon signed ranks test owing to the data being non-parametric. 
Table 3.37 Analysis of the differences between initial and 1 month assessment scores of 
the P group 
First First First eat First eat Fint First 
rest rest DisDAT- PAINAD intervention intervention 
DisDAT- PAINAD 1 month -1 month DisDAT-l PAINAD -1 
1 month -1 month eat eat month month 
rest rest DisDAT PAINAD intervention intervention 
DisDAT PAINAD DisDAT PAINAD 
Z score 
-0.3678 -0.530° -1.8978 -0.990· -2.670° -2.653° 
Asymp 0.714 0.596 0.058 0.322 0.008 0.008 
Si2nificance 
a) Based on positive ranks 
b) Based on negative ranks 
For both DisDA T and PAINAD scales post treatment scores were significantly lower 
than pre treatment scores (both p = 0.008). These were both based on the negative ranks, 
therefore the scores post treatment were significantly lower that those recorded pre 
treatment. 
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3.3.1.3 Assessment results - 1 month and 3 month scores 
The change in assessment scores at 3 months was also analysed using the Wilcoxon 
signed ranks test owing to being non-parametric. 
Table 3.38 Analysis of the differences between 1 month and 3 month assessment scores of 
the P group 
3 month 3 month 3 month 3 month 3 month 3 month 
rest rest eat eat intervention in terven tion 
DisDAT- PAINAD DisDAT- PAINAD DisDAT-I PAINAD -I 
1 month -1 month 1 month -I month month month 
rest rest eat eat intervention intervention 
DisDAT PAINAD DisDAT PAINAD DisDAT PAINAD 
Z score O.OOOa -0.216° -1.703° -1.222° -1.357' -1.035' 
Asymp 1.000 0.829 0.088 0.222 0.175 0.301 
Significance 
a) The sum of negative ranks equals the sum of positive ranks 
b) Based on positive ranks 
c) Based on negative ranks 
There were no significant differences demonstrated between the results obtained at 
month and those obtained at 3 months in the pain group. 
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3.3.1.4 Clinical Vignettes 
There were several different underlying causes of the pain identified during the study. 
Some were due to acute events such as cellulitis, others were due to more chronic 
problems such as arthritis. The vignettes below describe how some of the painful 
conditions were managed, the potential benefits of using pain/distress tools and some of 
the challenges of managing pain in such patients. 
3.3.1.4.1 Vignettes la and b 
These vignettes have been chosen to illustrate how tools can help guide management as 
well as the need for regular assessments. 
An 81 year old lady, who had been diagnosed with vascular dementia seven years 
previously, had been resident in the home for six years. She had been bed bound for some 
time and a previous stroke had left her with contractions of the left arm and leg. She 
became distressed whilst being dressed, grimacing, tensing up and groaning. She scored 
four during intervention on the PAINAD tool and the distress behaviours identified on the 
DisDA T increased during times of intervention. It seemed to be the movement of her 
contracted limbs that caused pain and this hadn't improved greatly despite regular 
baclofen. She was therefore started on regular paracetamol in addition to the baclofen for 
musculoskeletal pain. The change in medication was reviewed as outlined in the method 
section and discussed with the nursing home staff. They were unclear whether the 
additional paracetamol had made much difference. The assessment tools were therefore 
repeated which demonstrated a clear improvement on both tools. This was still 
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observable three months after starting the medication. In this way the tools had helped to 
demonstrate a reduction in pain behaviours and hence an improvement associated with 
commencing regular paracetamoJ. 
A 79 year old lady with dementia with Lewy bodies was observed to groan, frown and 
become tense during intervention. She had contractures of her arms and it was clear when 
her arms were moved that the behaviours were more obvious. She was started on regular 
paracetamol, and review after one month showed a reduction in the scores of both tools. 
Further observation at three months demonstrated that this improvement had not been 
maintained, as there was a recurrence of the behaviours seen on the initial observation. 
This highlights the progressive nature of conditions and the need for regular review. 
3.3.1.4.2 Vignette 2a and b 
These vignettes have been selected to exemplify the potential difficulties in assessing 
what the cause of distress is, and that several causes of distress may be present during one 
observation. The first vignette also illustrates the issues surrounding the time frame that 
behaviours are present for. 
An 83 year old gentleman with vascular dementia (We 9) was observed to become 
particularly agitated during bath times, shouting, swearing and hitting out at staff. He 
scored 7 on the PAINAD tool at bath times and many of the distress behaviours from the 
DisDA T tool were also observed. The staff felt he had always been very difficult to 
manage and just hated having anyone "interfering with him". There are clearly many 
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potential causes of distress that can occur when bathing elderly people with dementia 
[233] and attempting to ascertain which may be the cause of such behaviours observed 
can take several observations. It became clear that this participant's distress was much 
more apparent when he was sitting on the bath seat (e.g. constantly shouted "get me 
om") and was resolved to a certain extent when he was standing up. At other times he 
would be distressed when sitting on the toilet, but would sit without any distress on a 
relieving cushion whilst in the residents' lounge. There were no obvious signs of pressure 
damage to his buttocks but he had clearly lost weight, potentially making sitting on hard 
surfaces uncomfortable. It was therefore decided after discussion with the staff to try 
showering him instead and use towels to cushion the shower chair. The staff noticed that 
this did help, which was also demonstrated to a certain extent when repeating the 
assessment tools. On the occasion of repeating the observation he was more settled whilst 
being showered, however became agitated when the staff struggled to put his shirt on 
which was too small for him. As the length of time which a particular behaviour is 
present for can be reflected when using the PACA score with the DisDAT, the DisDAT 
score was reduced. The PAINAD score remained almost the same (8 out of 10), 
reflecting the episode of agitation whilst being dressed. 
An 80 year old gentleman with vascular dementia had a history of severe degenerative 
arthritis of the left hip as well as having broken his right hip and pelvis caused by a fall a 
year previously. Despite having a terrible short term memory, the memory of the fall and 
the pain suffered from the fall were still very fresh in his mind. Each time he was helped 
out of bed he would shout that he was going to fall and it would hurt, despite repeated 
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reassurances from the staff that they had him well supported. On observation it was 
difficult to decide whether he was in pain or was becoming distressed on account of a 
fear of falling and fear of being in pain. It required a further observation to recognise that 
both were probably the case. His analgesic medication was adjusted to control his pain 
more effectively. The scores were reduced after changing his medication, but some of the 
fears regarding falling remained since his difficulties with short term recall meant that 
any reassurances given were quickly forgotten. 
These cases demonstrate the difficulties in understanding exactly the causes of the 
observed behaviours. In both cases the participants were in pain, but other factors also 
caused distress, such as fear of falling or agitation caused by dressing. In identifYing and 
managing the painful aspects of washing or dressing, the scores on the tools were reduced 
and hence the overall distress was reduced. There may, however, be additional factors 
that are more difficult to manage, such as deeply held fears. The first case also 
demonstrates that without a time frame built into a scale, results can be skewed by 
behaviours that weren't present for all of the observation period. 
3.3.1.4.3 Vignette 3 
This vignette demonstrates some of the challenges in finding a suitable treatment strategy 
that is acceptable to the participant. One 97 year old participant with Alzheimer's disease 
became distressed on being helped out of bed. She had a history of arthritis of her hip 
(seen on X-ray) and was chair-bound during the day. It was difficult for her to localise 
her pain: sometimes she would describe hip pain, but occasionally other joints seemed to 
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be painful. She was started on regular paracetamol. However, she would frequently refuse 
to take this, as she did with many of her other medications. She was, therefore, started on 
Calpol (paracetamol in liquid form) with some success; however she would still 
intermittently spit it out or refuse to take it. The staff felt she was better when taking the 
analgesia regularly but at times just couldn't be persuaded that it would be of benefit to 
her to take her medication. More local therapies were discussed, but owing to the 
difficulty in knowing exactly where the pain was located these were not tried. Various 
non-pharmacological therapies, such as massage, had been tried previously without 
success. In addition, this participant frequently complained that she would rather be left 
alone; therefore the non-pharmacological strategies which had previously failed were not 
retried. The PAIN AD and DisDAT scores remained relatively unchanged throughout, 
mainly as there was no guarantee that the day of repeating the scores was a day that she 
had been complying with her medication. The extent to which the behaviours observed 
were caused by pain was very difficult to assess, particularly as a proper trial of 
medication was impossible. A plan was made, therefore, to continue to observe closely 
for potential pain and distress and use paracetamol as appropriate. 
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3.3.2 False positive group 
The following analyses were carried out to assess the nature of distress that may produce 
a false positive result on a pain assessment tool. 
Table 3.39 Underlying causesfor the false positive scores 
Number Cause for PAINAD score >2 
TC 19 Upset by other residents 
TCll Not understanding leading to embarrassment 
TC22 Not understanding leading to aggression 
TC24 Mood related and not understanding 
TC27 Not understanding leading to anxiety 
TC29 Upset by other residents and not understanding 
WC3 Not understanding and emotionally labile 
WC4 Irritation at being fed and possible hallucinations 
WC6 Frustration at inability to communicate, dislike of shaver and loud noises 
WCIO Not liking food, irritated by others 
WCI3 Anxiety caused by not understanding 
WCI4 Hearing loss hence not understanding 
WC21 Boredom 
WC25 Transient low mood (resolved without intervention) 
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Number Cause for PAINAD store >2 
CP22 Mood related (grumpy some mornings!) 
CP27 Upset by other resident 
CP30 Not understanding leading to frustration 
CP33 Visual loss causing difficulty in managing food 
CP40 Not understanding leading to anger and frustration 
CP41 Not understanding leading to anxiety and fear 
CP42 Feeling cold 
APl Not understanding leading to frustration 
AP14 Not understanding leading to anxiety and fear 
AP20 Possible sadness with anxiety at general situation 
AP23 Sadness at situationlemotionallability 
AP29 Generally feeling unwell, nauseated 
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3.3.2.1 Background neuropsychiatric scales 
The data from these scales was non-parametric, hence the pairs of observations were 
analysed using the Wilcoxon signed-rank test. 
Table 3. 40 Analysis of the differences between baseline and I month background 
neuropsychiatric scales of the FP group 
Second CAPE Second CMAI Second CSDD Second NPI-
-First CAPE -FirstCMAI -First CSSD First NPI 
Z score -0.4748 -2.070' -0.731 b -1.4768 
Asymp. 0.635 0.038 0.465 0.140 
Si2nificance 
a) Based on positive ranks 
b) Based on negative ranks 
There was a significant difference (p = 0.038) between the second and first CMAI scores 
in the FP group. As this calculation was based on the positive ranks, there was a 
significant decrease in CMAI score at the time of the second assessment. 
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3.3.2.2 Assessment results - initial and 1 month scores 
The observations were simply repeated at 1 month for the FP group. The data was also 
analysed using the Wilcoxon signed ranks test as it was non-parametric. 
Table 3.41 Analysis of the differences between initial and J month assessment scores of 
the FP group 
First First First eat Fint eat Fint Fint 
rest rest DisDAT- PAINAD intervention intervention 
DisDAT- PAINAD 1 month -I month DisDAT-I PAINAD -I 
1 month -I month eat eat month month 
rest rest DisDAT PAINAD intervention intervention 
DisDAT PAINAD DisDAT PAINAD 
Z score -2.448' -2.121' -1.292' -0.450' -1.427' -2.026' 
Asymp 0.014 0.034 0.196 0.653 0.154 0.043 
Sie;nificance 
There was a significant difference seen between the initial and 1 month scores for 
DisDAT at rest and PAINAD at rest (p = 0.014 and p = 0.034), as well as the initial and 1 
month scores for PAINAD on intervention. These were all based on negative ranks; 
hence there was a significant reduction in scores at 1 month on both scales at rest and the 
PAINAD score on intervention. 
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3.3.2.3 Assessment results - 1 month and 3 month scores 
The change in assessment scores at 3 months was also analysed using the Wilcoxon 
signed ranks test owing to being non-parametric. 
Table 3.42 Analysis of the differences between 1 month and 3 month assessment scores of 
the FPgroup 
3 month 3 month 3 month 3 month 3 month 3 month 
rest rest eat eat intervention intervention 
DisDAT- PAINAD DisDAT- PAINAD OisOAT-l PAINAO -1 
1 month -1 month 1 month -1 month month month 
rest rest eat eat intervention intervention 
DisDAT PAINAD DisOAT PAINAD DisOAT PAINAO 
Z score -2.0608 -0.5418 -0.8278 -0.137' -1.115' -1.011' 
Asymp 0.039 0.589 0.408 0.891 0.265 0.312 
Significance 
a) Based on negative ranks 
There was a significant difference seen between the I month and 3 month scores using 
the DisDA T at rest. As this was based on the negative ranks, the 3 month rest DisDA T 
was significantly greater than the I month rest DisDAT. There were no other statistically 
significant differences demonstrated. 
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3.3.2.4 Clinical Vignettes 
There was a proportion of participants in the study who scored above two on the 
PAINAD tool, owing to reasons other than being in pain. The causes of the behaviour 
seen were discussed with the nursing staff and fell into broad sub groups. Many of the 
participants in the study frequently did not seem to understand what was happening or 
what was being asked of them. This often led to the participant appearing anxious or 
frightened by what was going on around them or, for some participants, angry and 
frustrated that they were not able to do simple tasks and were having to be helped. Other 
participants seemed to be upset by other residents within the home and their reactions to 
these residents were the behaviours described on the PAINAD tool. Some participants 
simply appeared to have good or bad days, with changeable moods owing to unidentified 
causes, whilst others reacted to their environment, displaying behaviours presumed to be 
caused by boredom or generalised sadness, possibly reflecting a degree of insight. At 
times it was difficult to be certain as to the cause of the behaviour seen and occasionally 
the behaviour resolved without specific treatment. The vignettes below describe some of 
the causes for a false positive result on the PAINAD tool in more detail and the 
challenges faced in determining the cause for the behaviours identified during the 
observations. 
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3.3.2.4.1 Vignettes 4a and b 
An 81 year old gentleman with Alzheimer's disease was noted to use negative speech, 
frown and become tense whilst having a bath, needing to be reassured. He therefore 
scored four on the PAINAD tool and displayed several of the distress behaviours 
identified by the DisDAT. During bath time he became quite puzzled and unsure as to 
what was happening and what certain things were for. He was quite easily reassured and 
smiled and laughed whilst being bathed. It therefore seemed that the times of not 
understanding caused him to frown, become tense, use negative speech and he needed to 
be reassured to ease his anxiety over what was happening. Similar behaviour was also 
seen when he was observed having a meal. Again, once he understood why he had to sit 
at a table with others for his meal, the observed behaviour resolved and therefore it could 
be concluded that it was not due to pain. By evaluating what had caused the behaviours to 
start and to stop, it was clear that the cause for the observed behaviour was not pain. 
An 82 year old lady with vascular dementia appeared to react to not understanding by 
becoming angry and frustrated. When being helped out of bed and dressed, she became 
very angry, demanding that people get away from her and then proclaiming "Oh why 
can't I do it, what is wrong with me?". She tried to hit or kick anyone who came near her 
and did not respond to any reassurance or explanation. Once she was dressed she was 
quite calm and happy to be taken into the dining room for breakfast. She therefore scored 
seven on the PAINAD tool and displayed many of the distress behaviours documented 
for her on the DisDA T. When she was reviewed the following month she was much 
calmer and allowed the carers to wash and dress her without becoming as angry. This was 
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possibly because the home allocated certain carers to her so that she would recognise 
what they were trying to do and, therefore, be less aggressive towards them. Her scores 
were correspondingly lower at the second observation. 
These two vignettes help to illustrate different reactions that may be seen in those with 
dementia who are unable to understand what is happening around them. There were 
several other participants in this group who had similar reactions when unable to 
comprehend situations, some being more amenable to reassurance than others. This 
demonstrates the importance of the psychosocial environment for people with dementia 
[234]. 
3.3.2.4.2 Vignette 5a and b 
A 79 year old lady with Alzheimer's disease was observed pacing the corridors of the 
nursing home, frowning and muttering to herself. She would happily talk to the staff and 
denied any pain, but refused to sit in the main lounge with the other residents. During 
observation her PAINAD score was 3 and the pacing, frowning and muttering were all 
behaviours of distress that had been documented on her DisDA T assessment. She was 
then shown a quieter lounge without anyone sitting in it and when sitting in the quieter 
lounge, the behaviours resolved. It seemed, therefore, that the behaviours observed were 
due to her dislike of being in a room with large numbers of other residents and her need 
for a quiet space. 
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A 93 year old lady with Alzheimer's was observed to frown, mutter and become restless 
whilst sitting at rest, scoring 3 on the PAINAD tool. This seemed mainly on account of 
another resident sitting next to her asking her questions, which she did not understand and 
which caused her to become irritated. Owing to mobility problems, she was unable to 
move to another seat. The behaviours were resolved by a staff member suggesting that 
the resident questioning her should leave her alone and move to a different area of the 
lounge. 
Both these vignettes describe participants displaying behaviour caused by the general 
nursing home environment. The behaviours observed during these vignettes were 
alleviated by allowing space for quietness within the nursing home and by vigilance on 
the part of nursing staff. Several review articles have suggested that changes to the 
environment, such as allowing for quieter areas, may help to reduce agitated behaviour 
[70, 235, 236]. 
3.3.2.4.3 Vignette 6 
A 77 year old lady with long-standing Alzheimer's disease scored four on the PAINAD 
tool whilst being fed and five when being dressed in the morning. She was immobile and 
unable to communicate verbally. When being fed, she would grimace and become tense 
when the spoon was put in front of her mouth, but once she opened her mouth and ate the 
food, the behaviour resolved. It was concluded that the behaviour was probably due to 
not understanding what was happening whilst being fed. This participant also displayed 
similar behaviour when being dressed, which was much more obvious when she initially 
178 
was helped out of bed. The observed behaviour again might be caused by her 
misunderstanding the situation, leading to anxiety, but also it was felt that some of it 
might be due to pain. The participant had a history of osteoarthritis and was noted by staff 
members to be very stiff when first helped up. With this in mind a trial of regular 
paracetamol was proposed: sadly she died before this could be commenced. In the last 
few days of life the grimacing behaviour was noted to be occurring more frequently and 
she was prescribed oral morphine, by the emergency GP, to be given as needed. The staff 
felt that when the analgesia was given, there was no obvious difference to the grimacing 
behaviour, so it is possible that the cause of the behaviour was not pain. This vignette, 
similar to the participants in vignettes 2a and b, demonstrates that the cause of the 
behaviours observed is sometimes difficult to ascertain. In addition, it may be necessary 
to consider a trial of analgesia if the cause could potentially be pain. 
3.3.2.4.4 Vignette 7 
A 98 year old lady with dementia was observed to call out and moan loudly at rest and 
during intervention, giving her a PAINAD score of three. The staff had noted a change in 
this lady over several few days, becoming more withdrawn, refusing to eat or take any 
medication. At rest she would call out that she was being starved, yet refuse to eat and 
would groan and frown when being undressed. The GP had reviewed her and felt that this 
was due to her dementia progressing and she was nearing the end of life, with which 
family and staff agreed with. She denied any pain and was able to move without causing 
distress. This included her left hip, on which she had had surgery following a fracture. 
One hypothesis was that she was depressed; however, the withdrawal behaviour 
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gradually improved over a matter of days. When the scales were repeated there was a 
marked reduction in both scores which was sustained at 3 months. It was not clear to 
anyone involved in her care what the cause of the deterioration was, but it resolved 
without any specific intervention. 
3.3.2.4.5 Vignette 8 
A 94 year old lady with vascular dementia would become very distressed on being helped 
to get dressed, giving her a PAINAD score of three. She would scream loudly if left 
unattended and became frustrated by the nursing staff trying to help her to get dressed. 
The behaviours did not seem to be movement related and once she was dressed she 
became quite calm. It was therefore decided that the behaviours observed were not pain 
related and were potentially caused by wanting attention and by feelings of frustration. 
Shortly after the observation had taken place, she had a fall and fractured her left hip. She 
was admitted to hospital, had a dynamic hip screw inserted and discharged back to the 
nursing home. When the repeat observation was carried at one month she displayed 
similar behaviours as during the initial observation but also seemed to become distressed 
on movement, particularly of her left leg. This was highlighted to the statT who asked for 
the GP to review her. She was subsequently started on regular paracetamol as it was felt 
that she had movement related pain of her left hip. Although this participant was 
originally assigned to the false positive group on the basis of the behaviours observed, 
she subsequently was observed to be in pain on repeat observation. This vignette 
highlights the importance of repeat evaluation of behaviours observed as the underlying 
cause may change over time. 
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These clinical vignettes for those with a false positive result from the PAINAD tool 
highlight important issues surrounding the management of pain in those with severe 
dementia. In the first instance, using a PAINAD tool in isolation will incorrectly identify 
observed behaviour as pain, whereas there may be a range of different causes for the 
behaviour, as highlighted by the above clinical vignettes. The underlying cause may 
actually change over time as highlighted by vignette 8. It is possible that using a 
PAINAD tool simply identifies some of the behavioural and psychological symptoms of 
dementia (BPSD) which then have to be evaluated to identify the underlying cause. It is 
well established in the literature surrounding the management of "challenging behaviour" 
in dementia that identifying the antecedents to the behaviour is important in assessing the 
cause [67, 236] and the same is true when assessing behaviour that might be caused by 
pain. Utilising this approach, the underlying cause of many of the observed behaviours 
could be established. Some of the behaviours observed responded to reassurance, with 
others simply resolving over time. 
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3.3.3 Comparison of P and FP group scores 
Further analysis was also carried out to investigate whether the change in scores at the 1 
month assessment for both PAINAD and DisDAT were different in the P and FP groups. 
As the data was non-parametric, this was carried out using the Mann-Whitney test. 
Table 3.43 Analysis of the change in scores at J month of P and FP groups 
Mann Whitney U Z Score Exact Significance 
12 tailedl 
Rest DisDAT 61.5 -1.920 0.062 
1 month - initial 
RestPAINAD 75.5 -1.349 0.215 
1 month - initial 
Eat DisDAT 61.0 -2.256 0.039 
I month - initial 
EatPAINAD 84.5 -1.124 0.281 
1 month - initial 
Intervention 75.0 -1.501 0.145 
DisDAT 
1 month - initial 
Intervention 106.0 -0.191 0.869 
PAINAD 
1 month - initial 
This demonstrates that the changes seen between the scores obtained initially and at one 
month for the two groups were not significantly different apart from the DisDA T scores 
'obtained whilst eating. The median change in the P group was greater than the median 
change in the FP group; hence for this observation the change in DisDA T score was 
significantly greater in the P group. As this result just reaches significance and was the 
only significant result seen in this analysis, it is possible that this is a type one error. 
Repeat analysis would be necessary to investigate this further. 
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1 3.3.4 Summary of results from pain and false positive groups 
The table on p 160 documents the underlying causes for the pain observed, with both 
acute and chronic pain causes observed. A variety of strategies were used to manage the 
pain, employing both pharmacological and non phannacological techniques. Despite the 
study participants all having started treatment for their pain, a significant change in the 
background neuropsychological tests was not seen. There was, however, a significant 
change seen on repeating the assessment tools. A statistically significant change (p = 
0.008) was seen in both the DisDAT and PAINAD scores for the intervention observation 
following treatment for pain. This confinns the hypothesis that the tools are sensitive to 
change. There was no significant change seen when the assessments were repeated at the 
3 month stage. The issues surrounding assessment and management of pain are explored 
in more detail using the case vignettes. 
The underlying causes for the behaviour seen in the false positive group are documented 
in the table on p 170 and 171. The background neuropsychological tests were repeated 
one month after the initial tests were carried out. Despite specific interventions having 
not been suggested for the participants of this group, a statistically significant reduction 
in the CMAI score was demonstrated. In addition, a statistically significant reduction was 
also demonstrated in both the DisDAT and PAINAD scores at rest and the PAINAD 
score on intervention when the assessments were repeated at one month. The assessments 
were also repeated 3 months after the baseline assessments were carried out, with a 
statistically significant increase in the DisDA T score demonstrated at rest. The issues 
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surrounding assessing and managing the behaviour seen in this group of participants are 
also explored further using the clinical vignettes. 
Finally, analysis was also carried out to examine whether the magnitude of the change in 
scores differed between the pain and false positive groups. No statistically significant 
differences were demonstrated apart from the DisDA T scores obtained whilst eating. In 
this observation, the change in DisDA T score was significantly greater in the P group 
than the FP group. 
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3.4 Analysis of behaviours documented and observed 
These analyses were carried out to provide further information on the breadth of 
behaviours that may be associated with distress in those with severe dementia and how 
various factors may influence the number of behaviours seen. In addition, these analyses 
provide information on the behaviours observed by those experiencing pain and how this 
may differ from the behaviours observed by those in the false positive group. This 
explores further the reliability of both PAINAD and DisDAT in identifying pain. 
3.4.1 DisDA T 
The DisDA T (Disability Distress Assessment Tool) is designed to identify distress cues 
in people with severely limited communication. It is completed by carers documenting 
behaviours of distress and behaviours seen when that person is content. The tool was 
originally created for use with people with limited communication owing to learning 
difficulties. By completing the tool for the 79 participants in this study, data has therefore 
been collected regarding behaviours of distress seen in people with severe dementia. 
3.4.1.1 Behaviours of distress identified using DisDAT 
From 79 study participants, 129 different behaviours of distress were documented, with 
72 behaviours documented for only one person. Several distress behaviours were 
commonly documented; the 20 commonest distress behaviours are documented in the 
table overleaf. 
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Documented behaviour of distress Number of participants 
Frown 52 
Louder words or shouts 35 
Restless 30 
Tearful or cries 30 
Grimaces 28 
Becomes tense 25 
Moans or groans 24 
Eats less or won't eat 22 
Frightened expression 20 
Screams 19 
Stares 18 
Flushed skin 18 
Hits out 15 
Faster breathing 13 
Tries to bite staff 13 
Clammy skin 12 
Rigid posture 12 
Swears II 
Won't allow anyone to come close II 
Startled expression 10 
Table 3.4420 commonest distress behaviours documented using DisDAT 
186 
3.4.1.2 Unique behaviours 
There were 72 behaviours of distress that were documented in only one participant. These 
have been divided up into the headings in which they were described when completing 
the DisDA T. The unique distress behaviours under each heading for all participants are 
shown in the table below. 
Table 3.45 Number o/unique distress behaviours per DisDAT heading 
Behaviour Number or unique behaviours 
Facial signs 7 
Eye appearance 4 
Skin appearance 1 
Vocal sounds 11 
Speech 22 
Habits and mannerisms 13 
Body posture 11 
Body observations 3 
The unique behaviours of distress are outlined in more detail in the table overleaf. 
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Facial signs Eye Skin Vocal Speech Habits and Body posture Body 
appearance appearance sounds mannerisms observations 
opens mouth Dilated pupils Face goes red Sighs Copies the voices Rubs forehead Increased Faster pulse 
wide of others rocking 
Rolls eyes Cries without Deep breathing 
Tongue tears Tells you off Blows out lips Sits forward 
protrudes Good eye Can't concentrate 
further out contact Constant Complains Puts self on the floor Marches around on eating 
moan 
Thin lips Narrows eyes Calls out for Waves fist Draws legs up 
Loud trilling Grandparents 
Looks sullen noise Breathes through Jerky posture 
Says "I'm going teeth 
Looks vacant Sharp tone to die" Leans back when 
Pulls pads out walking 
Glares Grunts Threatens to kill 
you Refuses to do things Folds arms 
Looks through Shrieks 
you Loud and fast Rolls up trouser legs Runs away 
Louder foreign words 
moan/groan Wringing hands Pulls head back 
Says "don 'f' when drinking 
Tuts Head butts 
Gives out Shuffles in chair 
Harsh tone instructions Shakes any hands 
gripped Crawls around 
Goes quiet Calls out "the floor 
bairns'" I 
___ J 
Table 3.46 Unique distress behaviours documented for study participants 
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Other habit and manneri m were lamming door and lea ing th m al tab le. Th r 
were 12 other speech behaviour including a king for help, a ing" h d" and a kin g 
for tablet . 
3.4.1.3 Numbers of behaviours of distress 
For the 79 study participant , the mean number of b ha i ur id nl i fi d a 
8.22, with a range of 2 - 19. The hi togram below d m fl trat th e di tributi n Ih 
number of di stress behaviour id ntified . Analy i u ing K 1m - mlrn Tc I f 
ormality uggested that thi data i n t normall di tribulcd . 
Figure 3.20 Histogram of di tribution of the number of distr 's b haviollr ' id ntifled 
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3.4.1.3.1 Correlations of number of behaviours of distress with background data 
The relationship between the number of behaviours of distress and sex, diagnosis, home, 
analgesia prescribed and pain, false positive and no pain groupings was analysed. As the 
data is non-parametric, the Kruskal-Wallis test was used. 
Table 3.47 Analysis of the relationship between categorical background variables and 
the number of behaviours of distress 
Background variable Test statistic Significance (p value) 
Sex 8.855 0.840 
Home 12.118 0.597 
Dementia diagnosis 20.578 0.113 
Analgesia prescribed 12.602 0.558 
First assessment group 11.670 0.633 
There is no significant relationship demonstrated between the number of distress 
behaviours identified and the participants' sex, place of residence, dementia diagnosis or 
analgesia prescribed. In addition, the groups that the participants were assigned to after 
the first assessment, were not significantly related to the number of behaviours of distress 
identified. 
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The number of behaviours of distress was correlated with age, time since diagnosis and 
time since admission to home. As the data is non-parametric Spearman's correlation 
coefficient was calculated. 
Table 3.48 Analysis of the relationship between continuous background variables and the 
number of behaviours of distress 
Background variable Correlation Coemcient Significance (2 tailed) 
(Spearman's) (p valuel 
Age at consent 0.082 0.473 
Time since dementia -0.202 0.085 
diagnosis 
Time since admitted to -0.168 0.144 
bome 
There were no significant correlations between the number of behaviours of distress and 
age, time since diagnosis and time since admission. 
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3.4.1.3.2 Correlations of number of behaviours of distress with background 
neuropsychiatric scales 
The number of behaviours of distress was correlated with the initial background 
neuropsychiatric scales. As the data is non-parametric Spearman's correlation coefficient 
was calculated. 
Table 3.49 Analysis of the relationship between the background neuropsychiatric scales 
and the number of behaviours of distress 
Neuropsychiatric scale Correlation Coemcient Significance (2 tailed) 
(Spearman's) (p valu~ 
CSDD 0.29 0.01 
CAPE-DRS -0.052 0.650 
NPI 0.48 < 0.01 
CMAI 0.467 < 0.01 
There is a weak correlation between the distress behaviours and initial CSDD scores. The 
correlation between initial CMAI and NPI scores is moderate. 
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3.4.1.4 Number of behaviours of distress observed during observations where pain 
was present 
The table below denotes the number of distress behaviours, generated using the DisDA T, 
that were observed during observation where pain was assessed to be present. 
Table 3.50 Number of distress behaviours observed when pain was assessed to be present 
Participant No of DisDAT distress behaviours seen when in 
pain 
TC2 2 
TC 16 4 
TC23 3 
WC9 8 
WC20 6 
WC22 4 
CP 17 5 
CP 19 4 
CP25 2 
AP6 1 
AP9 3 
AP 17 1 
AP25 2 
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3.4.2 PAINAD 
The mean, median standard deviation and range of PAINAD scores has been calculated 
for P and FP groups, as well as the commonest scoring behaviours. To evaluate the 
commonest scoring behaviours documented for the pain and false positive groups, the 
assessments that scored greater than two were collated for each group. There were 15 
assessments where PAINAD was > 2 and the participant was felt to be in pain and 34 
assessments where PAINAD was> 2 and the participant was not felt to be in pain (false 
positive group).The chart below shows the PAINAD behaviours for each score. 
Figure 3.21 PAINAD 100/ [3] 
0 1 2 
Breathing Normal Occasional laboured Noisy laboured 
independent of breathing. Short breathing. Long 
vocalisation period of period of 
hyperventilation hyperventilation. 
Cheyne-Stokes 
respirations 
Negative None Occasional moan or Repeated troubled 
vocalisation groan calling out. Loud 
Low-level speech moaning or 
with a negative or groaning. Crying 
disapproving quality 
Facial expression Smiling or Sad. Frightened. Facial grimacing 
inexpressive Frown 
Body language Relaxed Tense Rigid. 
Distressed pacing. Fists clenched. 
Fidgeting Knees pulled up 
Pulling or pushing 
away. Striking out 
Consolability No need to console Distracted or Unable to console, 
reassured by voice distract or reassure 
or touch 
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Table 3.51 Distribution o/initial scores where PAINAD > 2 (Pain group) 
Breathing Negative Facial Body Consolability 
vocalisation expression language 
1 3 6 5 4 3 
2 0 4 6 4 4 
Total 3 10 11 8 7 
None of the participants who were felt to be in pain scored 2 for their breathing (i.e. had 
noisy laboured breathing or Cheyne-Stokes respiration). There was an even spread of the 
other scores. 
Table 3.52 Distribution o/initial scores where PAINAD > 2 (False Positive group) 
Breathing Negative Facial Body Consolabllity 
vocalisation expression language 
1 1 24 21 16 26 
2 0 8 6 4 3 
Total 1 32 27 20 29 
Again none of the participants in the false positive group scored 2 for their breathing. The 
breathing domain underscored compared with the other domains. The false positive group 
tended to score lower on each of the other domains as compared to the pain group. This is 
also reflected in lower mean and median scores in the FP group on intervention. These 
differences, however, were not found to be significant (p = 0.066) 
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In the assessments where the PAINAD score was greater than 2, the distress behaviours 
from the DisDA T that had been observed during that assessment were also collated. The 
10 most frequent behaviours are shown below. The number of times the behaviour was 
observed is shown in brackets. 
Table 3.53 Distress behaviours observed where PAINAD > 2 
Distress behaviours in False positive Distress behaviours in pain group 
group 
Frown (21) Frown (4) 
Grimace (9) Grimace (4) 
Screaming (8) Tense (4) 
Louder voice/shouts (7) Moan/Groan (3) 
Restless (6) Louder voice/shouts (3) 
Tense (6) Muttering (2) 
Cries (5) Hits out (2) 
Flushed skin (4) Faster breathing (2) 
Staring (4) Looks frightened (2) 
Looks frightened (4) Restless ( I ) 
As the number of times a specific behaviour was seen was small, particularly in the pain 
group, further statistical analysis was not possible. 
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3.4.3 Summary of analysis of behaviours documented and observed 
By completing the DisDAT with the participants' carers, information has been generated 
regarding distress behaviours seen in those with advanced dementia. From the 129 
different behaviours generated from the tool, the most frequent behaviour, frowning, was 
only documented for 52 participants. Hence even very common behaviours of distress 
may not be seen universally. From the 72 behaviours that were only documented in one 
participant, most of these were associated with vocal sounds and speech or habits and 
mannerisms and body posture. 
Further analysis was carried out regarding the factors associated with the number of 
distress behaviours documented. The Kruskal Wallis test was used to demonstrate that 
there was no significant association between the number of behaviours of distress and a 
participant's gender, dementia diagnosis, analgesia prescribed, place of residence or first 
assessment result. In addition, no significant correlation was demonstrated between the 
number of behaviours of distress and age, time since diagnosis and time since admission 
using Spearman's correlation coefficient. A weak correlation was demonstrated between 
the number of behaviours of distress and CSDD scores and a moderate correlation with 
CMAI and NPI scores. 
By examining the number of DisDA T distress behaviours observed when a participant 
was in pain, it was possible to demonstrate that on every occasion there was at least one 
observable behaviour of distress. Therefore, by creating a list of distress behaviours for 
each participant, distress behaviours caused by pain could be identified. 
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Analysis of the PAINAD scores (that were> 2) demonstrated that the breathing domain 
scored infrequently compared to the other domains in both the P and FP groups. The 
PAINAD scores were more evenly distributed in the P group, with the FP group tending 
to score lower. By collating the DisDAT behaviours that had scored when the PAINAD 
score had been > 2, it was possible to compare scoring behaviours for the P and FP 
groups. This demonstrated that many of the behaviours were the same in both P and FP 
groups even though the underlying cause for the behaviours was different. 
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3.5 Medication results 
3.5.1 Analgesia 
The following analyses test the hypotheses that analgesics may be prescribed 
inadequately for those with dementia and pain can be managed using both simple 
pharmacological and non-pharmacological techniques. 
3.5.1.1 Analgesia prescribed prior to study 
All those participating in the study had their medications documented on commencement 
of the study. This was organised into 3 categories; regular analgesia (excluding aspirin). 
as required analgesia or no analgesia. Regular analgesia included those on both regular 
and as required analgesia. This has been represented below in tabular and bar chart form. 
Table 3.54 Analgesia prescribed prior to study 
Analgesia prescribed Regular As required (PRN) None 
No of participants lJ 26 42 
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3.5.1.1.1 Regular analgesia 
The type of analgesia prescribed was also documented. Paracetamol was prescribed most 
frequently; none of the participants in the study was prescribed strong opioids. Baclofen 
was classed as an analgesic agent as it had been prescribed to ease painful muscular 
spasm. Several participants were prescribed antidepressants and anticonvulsants, but 
these drugs were prescribed for indications other than neuropathic pain. Some 
participants were taking more than one regular analgesic, hence the number of prescribed 
analgesics (13) is greater than the number of participants prescribed regular analgesia 
(11 ). 
Table 3.55 Regular analgesia prescribed prior to study 
Regular Analgesia prestribed Number or prestriptionl 
Paratetamol 7 
NSAID gel I 
Oral NSAID I 
Cotodamol I 
Codeine Phosphate 1 
Tramadol I 
Badoren I 
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3.5.1.1.2 As required analgesia 
The table below illustrates the analgesia prescribed on an as required (PRN) basis. Again 
by far the most common prescription was for paracetamol. 
Table 3.56 As required analgesia prescribed prior to study 
As required analgesia prescribed Number of prescriptions 
Paracetamol 26 
Cocodamol 3 
Codeine Pbospbate 1 
3.5.1.1.3 Comparing prescribing practice between bomes 
The differences in analgesic prescribing between the four homes have been represented in 
the table and histogram below. 
Table 3.57 Analgesic prescribing in the four homes 
Analgesia Tynemoutb Willow Court Cleveland Appleby 
Prescribed Court (TC) (WC) Park (CP) (AP) 
Regular 4 (25%) 3 (17%) 3 (12%) 1 (5%) 
As required 11 (69%) 7 (39010) 4 (15%) 4 (21%) 
(PRN) 
None 1 (6%) 8 (44%) 19 (73%) 14 (74%) 
Total 16 18 26 19 
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Figure 3.23 Histogram of analgesic pre rihing in the 4 home 
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The differences of analgesia prescribing between the homes have been evaluated further 
using Fishers exact test. This demonstrates a significant association between analgesia 
prescribing and home. 
Table 3.58 Analysis of analgesia prescribing and place of residence 
Analgesia prescribing and Value Exact significance 
place of residence (2 sided) 
Pearson Chi-Square 22.640 0.001 
Fisher'S exact test 23.859 < 0.001 
The association between analgesia prescribing and home has been further evaluated by 
comparing prescribing practices between the NHS continuing care ESMI home and the 
non-NHS EMI homes. This was again evaluated using Fishers exact test. 
Table 3.59 Comparison of analgesic prescription in NBS and non-NBS homes 
NBS Home Non-NBS Homes 
Regular analgesia 4 7 
As required analgesia 11 15 
No analgesia 1 41 
Total 16 63 
Analgesia prescribing and Value Exact significance 
. type of home 12 sided) 
Pearson Chi-Square 17.904 < 0.001 
Fisher's exact test 19.372 < 0.001 
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There was therefore a significant difference between analgesic prescribing practices in 
the NHS home compared to the non-NHS homes. The values are too small in each group 
for further statistical analysis, however from examining figure 3.23 on p 203 it is possible 
to see that almost all residents in the NHS home had analgesia prescribed in some form, 
either as required or regularly. Further data from additional homes would be required to 
investigate whether these differences are seen more widely and what the implications 
might be. 
The analgesic prescribing practices of the three non-NHS homes were also evaluated 
using Fishers exact test. This demonstrated that the differences in analgesic prescribing 
practice were not significant. 
Table 3.60 Analysis of prescribing practice between non-NHS homes 
Willow Court Cleveland Park Appleby Care 
Home 
Regular analgesia 3 3 1 
As required 7 4 4 
analgesia 
No analgesia 8 19 14 
Total 18 26 19 
Analgesia prescribing and Value Exact significance 
non-NBS home (2 sided) 
Pearson Chi-Square 5.293 0.265 
Fisher's exact test 5.181 0.260 
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3.5.1.2 Summary of analgesia results 
From examining the drug charts prior to the assessments commencing, most participants 
were not prescribed any analgesics. Of those who were prescribed regular analgesia, most 
were prescribed paracetamol, with the others prescribed either NSAID or a weak opioid. 
There were no participants who had been prescribed strong opioids. 
Those participants that had been prescribed "as required" analgesia were again mainly 
prescribed paracetamol. A few participants had been prescribed codeine in combination 
with paracetamol or codeine alone. 
A significant association was demonstrated between analgesia prescription and the home 
involved in the study. Additional analysis demonstrated a significant difference in 
prescribing practice between the NHS and non NHS homes. Further statistical analysis of 
the data was not possible; however, examination of the results graphically demonstrated 
that the majority ofNHS home participants had been prescribed analgesia. No significant 
differences were demonstrated in prescribing practice in the three non NHS homes. 
Analysis carried out earlier in this chapter also demonstrated a significant association 
between analgesia prescribing and the results of the first assessment. 
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3.5.2 Central nervous system drugs 
All participants had their medication documented on commencement of the study. Those 
with primarily central nervous system activity were then grouped into five categories in 
accordance with their description in the BNF [211]. The groups were antidepressants, 
anxiolytic/hypnotics, antiepileptics, antipsychotics and dementia drugs. The number of 
participants prescribed these medications regularly are summarised in the table below. 
Table 3.61 Central nervous system drugs prescribedfor study participants 
Antidepressants Anxiolyticl Antiepileptics Antipsychotics Dementia 
Hypnotics drugs 
Number of 27 21 19 31 3 
participants 
Percentage 34% 27% 24% 39% 4% 
of 
~articipants 
The association between the prescription of these groups of drugs and the groups 
following the first assessment was analysed using Fishers exact test owing to the small 
numbers in each group 
Table3.62 Analysis of antidepressant drug prescription in groups 
P group FP group NPgroup Total 
Prescribed 5 11 11 27 
antidepressants 
Not prescribed 8 15 29 52 
antidepressants 
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Value Exact significance 
(2 sided) 
Pearson Chi-Square 1.663 0.426 
Fisher's exact test 1.748 0.426 
There were no statistically significant associations demonstrated between those 
prescribed antidepressant drugs and the groups following the initial assessment. 
Table 3.63 Analysis of anxiolytic/hypnotic drug prescription in groups 
P group FPgroup NPgroup Total 
Prescribed 2 8 12 22 
AnxiolyticJbypnotic 
Not prescribed 11 18 28 57 
Anxiolyti~ypnotic 
Value Exact significance 
(2 sided) 
Pearson Chi-Square 1.208 0.593 
Fisher's exact test 1.115 0.593 
There were no statistically significant associations demonstrated between those 
prescribed anxiolyticlhypnotic drugs and the groups following the initial assessment. 
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Table 3.64 Analysis of antiepileptic drug prescription in groups 
Pgroup FPgroup NPgroup Total 
Prescribed 2 4 13 19 
Antiepileptic 
Not prescribed 11 22 27 60 
Antiepileptic 
Value Exact significance 
(2 sided) 
Pearson Chi-Square 3.167 0.220 
Fisher's exact test 2.868 0.220 
There were no statistically significant associations demonstrated between those 
prescribed antiepileptic drugs and the groups following the initial assessment. 
Table 3.65 Analysis of antipsychotic drug prescription in groups 
P group FPgroup NPgroup Total 
Prescribed 5 9 16 30 
AntipsYchotic 
Not prescribed 8 16 24 49 
Antipsychotic 
Value Exact significance 
(2 sided) 
Pearson Chi-Square 2.167 0.740 
Fisher's exact test 2.329 0.800 
There were no statistically significant associations demonstrated between those 
prescribed antipsychotic drugs and the groups following the initial assessment. 
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Table 3.66 Analysis of dementia drug prescription in groups 
P group FPgroup NPgroup Total 
Prescribed 1 2 0 3 
dementia drug 
Not prescribed 12 24 40 76 
dementia drug 
Value Exact significance 
(2 sided) 
Pearson Chi-Square 3.198 0.155 
Fisher's exact test 3.660 0.155 
There were no statistically significant associations demonstrated between those 
prescribed dementia drugs and the groups following the initial assessment. 
No statistically significant associations were therefore demonstrated between any of the 
central nervous system drugs and the groups following the first assessment. 
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3.6 Inter-rater reliability 
An assessment of inter-rater reliability was carried out to test the hypothesis that 
PAINAD and DisDA T can reliably be used to identity pain. In each of the four homes a 
sample of assessments were repeated by a second researcher who was unaware of the 
scores given from the initial assessment. The repeat observations were all carried out 
within a week of the initial assessment having been carried out. The tool (DisDA T or 
PAINAD) completed by the second researcher was same the tool completed by the main 
researcher in the initial assessment. The level of agreement between the scores was 
analysed using the Kappa statistic. 
Table 3.67 Analysis of strength of agreement between researchers' scores 
Number of Strength of 
participants Kappa Weighted agreement 
assessed statistic Kappa (Weighted 
twice Kappa) 
DisDATRest 13 0.414 0.343 Fair 
PAINADRest 12 0.089 0.128 Poor 
DisDAT Eating 11 -0.222 -0.262 Worse than by 
chance 
P AINAD Eating 7 0.097 0 Worse than by 
chance 
DisDAT 3 0 0 Worse than by 
Intervention chance 
PAINAD 6 0 0.175 Poor 
Intervention 
By using a weighted kappa statistic only the rest observation using the DisDA T showed 
fair agreement. The other observation agreements were either poor or worse than would 
have been expected by chance. 
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Chapter 4 - DISCUSSION 
4.1 Introduction 
The first objective of this research was to investigate the utility of a pain assessment and 
a distress assessment tool in a UK population with severe dementia. This objective was 
met by testing two hypotheses; that pain is common and under-recognised in this 
population and that such tools can reliably be used to identify pain. 
From a study population of79 participants, all with severe dementia, 16% were found to 
be in pain when assessed. Other studies, carried out in populations with moderate 
cognitive impairment, demonstrated that the proportion of patients with pain is between 
32-62% [116-118]. Hence, the proportion of participants with pain in this study is less 
than might have been predicted. The reasons for this difference are discussed later. 
Some participants had been identified by members of staff to have acutely painful 
conditions and treatment started. Other participants, who had developed painful 
conditions, had not been identified as having pain and were identified during the study. 
There were also several participants who were known to have potentially painful 
diagnoses whose pain was under-treated. Therefore, although pain was not as common as 
had been predicted by other research, there were instances where pain was under-
recognised. 
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A third of the participants in the study scored above two in one of their assessments 
using the PAINAD tool but were not felt to be in pain. Therefore the PAINAD tool 
cannot be reliably used to differentiate pain from distress from other causes. Those who 
were felt to have pain all scored greater than zero using the DisDA T, therefore some of 
the behaviour listed for each participant was observed when they were in pain. 
The second research objective was to demonstrate the ability of the tools to measure 
change in pain following change to the management regime, demonstrating that the tools 
are sensitive to change. There was a statistically significant change in both the PAINAD 
and DisDA T scores on intervention following change in management for pain. Therefore, 
both tools are sensitive to change. 
The third objective was to assess the nature of distress that may produce a false positive 
result on a pain scale. The majority of the behaviour observed seemed to be caused by the 
participant not understanding what was happening, leading to either fear and anxiety or 
anger and frustration. Other causes included distress caused by other residents, boredom 
and sadness. The CMAI scores for the false positive group were significantly different 
compared to those obtained by participants in the P and NP groups. The pain assessment 
tool used in this study identified behaviour from a wide variety of causes, not just pain. 
The same may be true of other pain assessment tools. 
The final objective was to examine the use of analgesia within nursing homes and in 
those identified as experiencing pain. Paracetamol was prescribed most frequently in all 
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the study homes, both as a regular prescription and as required. Those identified as 
having pain were managed either by non pharmacological methods or by prescribing 
regular analgesia using the WHO analgesia ladder. It was hypothesised that analgesia 
prescribing was inadequate for those with severe dementia who had pain. In this study 
almost halfofthose identified as having pain were already prescribed regular analgesia. 
The research findings are examined in greater detail in the chapters that follow. Initially, 
in section 2, I shall critique the design of the trial. In section 3, I shall compare the current 
research to previous research in the field. The results of the research will be discussed in 
section 4 to 12. In section 13, I shall discuss how the current research contributes to the 
principles of assessing and managing pain in dementia. Finally, in section 14, the 
implications of the research findings with regards to palliative care and dementia will be 
discussed. 
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4.2 Critique of trial design 
4.2.1 Recruitment 
The trial was specifically designed to assess good practice in pain management in severe 
dementia. Although some people with severe dementia are supported in their own homes, 
many live in nursing homes. In order to recruit sufficient numbers for the study, nursing 
homes were used as recruitment sites for the research. The homes were selected on the 
basis of having large numbers of residents with severe dementia and nursing staff who 
would be willing to participate in the study. 
It is possible that nursing homes with larger numbers of residents with severe dementia 
have better skills in recognising pain or distress in those unable to communicate. 
However, it would have been more difficult to recruit sufficient numbers for the study if 
the research was spread across more sites. It is also possible that homes with nursing staff 
that were willing to participate may have had a greater interest in managing pain and 
distress in their residents, which could have influenced the results. As this study relied 
heavily on nursing staff completing background neuropsychological scales and 
completing the pain and distress assessment tools, it would have been virtually 
impossible to carry out the study without the assistance of the nursing home staff. 
Nursing homes within the NHS and private sector were selected so that the results were 
applicable to both types of home. 
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4.2.2 Inclusions and Exclusions 
The level of dementia was assessed using the Clinical Dementia Rating scale (CDR) 
[134, 135] and those with a CDR score of 3 were deemed suitable for the research. The 
CDR has become one of the gold standards of global ratings of dementia in trials [237]. 
Other studies involving PAINAD have used the MMSE as a tool to assess levels of 
cognition, with a CDR score of three equating with 0-10 on the MMSE scale. The MMSE 
is susceptible to floor effects in those with severe dementia, as this group tend to score 
very few points [238]. In order to ask potential participants to complete the MMSE, 
assent would have had to be gained first. By completing the CDR with nursing staff, 
potential participants could be identified first and then assent gained for the study. 
As all the participants had severe dementia, they were not able to give informed consent 
for the study and hence assent was gained from the next of kin. Five potential participants 
had no next of kin and had a solicitor appointed to manage their affairs. All the solicitors 
listed were contacted to ascertain if they were able to give assent for the study to ensure 
that those without a next of kin were not excluded. Unfortunately none of the solicitors 
involved felt able to give assent for the research. The Mental Capacity Act [56], section 
32, was reviewed as to whether another person could be consulted with regards to giving 
assent. As the person needed to be interested in the participants' welfare but to have no 
connection with the project, it was difficult to identify such a person in all cases and 
therefore felt to be simpler to exclude this group of potential participants. 
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There were no other exclusion criteria used in this study. Other studies have used pain 
assessment tools specifically in those receiving medication for pain [3] or have excluded 
on the basis of recent admission to home or acute illness [183] or inability to report pain 
verbally [198]. By simply including all residents in a particular home with a CDR of 3, 
this research explored the utility of the assessment tools in all residents unable to report 
their pain reliably. 
4.2.3 Establishing dementia diagnosis 
Difficulties can arise in accurately ascertaining the underlying cause of a dementing 
illness; it is possible that this might have been the case for some of the study participants. 
Most study participants, however, had been reviewed by a consultant psychiatrist at some 
stage of their illness. It was presumed, therefore, that the underlying dementia diagnoses 
were reasonably accurate. 
4.2.4 Pain and distress tools 
There are numerous pain assessment tools designed for assessing pain that could have 
been used as part of the study. The criteria used for selecting suitable tools were that they 
had to be simple and easy to use, specifically designed for use in those with severe 
dementia and have some evidence of reliability and validity. Similar criteria were used by 
both Zwakhalen and Herr in their reviews of behavioural pain assessment tools for severe 
dementia [31, 183]. As discussed in the introduction, the Pain Assessment in Advanced 
Dementia (PAINAD) scale, adapted from OS-OAT and FLACC, has been found to be 
simple to understand and easy to use [31]. In the original study by Warden et al it was 
217 
found to have good inter-rater reliability but only moderate internal consistency [3]. 
Further work using the German version of the tool demonstrated good internal 
consistency and satisfactory retest reliability [118]. The PAINAD tool has been criticised 
for only covering common pain indicators and potentially ignoring more subtle pain 
indicators. In addition using a scale to score intensity of behaviours has not been 
substantiated in the literature [31] and work by Schuler et al demonstrated that the scale 
did not measure pain intensity [118]. However the PAINAD tool has been used to 
demonstrate cbange in levels of pain by administering the tool before and after PRN 
analgesic medication was given. The ability to identify change in pain following 
treatment has not been evaluated in other pain assessment tools. 
The reviews of behavioural assessment tools by Hadjistavropoulos and Herr both 
concluded that no current tool could be recommended for adoption into generalised 
practice [31, 170]. Two of the main criticisms of the current behavioural pain tools were 
that "patient's pain responses can be unique" and "research has not yet established the 
sensitivity of presence of individual behaviours as indicators of pain" [31]. The second 
assessment tool was selected to evaluate whether these concerns could be addressed by 
adopting a different approach. 
The Disability Distress Assessment Tool (DisDA T) was developed to document the wide 
range of signs and behaviours of distress of people with intellectual disabilities. By 
completing a list of distress and contentment behaviours for the specific person, the tool 
could be tailored specifically to the person, thus recognising their specific behavioural 
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signs. In addition, labelling the behaviours observed as behaviours of distress rather than 
pain acknowledges the lack of evidence that there are specific behaviours that indicate 
pain. The cause of the behaviours of distress could be pain, but equally could be due to 
fear or anger or other negative emotions. The tool is not designed to be a scoring tool as it 
was felt that it was not possible to put numerical values onto behaviours, however the 
tool can be used with monitoring sheets in order monitor change in the behaviours 
observed. Carers who have used the tool have found that it is simple and easy to use [4]. 
Although the tool was originally designed to be used for people with learning disability 
who were unable to communicate, it was felt that the tool would be suitable for those 
with severe dementia. There are no published studies using this tool in elderly people 
with dementia, this is one of the first studies to use the tool in this group. As the DisDAT 
is not a scored tool it is difficult to establish its psychometric properties, however work is 
currently on-going in this area. 
4.2.5 Assessment method 
It is argued that establishing validity for any pain or distress tool for use in those with 
severe dementia is very difficult as there is no gold standard with which to compare the 
tools [31, 170]. Other pain assessment tools use the patients self-report as the gold 
standard with which they are compared. Those with severe dementia, who have 
communication difficulties, cannot provide this gold standard; hence deciding whether a 
tool does measure pain is very difficult. Using pain tools during specific situations, 
typically felt to be painful, is a method that has been employed by several research teams 
[121, 183, 200]. This technique can be problematic as there may equally be other 
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negative emotions associated with the situation, particularly if the person does not 
comprehend the situation, owing to cognitive impairment. There may be associated fear 
or confusion as to what is happening, or anger at what is being done, all of which might 
be captured by the pain tool. It was therefore decided that using these tools in routine 
care, in order to try and identify pain, would be the initial method to assess utility. If pain 
was found during the routine care and treated, it was decided to assess whether the tools 
were able to measure that change. In these two ways the usefulness of the tools as part of 
care in those with severe dementia could be assessed. 
The observations took place at three different times in a participants' day, at rest, during a 
meal and during intervention. Other studies, as discussed previously, have used 
observations purely during intervention. Although a proportion of pain experienced may 
be musculoskeletal in nature and hence movement related, observing during other times 
in the day will help in capturing non-movement related pain. The original study by 
Warden et al used observations at three separate times, at rest, during a pleasant activity 
and during a potentially unpleasant activity such as toileting or transfers [3]. The original 
research plan was to use these three times; however, it became apparent that defining a 
period of pleasant activity for each participant in the study was going to be difficult. It 
was therefore decided that participants would instead be observed whilst eating a meal. It 
was felt that this may help to identify pain during chewing or swallowing. 
The participants were observed for approximately five minutes during each observation. 
Although observing for longer periods would allow more time for behaviours to be noted, 
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it was felt that this could potentially become intrusive and therefore distressing to the 
participant. It was also felt to be important that the observation time frame could be 
replicated by nursing staff during their every day practice. Other research has asked for 
staff to recall behaviours over a much longer time frame [198]; however, this may be 
subject to recall bias, rather than staff documenting what they had just witnessed. Some 
research studies have videoed participants for short periods of time, which may have 
advantages in allowing inter-rater reliability to be accurately addressed. It was felt, 
however, that fewer relatives would be happy to give assent for this to be carried out, 
particularly the recording of intimate care. Video taping was carried out in the study by 
Zwakhalen et af [183], but a quarter of those who originally consented to the study 
refused to participate further. 
The two assessment tools were both used at each of the observations. The behaviours for 
the DisDA T had been generated for the participant by asking at least two of the nursing 
staff involved in their care to complete the scale. This was in recognition that different 
members of staff may pick up different behaviours of distress, as discussed in the original 
research by Regnard et af [4]. At the time of assent being given, each participant was 
given a randomly assigned number. This was used to decide which tool the nurse or 
researcher used during the observation. It was felt to be important that both tools were 
used equally by both nursing staff and the researcher, so that it could be established that 
both could be used successfully by nursing home staff. Although both tools could have 
been completed by both nursing staff and the researcher during each observation, it was 
felt that this could affect how accurately the tools were completed. 
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It is possible that my presence in the participants' room during the observation may have 
affected the behaviours seen. It is difficult to know if having an observer present whilst 
routine care was taking place may have changed how the nursing staff carried out that 
care, with more time perhaps being given than would normally have been the case. It was 
always stressed prior to the observation that the purpose of the research was to assess the 
behaviours seen during the time of intervention and not the work of the nursing staff. If 
the research project prompted the staff to think more carefully about how routine care 
was given, this would be of benefit to the participant. In which case, this might in part 
explain the lower than expected prevalence of pain. Against this, however, is the number 
of participants who were felt to be distressed from reasons other than pain. An advantage 
of being in each particular home frequently for several months was that staff became 
accustomed to my presence as a researcher. 
Another potential concern was that my presence in the room whilst care was being given 
could be distressing to the participant. Prior to the observation taking place the nursing 
staff were told that if they felt that my presence in the room was precipitating distress 
then they would alert me and I would simply leave the room. One way of avoiding these 
biases would be simply to ask the nursing staff to complete the tools. It was, however, 
necessary for me to be present in order to evaluate what had provoked the behaviours 
observed and begin to assess what the underlying cause for the behaviours might be. 
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4.2.6 Establishing outcomes 
It is possible that not all episodes of pain were correctly identified. Without a gold 
standard (which would normally be self-report) it is impossible to be 100% certain that 
all behaviours were accurately interpreted. The decision about whether or not a 
participant's behaviour indicated the presence of pain was made from the observation as 
well as infonnation from other sources. This included review of medical, psychiatric and 
nursing notes, physical examination and repeat observations if necessary, as outlined in 
the methods. Although this assessment can not be termed a gold standard, it was as 
thorough as could be expected in routine care. 
As described in the methods, the false positive group was defined using the PAINAD 
scale. It was important to decide which participants without pain should be assessed 
further and the original data from Warden's study [3], the study by Leong et al [198], as 
well as work regarding V AS [230] suggested that those scoring above two out of ten 
potentially had significant behavioural markers of a negative emotion. The false positive 
group has been defined in this way uniquely in this study. The false positive group cannot 
be described as a control group to compare with the pain group. The false positive group 
demonstrated behaviours of distress from causes other than pain and changes were made 
to reduce their distress, but not as part of the research. In order to have a true control 
group, a group of participants with pain would need to be identified and reassessed 
without changes made to the management of their pain. This would be unethical; hence a 
true control group was not created for the study. 
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As described in the methods, a second researcher was used to assess inter-rater reliability. 
Although to provide true inter-rater reliability the raters should be observing at exactly 
the same time, this was difficult achieve owing to the work schedules of both researchers. 
In addition it was felt to be too intrusive to have more people observing intimate care. It 
was, however, felt to be important to gain some measure of inter-rater reliability of the 
two tools. 
4.3 Comparison with previously published trials 
The PAINAD scale was first published in 2003 by Warden et al [3]. When the current 
research study commenced, there had not been further published studies using PAINAD 
to assess pain. Since 2006, six studies have been published (the study by Gibson el al in 
2004 [196] was not published in a peer reviewed journal). These have been carried out 
mainly in nursing homes around the world; however none has taken place in the UK. The 
current research is the first to use P AINAD in UK nursing homes. 
Other work, as discussed earlier [152, 160], has demonstrated that self-report scales can 
be reliably used in those with mild to moderate dementia. These studies have also shown 
that self report scales are less successful for those with severe dementia, hence using 
behavioural assessment scales seems a sensible approach. Out of the published research 
to date, only the original study by Warden el al [3] solely used participants with severe 
dementia. The participants in the Leong study [198] had moderate to severe dementia but 
they were able to answer questions regarding their pain. The studies by Gibson, 
Zwakhalen and Schuler [118, 183, 196] all had participants with severe dementia, but 
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also contained participants with mild to moderate dementia. The participants in the 
research conducted by Basler et al [229] were verbally non-communicative and had 
dementia, however, owing to the original study being published in German, it is unclear 
how this was assessed. 
The previous studies involved varying numbers of participants. The mean number of 
participants from other studies using PAINAD was 77, which compares well with the 79 
participants in the current research. Most other studies used nursing staff to complete the 
scale, in common with this research. In addition, the majority of other studies used the 
PAINAD tool in conjunction with another pain assessment tool to provide a comparison. 
This research used a distress assessment tool, DisDA T to provide a comparison. As 
DisDA T has not previously been used with elderly participants with dementia, there are 
no other research trials with which to provide a comparison. No previous studies, 
however, have used PAINAD in conjunction with a distress assessment tool. 
The method of observation varied between the previous studies. In the Zwakhalen study, 
observations were carried before and during influenza inoculations as a painful event 
[183]. Gibson, Schuler and Basler all carried out observations at times of routine care and 
movement [118, 196, 229]. Leong asked the nursing staff to complete the PAINAD 
reflecting on the participants' pain behaviour over the previous week [198]; it is therefore 
possible that some behaviours were forgotten. The study by Warden et al used three 
different observation times: no stimulation, rest or pleasant activity and an unpleasant 
event [3]. Although a proportion of pain experienced by elderly participants with 
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dementia may be musculoskeletal in nature, it is possible to have pain during other times 
of the day. This approach was, therefore, adopted in this research to give a broader view 
of the participants' pain and not solely focussing on specific painful events or movement 
related pain. 
Only two previous studies have looked at the effects of the PAINAD scores after treating 
pain. The study by Warden et al also involved a second cohort of 25 participants and 
collected data on their PAINAD scores before and after administering as required pain 
medication. They demonstrated a significant improvement in PAINAD scores. Basler 
involved 12 participants with pain who had their PAINAD scores recorded before and 
after commencing analgesia [229]. They reported diminished pain behaviour two hours 
after commencing medication. Again, as the original paper was published in German, it is 
difficult to know how significant the change in scores was. The current research involves 
13 participants who have been identified as having pain and commenced on a 
management strategy for their pain. In common with the Warden and Basler studies, an 
improvement in P AINAD scores was seen on treatment of pain. 
Other studies have questioned the ability of PAINAD solely to identify pain. The original 
study by Warden discusses the possibility that alternative causes of the indicators 
included in the PAINAD scale have to be excluded, such as anxiety, resistiveness to care 
or negative emotions. This is highlighted in many of the questionnaire comments in the 
study carried out by van Iersel et al [201], where carers were concerned that some of the 
behaviours seen were caused by fear, anger or loneliness. Unlike the present study, none 
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of the previous studies has attempted to quantify the extent to which PAINAD scores 
might reflect reasons other than pain. Schuler et af [118] used the Neuropsychiatric 
Inventory and the Apathy Evaluation Scale to ascertain if the PAINAD was only 
measuring pain. There was no significant correlation between these scales and PAINAD 
scores in those with pain; they concluded that PAIN AD measures a psychological 
construct other than those measured by the two scales. However, as demonstrated in the 
current work, there may be a wide variety of causes for the behaviour seen and simply 
collating these all in a broad scale such as the NPI may lead to the importance of the 
different causes being lost. It is also worth noting that in Schuler et af, those felt not to be 
in pain did not have a PAINAD score of zero, again suggesting that the PAINAD tool 
may identify behaviour with causes other than pain. 
The previously published research using PAINAD is summarised in the table over leaf. 
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Research Warden Leong eta! Van Iersel Zwakhalen Gibson Hutchison Schuler Basleretal 
study eta! 2006 [198] eta! eta! eta! eta! eta! 2006 [229] 
2003 [3] 2006 [201] 2006 [183] 2004 [196] 2006 [200] 2007 [118] (English 
abstract, 
German 
paper) 
No of 19 in initial 88 157 128 80 27 99 12 
participants study, 25 in 
intervention 
study 
Degree of Mean Moderate to Not 47% had Mean 76% Mean Verbally non 
cognitive MMSEof severe documented severe or MMSEof diagnosed MMSEof communicative 
impairment 2.8 +/-4.5 dementia, very severe 13.9 +/- 8.2 with 12.1 +/- 9.7 patients with 
able to cognitive dementia, dementia (not 
answer impairment 23.6% had clear how this 
questions MMSE<25 was assessed) 
about pain 
Scales used PAINAD, PAINAD, PAINAO PAINAD, PAlNAD, PAINAD VOS PAINAD 
VAS, VDS and Abbey PACSLAC, abbey, (with a completed 
OS-OAT completed Doloplus-2 verbal and control by nurses 
by nurse numeric group with prior to 
and BPI, aMMSE> observation, 
participant informant 25 rated then 
BPI using a PAINAD 
VAS) 
Tool Research Nursing Nursing Nursing Nursing Nursing and Nursing Nursing staff 
completers team staff staff staff staff medical staff 
staff 
Setting Dementia Nursing Nursing Nursing Nursing Post surgery Nursing Geriatric clinic 
special care homes in homes in homes in homes in in USA homes in in Germany 
unit, USA Singapore Belgium Holland Australia Germany 
-
Research Warden Leong etal Van Iersel Zwakhalen Gibson ttal Hutchison Schuler Basler etal 
study etal 2006 ttal etal 2004 etal etal 2006 
2003 2006 2006 2006 2007 (English 
abstract, 
German 
paper) 
Scales Yes after No No Scales Scales No Scales Given 
repeated? PRNmeds completed completed at completed analgesics 
given in the before and rest and on after 2 mins after 1st 
second part during movement observation, observation. 
of the study influenza carried out PAINAD 
vaccination morning and repeated after 
evening treatment 
stopped in 5 
patients 
Outcomes Good inter- PAINAD 52% of PAINAD PAINAD More 39 had pain. PAINAD 
rater correlated nursing staff showed good showed fair analgesics Good internal scores 
reliability, well with feitPAINAD homogenicity , inter-rater given to consistency, remained low 
moderate NRPSbut was useful to reliability and reliability , group inter-rater only for those 
internal both judge pain. validity. very good assessed reliability and still on 
consistency. correlated Concerns PACSLAC internal using retest treatment 
Reduction of poorly with about specific found to be consistency PAINAD, reliability . 
PAINAD SRPS items and more useful but low unclear why PAINAD 
scores after ability to by care concordance those without scores higher 
medication in measure pain providers on movement cognitive in those with 
2nd part of not with impairment pain, but too I 
study discomfort informant were not did not 
BPI asked about measure 
their pain intensity 
Table 4.1 Previously published research using PAINAD 
To summarise, the current work is the first research study of using the PAINAD tool in 
UK nursing homes and the first to compare it with a distress tool. The numbers of 
participants in the study were comparable to other studies and used nursing staff to 
complete the scales. Unlike some other studies, the participants all had severe dementia 
and were not just assessed at times of intervention, but at other times during the day. Few 
studies have examined the effect of PAINAD scores on using analgesia and similar 
results were obtained in this work to those in other such studies. Although other studies 
have suggested that the PAINAD tool may identify behaviours due to reasons other than 
pain, none have to date examined how frequently this may occur or what the reasons for 
that behaviour might be. The sensitivity and specificity of the PAINAD tool has not been 
described in previously published studies. By using a PAINAD score of above two to be 
of relevance, the current work has demonstrated that PAINAD is a sensitive tool with 
regards to identifying pain, but has a specificity of 61 %. Although several aspects of the 
relative utility of both PAINAD and DisDAT has been demonstrated in this pilot study, 
such as the ability to demonstrate change in scores with treatment of pain, further work is 
necessary to explore the utility of the tools as part of the management of those with 
severe dementia. This is discussed in more detail in section 5.5. 
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4.4 Discussion of background data 
Of the 79 study participants, 72% were female. This percentage reflects UK data for 
dementia as detailed in the recent Kings College report of 2007, where the national ratio 
for dementia is approximately two women for every man affected [8]. This is due to 
higher mortality among men and higher age specific dementia prevalence in women. This 
effect is probably exaggerated in this study owing to the study specifically including 
those with severe dementia. Similar ratios were seen in other research involving PAINAD 
including the work by Zwakhalen and van Iersel [183,201]. 
In the current research, 53.2% of participants had Alzheimer's disease, 29.1 % had 
vascular dementia and 11.4% had mixed dementia. The Kings College report [8] 
estimated that around 62% of people with dementia have Alzheimer's disease, a higher 
proportion than our study population. In addition the report found that vascular and 
mixed dementia accounted for around 27% of cases, the current study population had a 
much greater proportion of vascular and mixed dementia. There are several reasons why 
this may have occurred. The vast majority of study participants had been given a 
diagnosis by a consultant psychiatrist; whether this is true of all ofthe Kings College data 
is not clear. The rates of cardiovascular disease in the north east of England are higher 
than in many areas of the UK [239], which may explain the larger proportion of study 
participants with vascular or mixed dementia. The number of participants with Dementia 
with Lewy bodies (DLB) is fewer than might have been expected; the prevalence is 
usually thought to be just under 20% of dementia cases [13]. This may in part be due to 
the majority of participants being female, whereas DLB has a slight male excess [13, 
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240] . From other studies conducted using the PAINAD scale, only Zwakhalen el al [183] 
reported the dementia diagnoses of study participants, with 32% having Alzheimer's and 
18.8% vascular dementia. 
The mean age of participants in the current study was 81.9, with the Kings College data 
reporting that two thirds of those with dementia are aged 80 and over [8]. Other studies 
that have used PAINAD had participants whose mean ages ranged from 78 to 88 [3, 118, 
183, 196, 200, 229]. 
The range of time since the participant was given a formal diagnosis of dementia is quite 
broad in this study, stretching from those who had only been given their diagnosis 15 
months previously to those who had been diagnosed 16 years ago. This probably reflects 
the differing prognoses with different types of dementia. Those with Alzheimer's disease 
have a variable prognosis of between 2 to 16 years (24 to 192 months), whereas those 
with vascular dementia have a shorter prognosis of around 5 years (60 months) [13]. In 
addition the participants had been resident in their current home from as little as 2 months 
up to over 9 years. It is possible that those who had only recently been admitted to the 
home might have been harder to assess, as the staff may not know them as well as those 
who had been resident in the home for a longer period of time. Having a broad range of 
times since the participants were admitted allows for this potential variability. 
In summary, the participants in the study were matched for age and sex to both national 
reports on dementia demographics and other similar research studies. There was a wide 
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range of both time since diagnosis and time since admitted to home, hence the 
participants would be representative of many of those with severe dementia. It is difficult 
to know whether having a greater proportion of participants with vascular dementia has 
affected the results obtained. Much of the research regarding how neuropathology of the 
dementing process may affect the pain experience has centred on Alzheimer's disease, 
with less research specifically focussing on vascular dementia. It has been hypothesised 
that both the medial and lateral pain pathways could be affected by infarcts in vascular 
dementia, possibly reducing the pain experience [131]. As these infarcts can potentially 
cause central post-stroke pain, it has been postulated that those with vascular dementia 
may experience more pain. This has been suggested by Scherder et al [142] in a small 
study. However, not all of the participants had CT or MRI evidence of vascular disease. 
A more recent study [143] looked at the relationship between cardiovascular risk factors 
and pain in people with cognitive impairment but left many unanswered questions 
regarding the role of these risk factors. With a lack of conclusive evidence surrounding 
whether any type of dementia either reduces or increases the pain experience, it is not 
possible to conclude whether the proportions of the various types of dementia could have 
influenced the eventual outcomes. 
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4.5 Discussion of the background neuropsychiatric scales 
4.5.1 Depression 
The study participants had a median CSOO score of 5, with scores below 6 usually 
indicating an absence of significant depressive symptoms. There were, however, 10 
participants (12.6%) who had a CSOD score of above 10 which may indicate major 
depression. Research carried out by Ballard et al [241] examined the prevalence of 
depression in those with Alzheimer's disease and vascular dementia, also utilising the 
CSDD. For severe dementia (MMSE < 10), 12.5% of their study population had scores 
indicating major depression, which compares well with the level of major depression 
identified in the current research participants. 
4.5.2 Dependency 
The original work by Pattie and Gilleard categorised those with a CAPE-BRS score of 
greater than 18 as being of maximum dependency due to severe impairment and those 
with scores between 13 and 17 being high dependency [227]. Other studies using CAPE-
BRS with participants with severe dementia have demonstrated a mean score between 21 
and 22 [242]. The majority of the participants in the study could be categorised as being 
either high or maximum dependency according to their CAPE-BRS scores. Only three 
participants scored less than 13, which would indicate medium dependency. The level of 
dependency of the participants is reflected by the level of care they required as all were 
resident in either EMI or ESMI nursing homes. 
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4.5.3 Psychopathology 
The mean NPI score for the study participants was 14.5. A study carried out in Belfast of 
435 patients with probable Alzheimer's disease used the NPI to examine levels of 
behavioural and psychological symptoms [243]. The group examined had a mean MMSE 
of 13 and a Functional Assessment Staging score of 6 (with 6 or 7 regarded as indicating 
severe dementia). The mean total NPI score of this study population was 41, considerably 
higher than the mean scores for the current research group. 
There are several potential reasons for the differences between the two populations. 
Although the MMSE was not measured in the current research, it is likely that the mean 
MMSE would be less than 13 as all the participants in the current research had a CDR 
score of 3 (which is often equated with an MMSE of less than 10). It is possible that 
neuropsychiatric symptoms are more obvious in the moderate stages of dementia and 
become less obvious in the more severe stages, as in the current population under study. 
In addition, only 6% of the participants in the Belfast study were resident in an EMI 
unit/ward, with the majority living at home. It is possible that in more specialised units 
components of the NPI, such as night time behaviours or depression, would have been 
identified and managed and therefore less likely to produce a score on the NPI. Finally 
the participants from the Belfast study all had Alzheimer's disease, whereas the current 
study involved participants with a range of dementia diagnoses. These factors may all 
contribute to the differences seen between the mean NPI scores in the current research 
and a large recent study. 
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4.5.4 Agitation 
The mean CMAI scores for the study participants was 52.2. A recent study of agitation 
using CMAI in 211 nursing home residents in Norway [244] found a mean total CMAI 
score of 42.7 in those with a Functional Assessment Staging score of 6 or 7. The paper 
discusses the reasons why levels of agitation are generally lower in Norwegian homes as 
the homes are smaller, have high staffing ratios and utilise person centred care 
techniques. There are few other studies looking at agitation levels using the CMAI. Most 
of these are of those with dementia living in the community or are drug trials where those 
selected are noted to have high levels of agitation. It is difficult therefore to compare the 
agitation levels seen in the current study population to other studies utilising the CMAI. 
In summary, the level of depression amongst the study participants was comparable to 
other research of depression in dementia. The level of dependency was in keeping with 
the placement policy for those with advanced dementia. Levels of psychopathology were 
lower than other studies; however it was difficult to identify studies carried out on similar 
populations. Levels of agitation were slightly higher than in a similar population studied 
in Norway. The lower psychopathology and higher agitation levels of the population 
studied may have influenced results obtained at one month; however without having 
immediately comparable studies, it is difficult to comment on the magnitude of this 
effect. 
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4.6 Discussion of the first assessment results 
From the 79 study participants, 13 (16%) were felt to be in pain during at least one of the 
three observations. The remaining 66 participants who were not felt to be in pain were 
subdivided as described previously, with 26 participants (33%) scoring above 2 on the 
P AINAD scale in at least one of the three observations. The level of pain detected by 
carrying out the observation was not as high as was originally anticipated when the study 
was designed. Research involving elderly nursing home residents has suggested that 
between 45-80% will describe substantial pain [28-30]. Although it is clearly difficult to 
define the proportion of those with severe dementia who experience pain, extrapolating 
from research carried out from those with moderate cognitive impairment suggests that 
between 32-62% [116-118] will experience pain. This is clearly more than the proportion 
that was identified by the current research study. There are several reasons why this may 
have occurred. 
1. The observation time frame was too brief 
Each observation, whether at rest, during a meal time or during intervention, lasted 
approximately five minutes. Occasionally the observation period was longer; particularly 
during intervention as the nursing staff were only able complete the tools once the 
intervention was complete. Other studies have used observation times of two minutes 
[118, 183,229], whereas Leong et al asked nursing staff to recall behaviours over a week 
[198]. Clearly if a participant is only observed for a short time frame such as five 
minutes, this leaves large periods of time where they are not observed as closely. There 
may be behaviours caused by pain that therefore simply go unnoticed. One alternative is 
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to observe a participant closely for a longer period of time; however this runs the risk of 
becoming intrusive and may provoke distress in the person being observed. Another 
possibility is to ask staff to recall behaviours observed over a time frame, similar to the 
method employed in Leong et al. This may be subject to recall bias and a more accurate 
record may be created by documenting immediately what has been observed. The five 
minute time frame was used in the original study by Warden el al [3] to strike a balance 
between being long enough to observe behaviour but not too long to become intrusive. It 
is acknowledged that in using three five minute observation times some behaviours 
occurring during the day (and therefore pain) may have been missed. 
2. The dementing process affects the pain experience 
There is evidence that the pain experience may be altered for those with severe dementia, 
which could potentially reduce the numbers of participants found to be in pain. As 
discussed in the introduction, the neuropathological changes that occur in Alzheimer's 
disease and vascular dementia have been postulated to affect pain pathways [130, 131]. 
Clinical evidence for an altered pain response to this has been provided by case reports 
[132] in Alzheimer's disease sufferers. There has also been research demonstrating a 
change in physiological parameters in response to acute pain stimuli [133, 136, 137] in 
those with Alzheimer's disease. The evidence for neuropathological changes affecting 
pathways has been challenged by recent work utilising tMRI techniques. This 
demonstrated that activity in both medial and lateral pathways was preserved in response 
to pain stimuli [141]. It is, therefore, difficult to say with certainty that dementia affects 
the pain experience in all sufferers. There may have been some participants within the 
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study sample who did experience pain in a different way to other participants; however it 
is impossible to know what proportion ofthe sample this might be. 
3. Behavioural pain scales do not assess pain as accurately as self report methods 
Both subjective (self report) and objective (behavioural assessment) approaches are used 
in the management of chronic pain. It has been suggested that self report cannot be 
replaced by pain behaviour observation [177] particularly as concordance between the 
two measures has been demonstrated to be either low or moderate [176-178]. It is 
possible that the different approaches constitute different but complementary components 
of the pain experience [177, 245]. In addition, patients do not always express pain 
behaviours in predictable ways [179]. The studies comparing behavioural assessment 
tools and self-report have principally involved chronic pain patients without cognitive 
impairment. The study carried out by Pautex et ai, as discussed in the introduction, 
demonstrated that an observational pain assessment tool also correlated only moderately 
with self assessment in a group of patients with severe dementia who were able to report 
their pain [174]. In addition, Gibson et al demonstrated low to moderate levels of 
concordance between PAINAD and a self report scale (Brief Pain Inventory) when used 
with patients with severe dementia [196]. It is possible, therefore, that behavioural pain 
scales do not always identify pain as accurately as might be gained from self report. This 
may therefore explain some of the differences between the predicted levels of pain 
obtained by self report and those identified utilising behavioural techniques. In addition, 
although every effort was made to identify the cause of the behaviour correctly, it is 
possible that behaviour caused by pain was misinterpreted. 
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4. Better pain assessment and management in the homes involved 
The nursing homes had several weeks from agreeing to the study to the actual 
observations commencing, during which time assent was sought from the relatives of 
potential participants. There could have been more of a drive to assess and treat pain prior 
to the observations starting. However this seems unlikely as only 10 participants were on 
regular analgesia and very few had had this recently commenced. It is possible that those 
in the NHS ESMI home would have had greater access to medical input and potentially 
had pain managed more successfully prior to the research starting. In addition, two of the 
nursing homes (Cleveland Park and Appleby) had regular weekly GP input. Despite these 
differences between medical input in the homes, it was demonstrated that the place of 
residence was not significantly associated with the groups in which the participants were 
allocated following the initial assessment. 
The most likely factors, therefore, leading to fewer participants being identified as being 
in pain were; the time frame for observation, the potential for dementia to affect the pain 
experience, the possibility that behavioural assessment methods may measure a different 
aspect of the pain experience than self report and the potential for the behaviour observed 
to be misinterpreted. It is difficult to be certain to what extent these factors influenced the 
levels of pain identified or if anything further could have been done to control for these 
issues. It is possible that other studies, that quantify levels of pain in those with dementia, 
were affected by these factors. For example, in the study by Schuler et ai, some of the 
behaviour observed may have been misinterpreted as pain behaviour by nursing staff, 
leading to higher levels of pain being recorded [l18]. 
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It is worth highlighting that although participants were assigned to the groups on the basis 
of the first assessment, this did not necessarily indicate that those not identified as having 
pain initially could not develop painful conditions at a later date. An example of this 
occurring has been provided in clinical vignette 8. 
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4.7 Discussion of the associations with groups 
4.7.1 Sex 
No significant association was found between the assigned groups following the first 
assessment and the sex of the participant. Epidemiological studies demonstrate that 
women compared to men will report more severe pain intensity, more frequent pain, pain 
in more areas of the body and pain of longer duration [246]. There are many painful 
conditions that are more common in women than men (such as head and neck pain and 
rheumatoid arthritis) that may account for the differences as well as an increased 
willingness of women to report pain and seek healthcare. The inclusion criteria for the 
study participants in the current research included being unable to communicate verbally 
in a reliable or consistent manner. The study participants, by definition, were unable to 
report their pain therefore potentially leading to the gender differences being unapparent. 
No other studies have specifically addressed whether gender differences in pain may be 
different in severe dementia. 
4.7.2 Dementia diagnosis 
There was no significant association found between the assigned groups following the 
first assessment and the dementia diagnosis of the participant. From examining table 3.9 
on p 139 regarding dementia diagnosis; it would appear that the proportion of those with 
vascular dementia with pain was greater than the proportion of those with Alzheimer's 
disease who had pain; however this was not statistically significant. 
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As discussed previously, the current published research regarding how dementia 
diagnoses may affect the pain experience is not fully conclusive, making it impractical to 
draw finn conclusions for all those suffering from dementia. This factor, coupled with the 
current research finding of no statistically significant associations between pain and 
specific dementia diagnoses, highlights the importance of assessing pain in all those with 
dementia, whatever their underlying diagnosis might be. 
4.7.3 Place of residence 
There was no significant association found between the assigned groups following the 
first assessment and the place of residence of the participant. All the homes involved in 
the study were located in the same geographical area and had large numbers of residents 
with severe dementia. A potential influence on pain management within the homes could 
have been the level of medical input within the homes. Tynemouth Court is a NHS ESMI 
unit with regular consultant psychiatrist review as well as input by junior medical staff. 
Both Cleveland Park and Appleby homes have weekly GP input from a local practice 
with most residents transferred to this GP's care. The participants at Willow Court are 
seen by their GP when requested to do so by medical staff at the home. Despite these 
differences regarding medical input, this does not seem to have affected the number of 
participants from each home that were found to have pain. 
In summary, no statistically significant associations have been demonstrated between 
these categorical variables and the groups assigned following the first assessment. The 
current research has not demonstrated that pain is more commonly seen in a particular 
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sex or for a particular dementia diagnosis. In addition, despite different homes being 
involved in the study, pain was not identified more frequently in any particular home. 
The lack of specific associations between these variables and pain being identified 
suggests that it is not possible to target a particular group when trying to identify pain. It 
is worth highlighting that some of the numbers in each subgroup for certain variables 
were quite small. It is possible that with greater numbers of participants some 
associations may have been identified. 
4.7.4 Age 
There was no significant association found between the assigned groups following the 
first assessment and the age of the participant. Studies examining the epidemiology of 
chronic pain in the community have demonstrated that age is a significant predictor of the 
presence of pain, with increasing proportions of people reporting chronic pain as they get 
older [247]. As discussed previously, numerous studies of elderly people have 
demonstrated prevalence of pain to be between 49% and 83% [30]. What is less clear is 
whether there is a difference between age groups within the cohort of patients who are 
elderly (often given as those over 65 years old). Several studies demonstrated that levels 
of pain are less with increasing age. The study by Won et al [103] highlighted that the 
presence of pain was lower amongst those aged over 85; there were also lower levels of 
reported cancer pain in the study by Bernabei et al [29] in the same age group. These 
findings were also borne out by a recent study by Zyczkowska et al [248] who 
demonstrated that the mean reported pain score in elderly nursing home residents was 
lower with each 5 year increment above the age of 65. Research carried out in Sweden by 
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lakobsson et al [249], however, demonstrated that pain was more common with higher 
age with the greatest prevalence of pain reported by those over 90. All the participants 
from these studies were able to give a report of their pain, unlike the participants in the 
current research. It is unclear whether levels of pain do alter with increasing age if people 
are unable to report their pain; this was not demonstrated by the current research. 
4.7.5 Time since diagnosis 
There was no association found between the length of time since the diagnosis of 
dementia had been made and the groups following the first assessment. The mean time 
since diagnosis was much less in the pain group than the other groups, however this was 
not statistically significant. As dementia progresses, potentially painful conditions may 
develop. Weight loss is frequently seen in advanced dementia that may lead to increased 
pressure damage. Loss of mobility may lead to increased falls and increased risk of 
fractures. Recurrent infections, that may be painful, are also more common [16, 67]. It 
could be hypothesised therefore that dementia becomes more painful as the condition 
progresses; however this was not seen in the current research. This may be because the 
research was carried out in EMIJESMI homes where these potential complications of the 
condition are well recognised and efforts therefore made to avoid them occurring. 
4.7.6 Time since admission 
Again there was no significant association with the length of time that the participants 
had been resident in their current home and the groups following the first assessment. The 
mean and median times since admission were much less for the false positive group than 
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the other two groups; however this was not statistically significant. It is possible that 
those who had been more recently admitted were less settled in their surroundings 
potentially causing more agitation. It is also possible that with some participants only 
being resident in the home for a short period of time, the staff may have had less 
opportunity to develop strategies for dealing with this agitation. These factors may 
explain some the differences between the groups. 
This study has, therefore, not demonstrated an association between these continuous 
variables and the groups assigned following the first observations. The current evidence 
regarding the effect of age on levels of pain for those over 65 is inconclusive and an 
association between age and pain was not demonstrated by the current research. Although 
there are reasons why dementia may become increasingly painful as the disease 
progresses, this was not demonstrated by the research. Finally, although there were 
differences seen between the groups in terms of the length of time that a participant had 
been resident in a home, these differences were not found to be significant. Again, the 
lack of specific associations between these variables and pain being identified suggests 
that it is not possible to target a particular group when trying to identify pain. 
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4.7.7 Background neuropsychiatric scales 
No significant association was found between the measures of depression, dependency 
and psychopathology (CSDD, CAPE-BRS and NPI) and the groups following the first 
assessment. Parmelee et al [150] demonstrated a strong association between pain and 
depression in nursing home residents, however all of the participants were able to report 
their pain and complete depression scales. There is little data regarding associations 
between pain and depression in those with severe dementia, presumably owing to the 
difficulties in measuring these parameters in people who are unable to communicate. It 
could be hypothesised, in those who are increasingly dependant, that there may be an 
increased frequency of painful complications of dementia, such as pressure damage. 
Although the median CAPE-BRS score was slightly greater in the pain group, this was 
not statistically significant. The NPI measures several variables including hallucinations, 
depression, irritability and aberrant motor behaviour. It could be presumed therefore that 
NPI scores may have been higher in the pain and false positive groups, rather than those 
who did not score highly on either the pain or distress scores. This was not seen in the 
results from the study participants. It is not obvious why there was not an association 
between depression, dependency and psychopathology and the groups as might have been 
predicted, but the small numbers in each group following the first assessment may have 
been a factor. 
There was however an association between agitation and the groups following the first 
assessment. The CMAI scores obtained for those in the false positive group were 
significantly greater than those in the other groups. The false positive group exhibited 
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behaviours that can be associated with pain, but were not actually felt to be in pain. It is 
possible that these behaviours were behaviours associated with agitation, which is a 
common behavioural symptom in severe dementia [67]. The underlying causes for the 
behaviour observed are discussed in greater detail later in this chapter. 
Therefore, although a significant association was not demonstrated between levels of 
depression, dependency and psychopathology in the groups following the initial 
assessment, a statistically significant association was demonstrated between agitation 
levels and those participants in the false positive group. This may suggest that the 
behaviours seen in the false positive group could have been behaviours that are often 
associated with agitation e.g. verbal aggression, restlessness. 
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4.8 Discussion of the initial P AINAD scores 
Analysis of the mean initial PAINAD scores demonstrated a significant difference in the 
mean scores for the eating and intervention observations. Further analysis of the data 
demonstrated that the mean initial P AINAD score for the eating observation was 
significantly higher in the false positive group and for the intervention observation was 
significantly less in the no pain group. 
From examining table 3.39 of underlying causes for behaviour for the false positive 
group it is possible to see that much of the behaviour that was observed occurred at meal 
times. This may explain why the scores on the P AINAD tool were higher for this group 
during this observation. There are numerous reasons why mealtimes can be distressing 
occasions; for example, if there are swallowing difficulties, dislike of food presented or 
upset caused by sitting in close proximity to others. Work carried out by Steele et al 
demonstrated that around 40% of nursing home residents will exhibit challenging 
behaviours during meal times [36]. In addition, other than the participant who had 
toothache, none of the causes of pain identified in the pain group (table 3.35 p 159) would 
be particularly worse during the eating observation. These reasons may explain why the 
mean PAINAD scores on eating were significantly greater in the false positive group than 
the pain or no pain groups. 
As the mean PAINAD score on intervention was significantly less in the no pain group, 
this may suggest that the PAINAD tool is able to differentiate when pain is not present to 
some extent during intervention. Although the mean P AINAD score on intervention was 
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higher in the pain group than the false positive group, this difference was not statistically 
significant (p = 0.066). Obtaining a higher PAINAD score on intervention does not 
necessarily mean that someone is in pain, as opposed to being distressed for some other 
reason. It may mean that obtaining a low P AINAD score during intervention indicates 
that pain or distress from another cause is less likely. There was one participant, 
however, who only scored one on the PAINAD tool but was felt to be in pain. Therefore 
a low score does not always exclude the presence of pain. 
There were no statistically significant differences demonstrated between the scores 
obtained at rest for any of the groups. There are two reasons why this may have occurred. 
Most of the pain identified in the pain group was musculoskeletal in origin and therefore 
may not have been painful whilst sitting at rest. A recent consensus statement regarding 
assessing pain in people with dementia recommended assessing pain during a movement 
based task, as it is more likely to identify an underlying pain problem [170]. 
Alternatively, the PAINAD tool might be less able to identify pain at rest, as opposed to 
pain on intervention. 
In summary, significantly higher initial P AlNAD scores were obtained for the false 
positive group during eating. As outlined above, meal times can be potentially distressing 
occasions. Significantly lower PAINAD scores were seen on intervention in the no pain 
group, suggesting that the PAINAD is a sensitive tool. As a significant difference was not 
demonstrated between initial false positive and pain scores from the intervention 
observation, this suggests that the PAlNAD tool is not specific. No significant differences 
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were seen between the scores at rest, either because there was no pain or other distress 
seen at those times or because the tool was not able to identify relevant behaviour at the 
rest observations. 
251 
4.9 Discussion of the results from pain and false positive groups 
4.9.1 Pain group results 
4.9.1.1 Causes of pain identified 
Table 3.35 on p160 demonstrates the underlying causes of the pain identified during the 
assessment and the strategies utilised to manage the pain. Two of the participants had 
pain owing to relatively acute events, one with cellulitis and a DVT and another with 
toothache. Both acute conditions had already been identified by the staff at the time of the 
initial assessment and a treatment plan made or already started. By the time that the 
assessment was repeated, both demonstrated an improvement on the tools. Another 
participant seemed to be in pain on having her nails cleaned but had no discomfort on 
examination of her hands or with movement during daily activity. It was decided that the 
pain was purely provoked by the procedure and the staff were alerted to the issue. 
Most of the pain identified in the study was caused by chronic painful conditions. Many 
of the conditions were not new diagnoses, but were documented in the participants' notes. 
It is possible, therefore, that many had worsened over a period of time and this had not 
been identified. As discussed previously, the majority of chronic painful conditions were 
musculoskeletal in origin, mainly caused by either arthritis or the development of 
contractures. Articular joint pain, foot pain and leg pain are known to become more 
common with increasing age [250] and most of the pain identified in the current research 
was in these areas. Several of the participants were identified as having pain secondary to 
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a more chronic cause that had not been previously documented. Two participants became 
uncomfortable after sitting on hard surfaces for a period of time owing to weight loss. In 
identifying this issue, lasting tissue damage was potentially prevented. Another 
participant (AP 9) was identified as developing a contracture of her arm that had not 
previously been recognised. 
Most of the pain identified was nociceptive in origin. The prevalence of neuropathic pain 
in the community is reported to be around 7-8% [251] and is associated with older age 
[252]. Around one in six of those with chronic pain have predominately pain of 
neuropathic origin [252], however none of those with chronic pain complaints in the 
current research had predominately neuropathic pain. This may partially be due to the 
small numbers (ten) of participants who were felt to be in pain from a chronic complaint, 
but may be due to potential difficulties in identifying pain of this origin in people with 
severe dementia. This is discussed in more detail in the section on analgesia below. 
Although the numbers identified as having pain were small, some interesting patterns 
have emerged that may guide how pain and distress tools are used. It would seem that 
acute events have often already been identified by nursing staff, but slower onset new 
conditions (such as contractures) may be missed. In addition, those with chronic painful 
conditions may require repeat assessments to identify whether their conditions are 
worsening and their pain medication needs reviewing. 
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The study by Pickering el al [139] examined analgesic consumption for acute and chronic 
pain in those with and without cognitive impairment. They demonstrated similar levels of 
analgesic consumption in the two groups for acute pain events, but significantly less 
analgesia was consumed by the cognitively impaired group for chronic pain. These 
findings corroborate the current research findings that acute events are often more readily 
identified. The lack of analgesia consumed for chronic pain in Pickering et al may be 
partially due to altered experience of pain, but may also be due to the signs of worsening 
chronic pain being more subtle and more easily over-looked. It is possible that using pain 
or distress tools on a regular basis may prevent this occurring and may allow chronic 
painful events to be readily identified and managed. 
4.9.1.2 Management of the identified pain 
A variety of strategies were employed to manage the pain identified during the study. The 
participants with acutely painful events had both already had a treatment plan made or 
started. The treatment was specific to the underlying cause and analgesia was given as 
well. The chronic painful events were managed with a combination of non-
pharmacological and pharmacological methods, depending on the underlying cause and 
the strategies that had already been tried. Those who became uncomfortable sitting on 
hard surfaces were managed by alerting the staff to the issue and by the use of pressure 
relieving strategies intervention. One participant became very tense and rigid during 
intervention, causing pain on movement, possibly because of anxiety. This was managed 
by a complementary therapist carrying out weekly massage to see if this would relieve 
some of the tension. There was a small reduction in the distress score using this strategy. 
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Other participants were started on regular analgesia. It was quickly realised that simply 
using PRN medication would be unsuccessful in managing the identified pain, since once 
the participants were in pain and had become distressed attempting to give them analgesia 
was very difficult. One strategy employed was to give analgesia prior to movement if the 
pain was associated with this activity. This was successful with one participant (AP6) 
who was prescribed regular analgesia, but was often uncomfortable on getting up first 
thing in the morning. His medication was, therefore, administered to him half an hour 
prior to getting up, which allowed him to be more comfortable once the analgesia had 
been absorbed. If the participants were not prescribed regular analgesia, giving PRN 
analgesia prior to movement was not always successful as times of movement were not 
always predictable. Most participants were therefore prescribed regular analgesia. 
Three participants were started on regular paracetamol. These participants had either not 
been prescribed any analgesics previously or were prescribed PRN analgesia. They were 
therefore started on analgesia from the lowest step of the WHO analgesic ladder. One 
participant with musculoskeletal pain was already on regular paracetamol and as required 
topical NSAID gel (WC20). The NSAID gel was therefore given regularly. Another 
participant (CP19, see vignette 2b), who was prescribed immediate release tramadol, was 
changed to the slow release preparation. It was felt that his pain was worse in the 
morning, potentially because of the night time dose wearing off, and the slow release 
tramadol provided a more consistent level of pain relief. One participant was prescribed 
procyclidine (AP9), specifically for the increased tone in her arm, by her own GP; a 
reduction in her pain and distress scores on intervention was seen at one month. 
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In summary, the management strategy employed for the pain identified depended on the 
underlying cause of the pain and the management that had previously been tried, with 
both non-pharmacological and pharmacological strategies utilised. The pharmacological 
management was linked to the WHO analgesic ladder and was given regularly as 
difficulties were encountered using PRN analgesia. 
4.9.1.3 Background neuropsychiatric scales 
Once pain was identified and treatment commenced, the participants were reassessed 
initially by repeating the neuropsychiatric scales. This occurred at approximately one 
month after the initial neuropsychiatric scales were carried out. There was no significant 
change demonstrated in levels of depression, dependency, psychopathology or agitation 
after commencing treatment for pain. As discussed previously, a strong association has 
been demonstrated between depression and pain [150]. By treating pain effectively, levels 
of depression may also be reduced. This effect was not demonstrated by the current 
research, possibly as the time frame was too short to demonstrate changes in levels of 
depression. In addition no specific association between pain and depression was 
demonstrated in this research, therefore if the pain group was not particularly depressed 
to begin with; it seems less likely that significant changes in depression would be 
demonstrated. 
One potential effect of treating pain might have been a change in the levels of 
dependency. It is possible that if someone is in less pain, then they are more able to 
participate in activities and hence would be less dependant. Although a statistically 
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significant change was not demonstrated, the results demonstrated a reduction in CAPE-
BRS scores with a significance ofp = 0.07. 
No significant change was seen with the NPI scores. This tool is multidimensional in 
nature [70], assessing several areas of psychopathology. Not all of the areas assessed are 
specifically associated with pain such as hallucinations and delusions; however some of 
the areas assessed are associated with pain, such as depression and sleep disturbance. The 
combination of factors assessed using the NPI may have prevented a change in 
psychopathology being elicited. 
Finally no significant change was demonstrated in levels of agitation following 
intervention for pain. The CMAI consists of a list of 29 agitated behaviours, a third of 
these behaviours appear on the PAINAD scale. It is possible that not all of the behaviours 
of the CMAI are associated with pain and therefore treating pain will not always reduce 
the behaviours identified using the CMAI. This could explain the lack of significant 
change in the agitation scores. 
In summary, no significant change in the scores of the neuropsychiatric scales was seen 
after the tests were repeated. This is possibly due to the time frame being too short 
between carrying out the tests for a significant change to be demonstrated. In addition 
some of the areas measured by the scales may not be specifically associated with pain, 
hence they would be less likely to change following treatment of pain. It is worth 
highlighting that the group identified as having pain was relatively small, with only 13 
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participants. This may have reduced the ability of a significant change in the 
neuropsychiatric scores to be demonstrated. 
4.9.1.4 Assessment results (1 month and 3 month) 
A significant change in the scores of both the PAINAD and DisDAT scores was 
demonstrated on intervention following a change in treatment for pain. It is interesting to 
note that the significant change occurred solely on the intervention observation. The 
majority of the pain identified during the research was musculoskeletal in nature, hence 
more likely to be more apparent during intervention. As expected, therefore, treating the 
pain identified during intervention led to a significant reduction in scores during 
intervention. One potential conclusion could be that these tools are unable to identify 
change in pain occurring at rest or during other activities. The work by Zwakhalen et al 
demonstrated lower scores at the time of rest and suggested that it is harder to estimate a 
person's pain at rest [183]. However, as so few of the participants had pain identified in 
situations other than during intervention, it is impossible to reach firm conclusions 
regarding the ability of the tools to identify change in all types of pain. 
The original study by Warden et al also demonstrated a significant change in PAINAD 
scores on giving as required medication for pain [3]. It is not clear, however, what the 
participants were doing at the time they were in pain and why they needed PRN 
medication. In the current research the assessment tools were not repeated immediately 
following analgesic provision, but were repeated simply during the same type of 
observation. This therefore demonstrates the ability of PAINAD to identify change in 
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pain in general rather than just following analgesic administration. The only other study 
examining the ability of PAINAD to identify a change in pain was published in Gennan 
[229] and the English abstract does not provide infonnation as to whether the change in 
PAINAD scores was statistically significant. 
There has not been any research published to date regarding the ability of DisDA T to 
identify a change in pain following intervention. By using behaviours generated by the 
nursing staff for a particular person and recorded using a PACA type scale, it has been 
demonstrated that DisDA T can also identify change in levels of pain. 
The participants were reassessed three months after the initial assessment. This was to 
evaluate whether the treatments that had been commenced were still effective or whether 
the pain had worsened over time. There were no statistically significant differences 
demonstrated between the scores obtained at the one month assessment and those 
obtained at the three month assessment. Although this could imply that repeating pain 
assessments frequently is not necessary to monitor pain control, it is worth noting that 
several participants had worsening scores and worsening pain at the time of the three 
month assessment (see Vignette 1 b). These participants all had chronic pain problems, 
therefore this group may need more frequent reassessment of their pain. It is also possible 
that the underlying cause of acutely painful events could have resolved. Regular 
reassessment of those with pain is therefore important to evaluate whether treatment is 
still required or can be stopped. 
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By repeating the tools following a change in pain management, statistically significant 
differences were demonstrated in both the PAINAD and DisDA T scores on intervention. 
Therefore both scales are able to measure change in pain following change to 
management regime, fulfilling objective 2 of the research. There were no significant 
differences seen in the scores obtained at the three month assessment. It cannot be said, 
however, that this is the appropriate time for reassessment. Identifying a specific time for 
repeat pain assessments for all of those with pain is problematic, precisely because pains 
are different as are individuals. 
4.9.1.5 Issues highlighted by vignettes 
The case vignettes chosen for the pain group emphasise specific issues surrounding both 
the use of pain and distress tools and how pain is managed in this group. The first 
vignettes (la and b) involve participants with pain from contracted limbs. They highlight 
how such tools can be useful in deciding whether a specific treatment has been beneficial, 
as the change in behaviour can be subtle. In addition they draw attention to the 
importance of repeating the assessments on a regular basis. For instance, in vignette 1 b 
the participant's pain had worsened over a two month timeframe. It is difficult to be 
specific regarding how frequently a pain or distress tool should be repeated. As discussed 
previously, both those suffering with acute and chronic pain problems may require 
reassessment as the underlying cause may have worsened or may have resolved. The 
natural history of the underlying condition is, therefore, an important factor that needs to 
be considered, although this will vary from person to person. Setting individualised 
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timeframes for reassessment of pain once treatment is commenced may be the most 
sensible approach. 
The second pair of case vignettes was chosen to demonstrate that the underlying cause for 
the behaviour observed is not always initially apparent. By repeat observation and 
carefully noting the initiating and resolving factors associated with the behaviours 
observed, the underlying causes were identified. In both cases there were other factors 
contributing to the observed behaviour, with anger and agitation in the first case and fear 
in the second. Several authors have highlighted that pain may be associated with other 
emotions, such as fear [141, 144], particularly if the person is unable to put their pain into 
context because of cognitive impairment. The complete resolution of the behaviour may 
not therefore be a realistic goal in all those with pain. This has also been highlighted in 
other published work regarding pain management in persons with cognitive impairment 
[180]. 
The vignette regarding we 9 (2a) also demonstrates a difficult aspect of scoring the 
PAINAD tool. As there is no time frame built into the tool, it can be difficult to decide 
whether a particular behaviour should be the main scoring behaviour within a specific 
domain. For example, if a participant's facial expression is mostly inexpressive during 
the observation, with a brief episode of frowning, it is difficult to know whether to score 
the facial expression for the behaviour that was present for the majority of the time, or the 
behaviour that might be due to pain. This problem occurred several times during 
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observations and it was decided to score for the behaviour that was present for the 
majority of the time. 
Using a PACA scale to record the DisDAT behaviours allowed for some reflection of the 
amount of time a behaviour was present as the behaviours that dominated the observation 
were the highest scoring. It could, however, be argued that the length of time a behaviour 
is present is not necessarily a reflection of its importance. A brief episode of a certain 
behaviour may be an important indication of underlying pain that should not be 
overlooked. Observing people with dementia for a specific time frame is used in other 
tools such as Dementia Care Mapping. This is an observational tool used to evaluate 
quality of care from the perspective of the person with dementia [253]. Mapping takes 
place over five minute periods, with the main events from the perspective of the person 
being recorded [254]. The validity and reliability of this approach has been established 
[253]. It is important, therefore, to try and reflect the importance of specific behaviours 
observed for that individual in the context that they occur. 
The final pain group vignette was chosen to highlight how finding a suitable treatment for 
some participants was not always straightforward. As discussed previously, deciding on 
the underlying cause for a behaviour can be difficult; however, if pain is a possibility, a 
trial of analgesia may be of benefit. Unfortunately, despite attempting several different 
approaches with this participant, none was particularly successful as a trial of analgesia. It 
is worth emphasising that there are different strategies that can be tried in order to 
manage pain and what works for one person may not be suitable for another. Advice was 
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sought regarding this participant from the palliative care services for people with learning 
difficulties, as many of the issues surrounding taking analgesia are very similar in both 
people with learning difficulties and people with dementia. It was decided, however, that 
as the underlying cause for the behaviour seen in this participant was not clear, close 
observation should be employed rather than pursuing further analgesic strategies. 
These vignettes, therefore, highlight many issues surrounding the use of pain or distress 
assessment tools and managing pain in those with severe dementia. They demonstrate 
how the tools can help with deciding whether a treatment has been of benefit and 
emphasise the need for regular reassessment. The vignettes also reveal the difficulties that 
can occur when deciding if pain is the cause of the behaviour observed, particularly when 
there are potentially several causes. They also highlight issues surrounding how long a 
behaviour should be observed for it to be relevant and therefore how much weight should 
be given to a specific behaviour. Finally, they show some of the challenges that may 
occur when selecting suitable pain relief strategies for those with severe dementia. 
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4.9.2 Results from the false positive group 
4.9.2.1 Background neuropsychiatric scales 
The background neuropsychiatric scales were repeated for the false positive group at 
approximately one month after they were originally carried out. The false positive group 
had all scored greater than two on the P AINAD scale during at least one of the three 
observations. The underlying cause of the behaviours seen at these observations was not 
felt to be pain. No specific interventions were suggested for the participants in this group; 
however there were changes in the way that some of the participants in this group were 
cared for. This was highlighted in the case vignettes and will be discussed in more detail 
later. 
Without specific interventions being suggested for the group, it could be presumed that 
levels of depression, dependency, psychopathology or agitation would not change after 
one month. Statistical analysis of the repeated neuropsychological tests revealed no 
significant change in levels of depression, dependency or psychopathology. There was, 
however, a significant decrease in levels of agitation in the false positive group. There are 
several reasons why this might have occurred. Although specific interventions were not 
suggested for this group, there were some changes made to the way some of the 
participants were managed. This may have arisen from nursing staff becoming more 
aware of agitated behaviour of study participants because of the research and attempting 
different techniques to manage this behaviour. If this management was successful it may 
have contributed to the reduction in agitation levels. Although the participants' 
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medication was not documented at the I month assessment, changes may have been made 
that could have influenced the behaviour seen. Most participants in this group had their 
medication documented at the 3 month assessment. Some had had an increase in 
antipsychotic medication, although others had had similar medication stopped. The 
changes in medication for some participants may have affected levels of agitation. The 
reduction in levels of agitation may also be a reflection of the natural history of the 
symptom, as the behavioural and psychological symptoms of dementia may fluctuate 
during the course of the illness [255] and may resolve spontaneously [66]. 
In summary, no statistically significant change was seen in the levels of depression, 
dependency or psychopathology; however a significant change was seen in the agitation 
scores. This could have been caused by changes in management strategies by nursing 
staff, fluctuation in levels of agitation or natural resolution of agitated behaviour. 
4.9.2.2 Assessment results (1 month and 3 month) 
The observations were repeated for the false positive group at approximately one month 
after they had originally been carried out. There was a statistically significant change in 
scores for both the DisDA T and P AINAD scale at rest, with the scores being significantly 
less at one month. There was also a significant reduction in the PAINAD scores on 
intervention. 
There are several possible reasons to explain the change in scores seen despite specific 
interventions not having been suggested. Some of the causes of the behaviour observed at 
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the initial observations were due to specific circumstances that occurred that day, such as 
participants being disturbed by other residents within the home. Although the repeat 
observations were carried out at the same times of the day as the initial observations, it is 
possible (and probable) that those specific events prompting the behaviour observed 
initially were not present at the time of the repeat observations. The scores were 
accordingly lower at the time of the repeat observation. It is unclear why a significant 
change was seen at rest, but it is worth highlighting that the period of rest usually 
occurred with the participant sitting in the main lounge, surrounded by most of the other 
residents in the home. The potential was therefore there for specific random events to 
occur, such as one resident being noisy and upsetting other residents, thus causing 
distress behaviours to be observed. 
The PAINAD scores for both rest and intervention were significantly less at the time of 
the second observation. This may be due to the group being defined by the PAINAD 
score that they obtained following the first observation. As the group had high PAINAD 
scores by definition, a change in the PAINAD score may have been more likely than a 
change in their DisDAT score. As highlighted previously, some changes to management, 
both pharmacological and non-pharmacological were made for some of the participants 
of this group. This may also account for a reduction in scores. Finally, the underlying 
causes for the observed behaviour could be described as the behavioural and 
psychological symptoms of dementia (BPSD). As BPSD may fluctuate during the course 
of dementia [255], the changes seen may simply be a reflection of fluctuating symptoms. 
In addition, some symptoms may resolve spontaneously [66] without specific treatment. 
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The observations were also repeated three months after the initial assessments had been 
carried out. There were no significant differences seen in most of the assessments, other 
than the DisDA T rest observation. The three month assessment scores for this 
observation were significantly greater than those from the one month assessment. The 
reasons for this are not obviously apparent. An increase in behaviours signifying distress 
in the absence of major causes might suggest transient incidents. These would need to be 
explored at the time for particular individuals. Concerns could be raised that as changes 
were seen in the scores from the assessment tools in the false positive group, this calls 
into question the significance of the changes in scores seen in the pain group. It is worth 
highlighting that the false positive group cannot be considered as a control group to the 
pain group, as the false positive group was defmed differently to the pain group. This 
causes difficulty in comparing the outcomes for the two groups. 
Significant changes were therefore demonstrated in both the PAINAD and DisDAT 
scores at rest and the PAINAD scores on intervention for those in the false positive 
groups. The change in scores at rest may have been caused by the specific circumstances 
that provoked the behaviour from the initial observation not being present at the repeat 
observation. The change in PAINAD score on intervention could have been owing to 
changes in management made by nursing and medical staff, natural fluctuation of agitated 
behaviour and by the group being defined by the level of their PAINAD scores. Most of 
the scores had not changed significantly at the time of the three month assessment. 
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4.9.2.3 Causes of behaviour observed and issues from vignettes 
Table 3.39 on p 170 and 171 lists the underlying causes for the observed behaviour. 
Approximately half of the participants in this group appeared not to understand what was 
going on around them. This is conveyed by vignettes 4a and b, with both participants 
unable to make sense of their situation. One participant reacted with fear and anxiety to 
the situation, whilst the other became angry and frustrated. These behaviours were 
identified on the PAINAD tool, leading to both participants scoring greater than two. 
Other causes of distress were also seen, such as distress emanating from the nursing home 
environment, as highlighted by vignettes 5a and b. As discussed previously, specific 
suggestions were not made for participants in this group; however there were occasions 
where changes to management were made. These included: specific carers working with 
certain participants to reduce anger; careful explanation to reduce anxiety; and the 
provision of quieter areas to reduce distress from the care environment. For other 
participants, the original cause of the behaviour resolved of its own accord, as highlighted 
by vignette 7. Despite the behaviour resolving, it was still important to attempt to identity 
what the underlying cause might have been. Finally, the cause of the distress might 
change, as highlighted by vignette 8, owing to a change in circumstances. This again 
demonstrates the importance of reassessment and revisiting what the causes of behaviour 
might be. 
If the PAIN AD score had been taken at face value, then the behaviour observed for these 
participants could have been incorrectly labelled as pain, leading to inappropriate 
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management. The PAINAD tool will clearly identifY when something is wrong, as 
demonstrated by the scores obtained for the participants of both the pain and false 
positive groups. What the tool failed to do was to differentiate between when the cause of 
the behaviours seen was pain and when it was caused by something else. This is 
demonstrated further by the fact that significant differences in the initial PAINAD scores 
were not seen between the false positive and pain groups, other than during the eating 
observation. Hence simply identifYing that something is wrong and that someone is 
distressed may be the first step in assessing pain. The second step would be to assess 
what the cause might be, with one of the possibilities being pain. This would prevent 
behaviour, from causes other than pain, being inappropriately labelled and managed. By 
careful evaluation of the antecedents of the behaviour, what stopped the behaviour and 
knowledge of medical and personal history, the cause of the behaviour can be identified 
often and suitable management strategies devised. 
4.9.3 Results from both P and FP groups 
Analysis was also carried out to assess whether the change between initial and I month 
DisDA T and PAINAD scores was similar in both the P and FP groups. No significant 
differences were demonstrated in the proportion by which the scores changed, other than 
the DisDA T score from the eating observation. This seems likely to be a type 1 error and 
may not be of consequence given there is no more rational explanation. Therefore the 
proportion by which the scores changed in each group was comparable, suggesting that 
the scales can identifY change to a similar degree in both groups. 
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4.10 Discussion of the behaviours documented and observed 
4.10.1 DisDAT results 
From completing the DisDAT for the participants in the study, a large quantity of data 
has been collected regarding the behaviours of both contentment and distress that can be 
seen in persons with severe dementia. The results collected mainly focussed on the 
behaviours of distress, with 129 different behaviours being documented for 79 
participants. Clearly, with such a wide variety of behaviours being recognised by nursing 
staff, it would be difficult to create a single assessment tool that would assess all these 
behaviours. The commonest identified behaviours of distress were not behaviours of 
distress for all participants. It has been argued that assessment scales should be matched 
to the patient, with the patient able to demonstrate all the behaviours by which they are 
being assessed [182]. Otherwise even using common behaviours, such as frowning, could 
lead to some patients being assessed using behaviours that they will not demonstrate, no 
matter how severe the distress. 
In addition, 72 behaviours were unique behaviours only documented for one participant. 
The issue of the wide variation in behaviour seen and the unique nature of an individual's 
behaviour are discussed in the review of pain assessment tools by Herr et al [31]. They 
highlight that a patient's pain responses can be unique and that pain assessment tools 
should assess as broad a range of pain indicators as possible. Research carried out by 
Closs et al. [205] by interviewing nursing home staff about pain cues in 113 residents, 
identified an extensive range of cues including body movements, facial expressions, 
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verbal and vocal cues. This work discusses how both formal and informal carers are able 
to identify a variety of cues, but may identify different cues. In the current research at 
least two nursing staff were asked for their opinions when the DisDA T was completed. 
Table 3.44 on pl86 lists the 20 most common behaviours of distress identified by 
completing the DisDAT. Most ofthese behaviours are found on pain assessment tools but 
some, such as skin changes and looking startled or staring, would not have produced a 
score on the PAINAD tool. The distress behaviours that were observed during times of 
pain are discussed later. Although there were behaviours that were recognised more 
frequently than others, unique behaviours may be just as important. The original research 
by Regnard et af. [4] suggested that each patient has their own "language of distress" and 
focussing only on the common cues may risk ignoring important markers of distress. 
Table 3.45 on pl87 summarises the types of unique behaviour documented, with more 
detail on the unique behaviours given in table 3.46 on p188. The most common form of 
unique behaviour was speech, followed by habits and mannerisms. From the table 3.46, it 
is possible to see that some of the behaviours identified could quite easily be 
misinterpreted as not being associated with distress, such as rolling up trouser legs. Hence 
using the expert knowledge of nursing staff is vital in interpreting behaviour. Work 
carried out by Parke demonstrated that nursing staffwho know their patients well are able 
to recognise change in behaviour and begin to evaluate what the change signifies [165]. 
Qualitative research by Regnard et al. highlighted that both professional and family 
carers felt that documenting behaviours of distress would help when a person was 
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transferred to other settings, such as to hospital, as those caring for the person may not be 
able to understand idiosyncratic behaviours [4]. 
In summary, a wide variety of behaviours was documented by completing the DisDAT 
for the study participants. Over half of the behaviours documented were only seen in one 
participant. The ability to recognise the meaning of the behaviour seen, often specific to 
the person, is vital in identifying distress. 
4.10.1.1 Correlations of number of behaviours of distress with background data 
Further analysis was carried out on the number of behaviours of distress that were 
documented for each person. As discussed previously, women, when compared to men, 
will report more severe pain intensity, more frequent pain, pain in more areas of the body 
and pain of longer duration [246]. There was, however, no association between the 
number of behaviours of distress identified and the sex of the participant. There were no 
significant differences between the number of behaviours identified by the staff from the 
four homes, which suggests that staff at each of the research sites were able to identify a 
range of behaviours for all their residents participating in the research. In addition the 
length of time that a participant had been resident in the home was not correlated to the 
number of behaviours of distress identified. Some participants had only been resident in a 
certain home for two months, yet nursing staff were able to discern behaviours of 
distress. This was also borne out in the study by Closs et al. [205], where again many 
staffhad only known their residents for two months, yet were able to identify pain cues. 
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There was no significant association demonstrated between the dementia diagnosis and 
the number of behaviours of distress identified. However, it might be hypothesised that as 
the condition progresses the number of behaviours of distress identified might be less. 
This is partially predicted on the view that "challenging behaviour" slowly bums out as 
dementia progresses. Similarly, the repertoire of distress behaviours might also narrow. 
For example one participant, for whom only one behaviour of distress could be identified, 
died the day after the DisDA T was completed. However, on analysis of the data, a 
significant correlation between the number of behaviour of distress and time since 
diagnosis was not demonstrated (p = 0.085). There was no significant association 
demonstrated either between the age of the participant or their analgesic prescription and 
the number of behaviours of distress. 
4.10.1.2 Correlations of number of behaviours of distress with background 
neuropsychiatric scales 
The potential correlations between the number of behaviours of distress and the 
background neuropsychiatric scales were assessed using Spearman's rank correlation. 
This demonstrated a weak correlation between the CSDD scores and a moderate 
correlation between the CMAI and NPI scores and the number of behaviours of distress. 
This may be owing to the observable manifestations of depression, agitation and 
psychopathology being seen as behaviours of distress. Therefore, a participant known to 
be agitated may display a wider variety of behaviours of distress. The correlation between 
depression scores and the number of behaviours may be weaker as there may be less 
observable behaviour if someone is depressed, as opposed to if they are agitated. There 
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was no significant correlation demonstrated between the CAPE-BRS scores and the 
number of behaviours of distress. This suggests that however dependant a person may be, 
there will still be a range of behaviours of distress that may be recognised. 
Therefore, for the background parameters that were measured in this research, no 
significant associations with the number of behaviours of distress were demonstrated. 
This suggests that a list of behaviours of distress can be identified for most elderly 
patients with severe dementia, regardless of many factors including dementia diagnosis, 
age, dependency or length of time in the home. The behaviours associated with 
depression, agitation and psychopathology may have led to the correlation seen between 
these variables and the number of behaviours of distress. 
Table 3.50 on p193 lists the number of distress behaviours seen during the assessments 
where pain was felt to be present. It demonstrates that for all of these assessments, at least 
one distress behaviour was observed. Creating a list of distress behaviours for those 
unable to communicate their pain is therefore a useful method of recognising behaviour 
that may be caused by pain. 
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4.10.2 PAINAD results 
To investigate further the commonest scoring behaviours documented for the pain and 
false positive groups, the assessments that scored greater than two were collated for each 
group. In both groups, the breathing domain scored less than the other parameters. This 
was identified in the original work by Warden et al [3], who demonstrated that the 
reliability of the PAINAD tool could be improved by either deleting the breathing item or 
combining with the negative vocalisation item. They decided to retain breathing as a 
separate item as many patients with advanced dementia have intercurrent respiratory 
illnesses and as changes in respiration can be seen in acute pain. Whether intercurrent 
respiratory illnesses are always painful is debatable, hence this may not be a good reason 
to retain an item for a pain scale. Other published work utilising PAINAD has found that 
breathing was a low scoring item [183, 201]. The research conducted by Schuler et al 
[118] demonstrated that consolability scored higher in those without pain than those with 
pain. Using consolability as an item on the PAINAD tool was also questioned by van 
Iersel et al [201], who suggested that consolability was the result of a treatment, rather 
than an indication for it. The consolability item did however score reasonably highly with 
both the pain and false positive groups. 
The distribution of the scores was different between the two groups, with those in the 
false positive group tending not to score on the higher ranked behaviours (the ones 
scoring two). This is reflected in the different mean and median scores for each group 
(tables 3.25 and 3.26, pI53). These differences were not demonstrated to be significantly 
different. Therefore, although those without pain may tend to score lower than those with 
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pain, these differences cannot be used to decide whether someone has pain or the 
behaviours are due to an alternative cause. 
Further analysis was also carried out to examine which DisDA T behaviours were 
documented when a PAINAD score greater than two was obtained. The ten most 
frequently occurring behaviours in both the pain and false positive groups are tabulated 
on p 196. This demonstrates that many of the behaviours seen in the two groups were the 
same, even though the underlying cause was different. There were four behaviours 
observed frequently in the pain group that were not observed as frequently in the false 
positive group. All of these behaviours were seen in the false positive group, but to a 
lesser frequency. The same is true for the frequently observed false positive behaviours 
that were not seen as frequently in the pain group. 
The research has demonstrated that the breathing item on the PAINAD tool scores 
infrequently, as also demonstrated in previous research utilising PAINAD. Despite the 
apparent differences in the scoring on PAINAD from the pain and false positive groups, 
significant differences in overall scores were not demonstrated. As 33% of the study 
participants scored greater than two on the PAINAD tool, despite not being in pain, this 
suggests that PAINAD is not specific with regards to identifying pain. There were many 
behaviours, generated by using DisDA T, that were seen in both the pain and false 
positive groups observations. This therefore calls into question the ability of any 
behavioural assessment tool to differentiate pain from other causes of distress. 
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4.11 Discussion of medication results 
4.11.1 Analgesia results 
The analgesic prescriptions of all participants were documented at the start of the 
research. The analgesics were divided depending on how they were prescribed. Those 
who were prescribed analgesia both regularly and "as required" were put into the regular 
analgesia group. In the current study 14% of participants were prescribed analgesia 
regularly, 33% solely on an "as required" basis and 53% were not prescribed any 
analgesia. There are few studies that look specifically at general analgesic prescribing in 
nursing homes, with most examining prescribing practices for those with pain [104] or 
the analgesics that were prescribed [256, 257] rather than how the analgesics are 
prescribed. A recent study carried out by Smalbrugge et al [258] of 290 Dutch nursing 
home residents demonstrated that 45.9% were prescribed regular analgesia, 8.6% "as 
required" analgesia and 45.5% were not prescribed any analgesia. It is possible that these 
differences between the current research and the Smalbrugge study may be caused by 
differences between nursing homes in Holland and the UK. One such difference is that 
Dutch nursing homes often have specifically trained nursing home physicians, which may 
lead to the differences seen. 
4.11.1.1 Analgesic drugs prescribed 
Paracetamol was the most commonly prescribed drug, both as a regular prescription and 
on an "as required" basis. This is in keeping with the study by Allcock et al [109] carried 
out in nursing homes in Nottingham, which demonstrated that paracetamol was the most 
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"often" used analgesia for pain. Paracetamol was also the most frequently prescribed 
analgesic in nursing homes in the studies conducted by Smalbrugge and Won [104,258]. 
The frequent prescription of paracetamol for pain is probably accounted for by a) it is the 
first step of the WHO analgesic ladder, b) its lack of gastrointestinal side effects and c) 
the small incidence of drug interactions [125]. It is, therefore, regarded as a relatively safe 
drug to be used in this population. 
Weak opioids were the next most frequently prescribed analgesic, sometimes prescribed 
in combination with paracetamol. None of the participants in the current research was 
prescribed strong opioids. The finding for weak opioid prescription are similar to those 
found in the study by Allcock et al [109], however 19% of nursing home residents in 
their study were "often" prescribed strong opioids for non-malignant pain. In the study by 
Won et al [104] examining prescribing patterns in nursing homes, 3% of the residents 
who had pain were prescribed strong opioids. It is possible that, as the comparable studies 
of analgesic prescribing in nursing homes involved larger numbers of participants, the 
number of participants in the current research was too small to identify participants 
requiring strong opioids. Another possibility is that strong opioids were prescribed less 
owing to concerns regarding side effects, such as confusion. Several authors have 
demonstrated that opioids are prescribed less frequently to those with more severe 
cognitive impairment [120, 121, 259, 260] and have cited fears regarding worsening 
confusion as a potential reason for this phenomenon. Research by Allen et al [261] 
examining nursing home residents' activity in relation to analgesia prescribed, after 
controlling for functional ability, demonstrated that those prescribed opioid analgesics 
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spent less time being inactive than those not prescribed analgesic medication. The authors 
suggest that this may have been due to the opioids controlling pain better, allowing 
greater activity and not causing sedation. Despite all these potential reasons, a possible 
cause for strong opioids not being prescribed could have been that these drugs were not 
required to control their pain. None of the participants was prescribed strong opioids 
following the assessments for pain. 
Only two participants were prescribed NSAIDs, with one prescribed oral diclofenac and 
the other prescribed ibuprofen gel. This is a smaller proportion than in the studies by 
Smalbrugge (20%) and Allcock (46% "often" prescribed NSAIDs) [109, 258]. The 
American Geriatrics Society has suggested that NSAIDs should be avoided in those 
needing long term daily analgesic therapy in view of gastrointestinal side effects [123]. It 
is possible that local prescribing practices reflect these concerns. 
Only one participant was prescribed an adjunct analgesic (Baclofen) in the current 
research. In the study by Allcock [109], antidepressants and anticonvulsants were 
prescribed "often" for 4% of nursing home residents; most other comparative studies do 
not have data for adjuvant analgesics. It would seem, therefore, in both the current study 
and other research carried out in nursing homes, that adjuvant analgesics are infrequently 
prescribed. If identifying pain in those with severe dementia is difficult, then 
understanding the nature of the pain may be more challenging. The lack of prescription of 
adjuvant analgesia, particularly for neuropathic pain, may be due to the difficulties in 
recognising neuropathic pain in those with cognitive impairment. Neuropathic pain has 
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several characteristics: there is often an area of abnormal sensation associated with the 
pain, there is often a hyperpathic state characterised by allodynia, summation and 
radiation of the pain and neuropathic pain is often described in a specific way (as 
burning, shooting etc.) [262]. Eliciting the history and physical signs of neuropathic pain 
will be more challenging in patients with severe cognitive impairment who may be 
unable to describe their pain or respond to questions regarding sensation. Hence 
recognising that pain has a neuropathic origin may be more challenging and the 
appropriate prescription of medication for neuropathic pain may occur less frequently. 
The level of non-pharmacological strategies for pain management, employed prior to the 
current study, was not formally assessed. If a participant was found to be in pain, then the 
non-pharmacological strategies that had already been tried were discussed with nursing 
home staff. 
In summary, paracetamol was the most commonly prescribed analgesic in the current 
research, in keeping with other research examining the prescribing practices in nursing 
homes. Weak opioids and NSAIDs were prescribed less frequently, with no participants 
prescribed strong opioids. This may reflect the fears regarding prescribing opioids for 
those with severe dementia or may also be simply due to the number of study participants 
and the severity of their pain. Few adjuvant analgesics were prescribed, potentially due to 
the difficulties in assessing the nature of pain in those with severe cognitive impairment. 
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4.11.1.2 Association of analgesia with groups following initial assessment 
Analysis using Fisher's exact test of the data regarding analgesic prescription and groups 
following the initial assessment revealed a significant association (p = 0.011). As 
discussed previously, the numbers for some of the groups were too small for further 
analysis. There are, however, several interesting points for discussion from examination 
of table 3.11 on p141. From those who were found to have pain, six were already 
prescribed regular analgesia. Several studies examining the prevalence of under-treated 
pain in the elderly have used prescription of analgesia to indicate that pain is adequately 
treated [2, 104, 257, 261, 263]. The finding that 46% of those with pain were already 
prescribed regular analgesia suggests that using analgesia as a marker for adequate pain 
management is misleading. In addition, a recent review of pain management stated that 
"pain per se should be assessed, rather than surrogate measures such as analgesia use" 
[230]. These finding have important implications for designing future research regarding 
pain prevalence. 
4.11.1.3 Association with homes used in tbe study 
Analysis using the Fisher's exact test demonstrated a significant association between the 
homes involved in the research and how analgesia was prescribed (p < 0.001). This was 
further investigated by comparing the three EM] homes with each other. No significant 
differences were found in analgesic prescribing practices. The analgesic prescribing 
practices of the NHS ESMI home was then compared to the non NHS EMI homes. 
Further analysis using Fisher's exact test demonstrated a significant association between 
type of home and how analgesia was prescribed. By examining table 3.57 on p202, there 
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are obvious differences between prescribing practices. In the ESMI home only one person 
did not have analgesia prescribed and 69% participants had as required analgesia 
prescribed, mostly paracetamol. It is possible that this was a policy decision at the ESMI 
home; however there was no association demonstrated between those who had pain and 
the place of residence. Therefore having most residents prescribed some form of 
analgesia did not lower levels of identified pain. 
It is possible that having analgesia "as needed" for unpredictable pain may be of benefit 
so that pain relief can be given by nursing staff without needing to wait for medical staff 
review. This does, however, rely on the nursing staff being able to recognise when the 
person is in pain. Work carried out by Nygaard and larland in Norwegian nursing homes 
demonstrated that those with dementia were less likely to receive PRN analgesia than 
those who were cognitively intact [264]. Even if pain is successfully identified it can be 
challenging to give suitable analgesia. Once the person has pain they are often distressed, 
making it more difficult to administer oral medication. Therefore if pain is frequently 
occurring, prescribing regular analgesia is more successful. This was recognised whilst 
carrying out the current research and reflected in the analgesia prescribed for those with 
pain, with most participants being prescribed regular analgesia. (Table 3.35, p160) 
To summarise, statistically significant associations were demonstrated between the 
analgesia prescribed and the groups following the first assessment and also the type of 
home. Using prescription of analgesia as an indication of adequate pain control may be 
misleading, as demonstrated by six of those with pain already being prescribed analgesia. 
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Over two-thirds of the participants from the NHS home were prescribed PRN analgesia; 
however this may simply reflect prescribing policy. Ifpain is occurring frequently, giving 
analgesia regularly may be more successful than relying on PRN analgesia. 
4.11.2 Central nervous system drugs 
A statistically significant association was not demonstrated between the prescription of 
any of the drugs with central nervous system actions and the groups following the first 
assessment. Particularly of note is the lack of an association between the false positive 
group and antipsychotic drug prescription. This group has been demonstrated to have 
significantly higher CMAI scores than the other groups. A high proportion of nursing 
home residents with dementia are treated with antipsychotic medication for behavioural 
symptoms [265]. The lack of an association may be due to the application of good 
practice guidelines that recommend utilising psychological or environmental options as a 
first line approach [266]. 
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4.12 Discussion of inter-rater reliability 
To obtain a measure of inter-rater reliability, a proportion of observations were repeated 
by a second researcher. Initially it was envisaged that this would occur at the same time 
as the main researcher. Owing to the work schedules of both the main and second 
researcher this was impossible to carry out and therefore the repeat observations were 
carried out within a week of the observations conducted by the primary researcher. This 
factor is likely to have strongly influenced the results as specific circumstances, that may 
affect behaviour, can vary from day to day. In addition, the number of dual observations 
is small, particularly for the intervention observations. These factors may explain to a 
certain extent why the agreement between most of the observations was poor or worse 
than would have been expected by chance. 
If both researchers had carried out the observations at the same time, it is possible that 
this may have influenced the behaviour seen. As discussed previously, the presence of a 
researcher in the room whilst care was being given could potentially be distressing to the 
participant. It was felt that this issue did not occur to a great extent during the research. 
The presence of two unknown people, however, could have been more distressing and 
may have led to several observations having to be abandoned. 
Other potential influencing factors are connected with the tools themselves. The 
behaviours on the DisDA T were initially recorded by the main researcher from the 
background knowledge of the nursing staff and would therefore be more easily 
understood by the main researcher. It is possible that the behaviours described may not 
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have been interpreted in the same way by the second researcher. In addition, the lack of a 
time frame in the PAINAD tool for the length of time a behaviour is observed may have 
affected the results. For example, if a participant had smiled and then briefly grimaced 
during an observation, the facial expressions observed may have been scored differently 
by the two researchers. 
It is worth noting that the inter-rater reliability of PAINAD has been addressed in several 
previous studies, describing it as good [3, 183] or fair [196]. The inter-rater reliability of 
DisDA T has not been established yet, although there are ongoing research studies aiming 
to address this. 
In summary, as the inter-rater reliability was not carried out at the same time, a true 
measure of this aspect of the tools' utility was not accurately established. Carrying out 
true inter-rater reliability would pose some difficulties, especially for some participants 
where distress might be caused by having two researchers present. Despite the lack of 
agreement between most observations, interesting issues have been raised. For instance, 
when using DisDA T, it is important to ensure that behaviours listed are readily 
understandable by all; in addition, the research has also demonstrated the variability of 
behaviour in those with severe dementia. This variability may make it necessary for 
assessment tools to be repeated to obtain a true picture of a person's behaviour. In view 
of the difficulties highlighted by this study regarding the establishment of the inter-rater 
reliability of both tools, further firm conclusions about this aspect of validity require 
further research. 
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4.13 The assessment and management of pain in dementia 
From reviewing the literature on pain in those with severe dementia, there are few studies 
that address the prevalence of pain in this group. Some research studies have involved 
those with moderate levels of dementia [116-118], but many studies examining pain in 
dementia excluded participants with more advanced dementia because of communication 
difficulties. The current research found that 16% of the study participants were in pain 
during at least one of the baseline assessments. This is less than the figures of 32-62% 
that were given as the percentages of those in pain in studies of people with moderate 
dementia [116, 117]. I have conjectured that this might be caused by the combination of a 
short observation period, the effects of dementia on pain pathways and the behavioural 
tools assessing a different aspect of pain experience from self-assessment tools, which 
were used in one of the earlier studies [116]. How much these factors have potentially 
affected the true prevalence of pain in severe dementia is difficult to quantify. It does 
remain important, however, that pain is adequately identified and managed. Many of the 
participants who were found to be in pain had not had their pain identified and clearly 
benefited from this being alleviated. As there were no specific associations with pain and 
variables such as dementia diagnosis, age or sex, it is not possible to target one group 
specifically in terms of assessing for pain. 
4.13.1 The use of pain assessment tools 
The American Geriatrics Society, in their guidelines regarding the management of 
persistent pain in older persons, suggest that pain should be assessed in those with 
moderate to severe dementia via direct observation or history from care givers [123]. 
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They recommend observing for evidence of pain-related behaviours and unusual 
behaviour that might trigger assessment for pain. Pain assessment tools may have a 
variety of purposes; to identify the presence of pain, determine the severity of pain and 
assess the effectiveness of interventions to treat pain [170]. The current research has 
questioned the ability of PAINAD solely to identify pain. Although most of the 
participants who were felt to be in pain had PAINAD scores of greater than two, 33% of 
the study participants also had PAINAD scores of greater than two who were not felt to 
be in pain. It would appear, therefore, that PAINAD will identify behaviours that may 
indicate pain, but further analysis of the observed behaviours is still then required. This 
was highlighted in the review of pain tools carried out by Keela Herr who commented 
that ''the identification of pain indicators using a standardised tool is only one step in a 
complex diagnostic process" [31]. It is difficult to extrapolate this finding to all 
behavioural pain assessment tools, but it has been argued that there is no evidence that 
there are any behaviours that solely indicate pain [4]. It becomes likely, therefore, that 
other assessment tools, consisting of a list of pain behaviours, may also identify 
behaviour that is not caused by pain. This was a finding of a recently published paper, 
demonstrating that Doloplus-2 may also identify discomfort from causes other than 
somatic pain [192]. 
A recent consensus statement regarding pain assessment, in those unable to communicate, 
highlighted that most pain assessment tools cannot be considered to represent definitive 
indicators of pain [170]. The recent NICE-SCIE guideline [20], however, states that 
health and social care professionals should use an observational pain assessment tool, if 
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helpful, when assessing whether a person with dementia is in pain. It is highlighted that 
the possibility of other causes for unexplained changes in behaviour should be 
considered. 
When behaviour pain assessment tools do identifY pain, can they assess severity of the 
pain? This question was not specifically addressed by the current research. However the 
research by Schuler et af [118] compared the scores from using the PAINAD with a V AS 
of intensity of the assumed pain completed by the nursing staff. They found no 
relationship between intensity of assumed pain and the magnitude of pain behaviour 
displayed, concluding that PAINAD does not provide a graded pain severity scale. The 
lack of a relationship may simply reflect the difficulty caused by a surrogate trying to 
assess how severe the pain is, however, there are other reasons why assessing severity 
using observed behaviour is problematic. A patient needs to be able to display all of the 
behaviours contained within the scale for that scale to be suitable for use [182]. If a 
patient is immobile and completely dysphasic, they will be unable to produce a high score 
on most scales, no matter how severe the pain is. In addition, individual variability in 
observed behaviour exists not only on account of the existence of pain, but also on 
account of its severity. This makes creating a tool that can adequately capture this 
variability extremely challenging [31]. There has not been any research published that 
shows a correlation between pain intensity and either a specific behaviour or number of 
behaviours in any population [182]. 
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The current research did demonstrate, however, that behavioural pain assessment tools 
can assess the effectiveness of interventions to treat pain. The PAINAD score for those 
with pain was significantly less following intervention for pain. Several authors have also 
highlighted that behavioural pain tools can be used for this purpose [31, 182]. It would 
therefore seem that behavioural pain assessment tools will identify pain (as well as 
behaviour owing to other causes), but can be used successfully to indicate the efficacy of 
interventions for pain. They are, however, unreliable indicators of pain severity. 
4.13.2 The use of behavioural distress assessment tools 
The current research also utilised a distress assessment tool, DisDA T. This tool differed 
from PAINAD in several respects. The main differences were that it sought to identify 
distress rather than pain and the behaviours that fonned the tool were behaviours that the 
participant had been recognised to display. The principle of identifying distress first and 
then evaluating the cause, would prevent the incorrect labelling of behaviour as caused by 
pain that can occur if pain tools are used at face value. Many of the published pain tools 
have identified that this can be an issue [3, 185, 187, 192], yet do not provide advice on 
how to decide what the cause of the behaviour is. The current research has demonstrated 
that by using a pain assessment tool, a third of those participating had significant scores 
but had distress from causes other than pain. Alleviating this distress is clearly important. 
A recent report highlighted that those with advanced dementia often have unresolved 
symptoms of distress contributing to suboptimal terminal care [19]. Identifying and 
attempting to manage distress, whatever the cause, would seem an essential goal in good 
quality care for those with severe dementia. 
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Using the DisDA T to create lists of distress behaviours highlighted the huge variation 
seen in behaviours that the study participants might display. Concerns have been raised 
by several authors that using a limited number of behaviours to assess pain runs the risk 
of ignoring unique behaviours that might indicate pain [31, 170]. Therefore, by creating a 
list specifically relating to the person, these unique behaviours are captured. This 
approach does presume that those caring for the person recognise and correctly interpret 
all the person's behaviours of distress. On a few occasions, whilst the DisDAT was being 
completed, staff would remark that they were unsure of the true significance of certain 
behaviours, whether they were habitual or indicative of distress. This can be an issue with 
any list of behaviours that are used as a tool for assessing pain or distress. A further issue 
is ensuring that the behaviours documented are understandable to all that will be using 
the tool. The DisDA T was not designed to be a scoring tool, but monitoring sheets can be 
used to monitor a therapeutic intervention. The current research has demonstrated that the 
DisDA T can be used to assess the effectiveness of interventions by using such monitoring 
sheets (Appendix p331). 
4.13.3 Using behavioural assessment tools as part of good quality care 
Published research suggests that around 25% of nursing homes use a standardised pain 
assessment tool [109]. The current research findings have suggested that using a 
behavioural distress tool may be a more appropriate method to identify behaviour and 
monitor the effectiveness of interventions. The current research has also given indications 
of how such tools should be used. The underlying causes for observed pain could be 
divided into three broad groups: acute pain events, worsening of known chronic 
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diagnoses and new, slower onset painful conditions. The acute events had often been 
identified by the staff, whereas worsening of chronic conditions or new slow onset 
problems had not been identified. In order to ensure that the pain is identified in all cases, 
regular use of behavioural assessment tools in all of those with severe dementia is 
required. In addition, simply performing an assessment is meaningless unless an 
evaluation of the behaviour seen takes place and appropriate action taken to alleviate the 
underlying cause. This may require input of not only the nursing staff but other members 
of a multidisciplinary team. The frequency with which the assessments take place is 
important in order to avoid burdening carers, but they should not be so infrequent that 
pain is missed. One potential solution is to perform an assessment, prior to a formal 
review of a person with dementia, so that this information can be reviewed by all of those 
involved in their care. Carrying out assessments in this way will depend on how 
frequently such reviews take place. The current research did not reassess those found not 
to be in pain or distress from other causes, following the baseline assessment. It is not 
possible from the current work therefore to provide a timeframe for regular pain review; 
this is an area for potential future research. 
A more frequent review of pain will need to be undertaken in those recognised to be in 
pain, and who have had changes made to their treatment. In the current research a 
significant difference was not seen between the one month and three month scores. There 
were, however, some participants whose pain worsened in this two month time frame (see 
vignette 1 b). A sensible approach may be to review on a regular basis once a change to 
management has been implemented and then plan regular reviews of their pain depending 
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on the natural history of the underlying condition. As highlighted previously in the 
discussion, complete resolution of all behaviours seen may not be a suitable goal of pain 
treatment [180]. 
The amount of time that should be observed in order to complete a behaviour assessment 
is an interesting question. Some tools, such as PAINAD, describe the observation being 
carried out for a specific period oftime (five minutes). This short time frame was used in 
the current research, although concerns could be raised that only observing for a short 
time frame may risk ignoring large parts of a person's day where pain may occur and 
behaviours not be observed. One solution is to broaden the time frame, for example, 
completing the tools recalling the behaviours seen over the course of a day. This will 
create a better overall picture, yet it runs the risk of behaviours being either ignored or 
forgotten. Interpreting the behaviours that are documented will be more challenging as 
the exact circumstances that either provoked or alleviated the behaviour may be difficult 
to recall. This way of using behavioural tools has not been explored by the current 
research and would provide a focus for future research. 
4.13.4 The management of pain in dementia 
In managing the pain that was identified during the study, several factors were critical. 
Identifying the underlying cause was the first step, using medical and OP records as well 
as examination of the participant. Following a review of previously used therapies, 
suitable management was planned. This took into account factors such as how able the 
participant was to take medication, known allergies and other medical conditions such as 
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renal impairment. If medication was given, it was given regularly and its effectiveness 
reviewed regularly. These pain management principles are well established [123, 208], 
however it was important for the research to demonstrate that following such principles, 
effective management strategies could be found. The current research did demonstrate 
that non-pharmacological techniques were useful in managing the identified pain; this 
relied to some extent on the willingness of the nursing home staff to ensure that changes 
to management were carried out. 
Paracetamol was prescribed frequently for pain prior to the study commencing. This drug 
was also prescribed several times to treat musculoskeletal pain identified during the 
study. The efficacy of paracetamol in this population was demonstrated in this study. 
NSAIDs were not frequently used in the current research, other than in topical form for 
painful joints. This reflects recommendations to avoid regular prescription of oral 
NSAIDs in this group owing to potential side effects in this population, and also recent 
research evidence regarding the use of topical NSAIDs [267]. Although strong opioids 
were not prescribed for any participants in the current research, the participants 
prescribed weak opioids may require prescription of these drugs should their pain 
worsens in the future. 
To summarise, the current research has demonstrated the need for an individualised 
approach to managing pain in dementia, utilising a range of pharmacological and non-
pharmacological therapies tailored to the underlying cause for the pain. The principles of 
the WHO analgesic ladder were used successfully to manage pain; however the 
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continuing review of those identified as being in pain is vitally important to ensure pain 
management remains adequate. 
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4.14 Palliative care in dementia 
The current research has highlighted the need for regular assessment of those with 
advanced dementia, not just with regards to pain, but also to assess distress from a wide 
range of causes. Such assessments could potentially require input from a wide ranging 
multidisciplinary team. This might include psychiatrists, palliative care physicians and 
geriatricians as well as nursing, physiotherapy and speech therapy input. The challenge 
of improving the quality of care for those with advanced dementia has recently been 
recognised by several key national and international bodies such as the WHO [10], 
NICE-SCIE [20] and the Department of Health [268]. How this challenge is met in the 
UK, particularly in the face of the rising numbers of people with dementia, is an area of 
debate at both national and local levels [269]. The accessibility of palliative care services 
for those with advanced dementia is one component in improving quality of care. 
As discussed in the introduction, defining the terminal stage of dementia can be 
problematic, particularly as those with dementia do not necessarily deteriorate in an 
ordinal manner [98]. There may be palliative care issues occurring throughout the course 
of the illness, not just in the final few months. The identification of such issues also 
requires appropriate referral to those most able to deal suitably with them. There may not 
be a specific point during the illness where the emphasis changes from active to palliative 
care, rather there will be a balance of approaches depending on the specific situation [95]. 
In the US, hospice care is the standard method for providing quality end of life care, 
provided to patients in the last six months of life. Although this type of care is increasing 
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for those with dementia [270], only around one in ten will be enrolled in hospice care. 
Research has demonstrated levels of increased satisfaction amongst families whose 
relatives are cared for in such programmes [271, 272]. Other groups in the US have 
recommended that those with dementia would benefit from similar care throughout their 
illness. The Palliative Excellence in Alzheimer Care Efforts (PEACE) programme 
incorporates advance planning, patient centred care, family support and a palliative care 
focus from diagnosis to terminal stages [273]. Initial feedback suggests high levels of 
satisfaction from both patients and carers to this approach. A recent review of the 
scientific evidence for the efficacy of a palliative care approach in advanced dementia, 
concluded that there is only equivocal evidence for such an approach [274]. Only two 
papers were identified by the review that met full criteria for inclusion and both papers 
originated from the US. The authors acknowledge that carrying out randomised 
controlled trials of end of life care for these patients is problematic, leading to a lack of 
such trials. 
As palliative and hospice care is structured and financed differently in the UK, it is 
difficult simply to adopt models of care from other countries, such as the US, and apply 
them directly. The numbers of patients with dementia admitted to hospices are currently 
small [10, 15], with only 1-2% of admissions having dementia as the primary diagnosis. 
The reasons for this are not clear; one possible reason may be the beliefs regarding which 
patients can be referred to hospices. It is possible, however, that many potentially suitable 
patients are not referred as there are concerns regarding removing them from their current 
environment and placing them in another, not suited to those with dementia. If this is the 
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case, then providing care to the level that might be achieved in a hospice environment 
should be attempted wherever that person is, whether it is their own home, a hospital or 
care home. 
The range of palliative care issues that may be seen as dementia progresses will vary 
from person to person. The focus of the current research has been on the assessment and 
management of pain and has highlighted the importance of recognising distress from a 
variety of causes. Other important issues may include feeding issues, support for families 
and end of life care, as discussed in the introduction. Recognising these issues is one 
aspect; however having the available resources to meet these needs is another. During the 
course of the research it became apparent that providing non-pharmacological strategies 
to deal with pain could be more challenging than one might expect for palliative care 
patients. Accessing the services of physiotherapists, occupational therapists and 
complementary therapists was not impossible, but much less readily available than might 
be to those under the care of a hospice. 
It has been recognised that general palliative care should be provided by all of those 
caring for patients with chronic progressive illnesses, with specialist palliative care 
provided by skilled multi-professional teams [76]. With this principle in mind, adequate 
training must therefore be delivered to all professionals involved in providing care to 
those with dementia. Staff shortages within nursing homes may prevent members of staff 
from attending such training sessions and limit the ability of staff to deal effectively with 
a variety of palliative issues including the management of pain [204, 260, 275]. There 
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may also be high staff turnover within homes, reducing the capacity to maintain a core of 
highly trained staff with in depth knowledge of the people they care for. These barriers 
were highlighted by work carried out by Hockley el al in promoting the Liverpool care 
pathway for the dying in nursing homes [89]. They also discussed the difficulties 
encountered in dealing with the many different GPs connected with one home in terms of 
coordinating services. Two out of the three EMI homes in the current research had most 
of their residents' care transferred to one GP, who provided weekly visits. Inadequate 
physician presence in nursing homes has been highlighted in other work as a barrier to 
the delivery of high quality care [260, 275]. 
The provision of education and training should not only include those who provide day to 
day care for those with dementia, but also for the specialist teams that may also be 
involved in their care. Few community palliative care clinical nurse specialists hold a 
specialist qualification in the care of older people [22] and many dementia care specialists 
lack confidence in providing palliative care [63]. A collaborative approach between the 
different groups involved in providing care, sharing knowledge and expertise has been 
suggested as a method of enhancing care [276]. Developing links therefore between 
psychiatry of old age, palliative care and geriatric medicine is critical in providing 
coordinated care for those with dementia [63]. 
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Chapter 5 - CONCLUSIONS 
5.1 Summary of thesis aims 
This thesis reported the results of a pilot study assessing good practice in pain 
management in severe dementia. The purpose of the study was to investigate the utility of 
a pain assessment tool and a distress assessment tool in a UK population with severe 
dementia and demonstrate the ability of the tools to measure change in pain following 
change to management regime. This was carried out by completing the tools following 
three observations, managing any pain observed and then repeating the tools. In addition, 
the study assessed the use of analgesia within the nursing homes and also examined the 
nature of distress that may produce a false positive result on a pain scale. The overall aim 
was to demonstrate the importance of managing pain as part of good quality palliative 
care for people with severe dementia. 
5.2 Summary of outcomes of literature review 
In this section I shall summarise the results of the literature review presented in Chapter I 
and show how the review generated my research hypotheses. The literature review 
covered a wide range of issues pertaining to palliative care and pain in severe dementia. 
As dementia is a progressive life threatening condition, it has been recognised that the 
principles of palliative care should apply to patients with dementia [1, 15, 16]. The 
palliative needs of dementia patients have been examined retrospectively using 
interviews and MDS data [34, 35] and the identified needs discussed in more detail. 
Decision making surrounding physical issues such as feeding and treating infections can 
299 
be complex and the need consider advance care planning was highlighted. The specific 
needs of those with dementia regarding family support, psychological and spiritual issues 
and end of life care were examined and recent initiatives to address these concerns are 
discussed. The timing of such input was also debated, with the recognition of the 
difficulties in identifying the end of life phase of dementia. As many of the discussed 
issues can occur at any stage in the illness [101], the importance of a balance between 
palliative and active approaches was emphasised. 
5.2.1 Pain in dementia 
The literature review of pain in dementia initially considered levels of pain in elderly 
population to give an indication of potential levels of pain in those with severe dementia. 
Although pain was found to be common [2, 103] and often under-treated, it was 
recognised that those with severe dementia were invariably excluded from such studies. 
Other methods of evaluation the prevalence of pain were therefore reviewed. The studies 
carried out by Morrison and Feldt [120, 121] demonstrated the differences in opiates 
given, following hip fracture, to those with cognitive impairment compared to those with 
normal cognition. This raised the issue that the neuropathological changes of dementia 
may affect pain pathways and the evidence for and against this phenomenon was 
discussed. Although there are published case reports [132] and theoretical evidence [130, 
131] for altered pain perception in Alzheimer's disease, this has not been demonstrated 
by recent work utilising fMRI techniques [141]. There is less published evidence 
regarding vascular dementia and the studies available are far from conclusive. The 
potential impact of neuropathological changes regarding pain perception is difficult to 
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quantify as dementia progresses. Therefore defining the true prevalence of pain in severe 
dementia is complex. 
The first research hypothesis to be tested was that pain is common and under-recognised 
in this population 
5.2.2 The assessment of pain in dementia 
The literature review also described the use of self assessment pain tools in dementia and 
highlighted that most scales could not be completed with worsening cognitive ability. The 
use of behavioural pain assessment tools was debated and several problems with this 
approach were raised. Recent reviews of such tools [31, 184] have demonstrated that the 
lack of behaviours solely indicating pain may lead to pain being over identified. In 
addition, many behavioural pain tools risk ignoring unique indicators of pain. A recent 
review was unable to recommend one tool for use across population and settings [170]. In 
view of these issues, two different tools were chosen for use in the study, PAINAD [3] 
and DisDAT [4]. The published evidence surrounding the utility of PAINAD was 
discussed, including its ease of use and change in scores seen on treatment of pain [3. 
195, 229]. The concerns that have been raised regarding PAINAD identifying behaviour 
that was not caused by pain [201] were explored, as well as concerns that the tool cannot 
indicate pain intensity [118]. The principles regarding the use of DisDA T were discussed, 
including its aim of identifying distress rather than pain and allowing unique behaviours 
to be utilised in assessment. 
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Several research hypotheses were created following this review: that behavioural 
assessment tools can reliably be used to identify pain and the tools are sensitive to 
changes in pain. In addition, assessing the nature of distress that may produce a false 
positive result on a pain scale formed another research objective. 
5.2.3 The management of pain in dementia 
The literature review regarding pain management initially covered some of the issues 
regarding prescribing drugs for elderly patients, including pharmacodynamic and 
pharmacokinetic changes that can alter drug actions. The different groups of drugs that 
form the WHO analgesic ladder were discussed and the principles regarding their use in 
elderly patients were examined. Adjuvant analgesia and non-pharmacological approaches 
were also considered, including prevention of painful events. The literature regarding 
prescribing analgesics to all agitated patients was reviewed and several concerns were 
raised regarding this approach. 
The principles regarding analgesia prescription lead to the final hypotheses being formed. 
These were that analgesia is prescribed inadequately for those with dementia and that 
pain identified can be managed using both simple non-pharmacological and 
pharmacological techniques. 
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5.3 Main findings of the research 
In order to test these hypotheses, I undertook a pilot study of 79 nursing home residents 
with severe dementia. The participants all had a CDR score of three and were resident in 
four homes in the North Tyneside area. 
5.3.1 Background 
Many of the characteristics of the population included in the research were comparable to 
national data and other published studies. The proportion of participants with vascular 
dementia was higher than might have been predicted, with fewer participants diagnosed 
with Dementia with Lewy bodies. It was not clear whether these differences influenced 
the results of the research. The wide variation in time since diagnosis and time since 
admitted to the home meant that the participants were representative of a broad range of 
patients with dementia. The background neuropsychiatric scales demonstrated that levels 
of depression were similar to those seen in other dementia research and levels of 
dependency were in keeping with placement policy for those with advanced dementia. 
Levels of psychopathology were lower than those seen in other research studies of 
dementia, with agitation levels slightly higher. 
5.3.2 Results from baseline assessments 
Following the baseline assessments, 16% of participants were found to be in pain with 
33% of participants scoring above two on the PAINAD tool, owing to behaviour from 
causes other than pain. From this data the sensitivity of PAINAD was shown to be 92% 
and specificity 61 %. The proportion of participants found to be pain was less than had 
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been expected from studies carried out in patients with moderate dementia. I therefore 
questioned the hypothesis that pain is common in patients with severe dementia. The 
potential reasons for the prevalence of pain in this study were discussed. The low 
prevalence of pain was felt to be caused by a combination of the amount of time used to 
observe the participants, the possible effects of dementia on pain pathways, the fact that 
behavioural assessment quantifies a different aspect of the pain experience to self report 
and that some of the behaviour could have been misinterpreted. Although PAINAD was 
found to be highly sensitive with regards to pain, I highlighted that the low specificity 
suggests that this tool cannot be reliably used to identify pain. 
5.3.2.1 Associations with groups from baseline assessment 
Statistically significant associations were not demonstrated between a range of variables 
and the results following the first assessment. These included participants' sex, dementia 
diagnosis, time since diagnosis or age. I discussed, therefore, that targeting a specific 
group of patients with advanced dementia would not identify more pain. There was a 
statistically significant association demonstrated, however, between the scores on the 
CMAI and the false positive group. The behaviours that were documented were therefore 
behaviours associated with agitation. 
5.3.2.2 Initial P AINAD scores 
There were differences demonstrated in the magnitude of the PAINAD scores in each of 
the groups from the baseline assessment. The eating observation scores were significantly 
greater in the false positive group and I discussed that challenging behaviours are 
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commonly seen at mealtimes [36]. The intervention observation scores were significantly 
lower in the no pain group, and I suggested that the PAINAD tool may be able to detect 
when pain is not present. A significant difference was not demonstrated between the 
PAINAD scores for the pain and false positive groups for the intervention observation. 
The ability of the PAINAD tool to differentiate between behaviours caused by pain and 
those not caused by pain was therefore questioned. 
5.3.3 Results from pain and false positive groups 
5.3.3.1 Pain group 
The causes of the pain identified in the study were first considered. The majority of the 
pain identified was chronic in nature, with the acute pain having already been identified 
by nursing staff. As the pain identified was caused by both new diagnoses and previously 
documented diagnoses, I discussed that all patients with severe dementia may require 
regular assessments. This would allow monitoring of known painful conditions and 
identify the onset of new pathologies. I highlighted the need to recognise the underlying 
cause of the pain, with identified pain managed by simple pharmacological and non 
pharmacological techniques. A significant difference was demonstrated in the scores on 
both tools once treatment had started for the identified pain, confirming the hypothesis 
that the tools are sensitive to change. I debated the timeframe for repeating the 
assessments, as although a significant difference between one month and three month 
scores was not demonstrated, some of the pain group had pain at the three month 
assessment. The need for an individualised time frame for pain assessments was therefore 
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suggested. The absence of significant change in the neuropsychiatric scores was 
potentially caused by repeating the scores too soon after implementing pain management 
strategy. I discussed other important issues (using vignettes), such as how the tools can 
aid in deciding if treatment has been effective and the difficulties that may be 
encountered in determining the cause ofthe behaviour. 
5.3.3.2 False positive group 
The behaviour seen in the false positive group had a wide variety of causes, with much of 
the behaviour initiated by the participant either not understanding the situation or 
becoming distressed by the environment. A statistically significant difference was 
demonstrated in the agitation scores when repeated at one month. I discussed that this 
may reflect the fluctuant nature of BPSD [70] and that the homes had attempted to 
manage some the causes of the identified behaviour. Significant differences were seen in 
the scores on both tools at rest, possibly owing to the specific circumstances initiating the 
behaviour not being present at the repeat assessment. Both the changeable nature of 
BPSD and management strategies introduced by the home were thought to have 
contributed to the significant change in the PAINAD score on intervention. I discussed 
the possibility that all of the participants within this group could have been incorrectly 
labelled as having pain. The recommendation was therefore made that identifying distress 
should be the first step in identifying pain. 
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5.3.4 Behaviours observed and documented 
The research demonstrated the range of behaviours that may be recognised as caused by 
distress and that many behaviours of distress are unique. A variety of behaviours could be 
documented for all participants, regardless of factors such as age or length of time in the 
home. The number of behaviours documented was moderately correlated with agitation 
and psychopathology scores, suggesting that those with agitation may display a wider 
variety of behaviours of distress. The pattern of behaviours using the PAINAD tool 
differed between the pain and false positive groups, but the total scores for each group 
were not significantly different. In addition, as many of the distress behaviours identified 
were the same in both the pain and false positive groups, I questioned the ability to 
differentiate between pain and non-pain distress by identifying certain behaviours. 
5.3.5 Medication results 
The current research demonstrated that analgesic prescribing practice in the study homes 
was largely in keeping with published guidelines on pain management, although no 
participants were prescribed strong opioids. The finding that 46% of those with pain were 
already prescribed regular analgesia confirms the hypothesis that analgesics may be 
prescribed inadequately for those with dementia. I also highlighted additional issues such 
as the need to prescribe analgesia regularly. 
5.3.6 Inter-rater reliability 
Although true inter-rater reliability was not achieved in this study, important issues such 
as the variability in behaviour seen in severe dementia were highlighted. 
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5.4 Strengths and limitations of the research 
5.4.1 Generalisability of the study 
An important strength of this pilot study was that all participants had a diagnosis of 
severe dementia and thereby were appropriate to have their pain assessed using a 
behavioural assessment tool. As there were no other exclusion criteria, a broad range of 
participants were involved, including participants who would often excluded from other 
studies. All participants were assessed using the tools, therefore using PAINAD and 
DisDA T as they would be used in day to day practice. Both NHS and non-NHS homes 
were used in the study, broadening the applicability of the research findings. 
There are some factors that limit the generalisability of the research. All the participants 
in the study were Caucasian and, with only one exception, all British. It is therefore 
difficult to generalise the study findings to different racial or cultural groups. The 
proportion of participants with vascular dementia was greater than might have been 
expected and those with dementia with Lewy bodies less than might have been predicted. 
The under representation of those with dementia with Lewy bodies may affect the 
applicability of the research findings to this group. Although many people with advanced 
dementia live in nursing homes, a proportion live in their own home. The research did not 
include any participants other than those living in the nursing homes involved in the 
study. In addition, all the homes included in the study had large numbers of residents with 
dementia. The findings may not be as applicable to nursing homes with only a few 
residents with advanced dementia. 
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5.4.2 Research design 
The assessments were carried out by both the researcher and nursing staff from the home, 
demonstrating that the tools could be completed by nursing staff as part of routine 
practice. The participants were observed on three different occasions to give a broader 
picture of the behaviours that may be identified in different situations. The length of time 
for each of the observations has been discussed in some detail and difficulties could have 
been encountered with observing for longer periods oftime. It is acknowledged, however, 
that many potentially important behaviours were not identified by the timeframe given to 
the observations. 
There is no gold standard for identifying pain in those unable to communicate their needs. 
Any study attempting to investigate this important issue can be criticised for potentially 
misinterpreting behaviours that could be caused by pain. The underlying cause of all the 
behaviours that were observed during the research was discussed with the nursing staff 
present and provoking and alleviating factors identified. If the cause was thought to be 
pain then the participant was examined where appropriate and previous medical notes 
reviewed. Despite these measures, it is still possible that some behaviours were not 
identified correctly. 
Finally, the number of participants identified as having pain was relatively small. The 
prevalence of pain in those with moderate dementia has been demonstrated to be between 
32-62%; therefore far more participants were expected to have pain than were eventually 
identified. Producing definitive conclusions from a small sample of participants (13) is 
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difficult and this limited the statistical analyses that could be completed. In spite of the 
small numbers identified as having pain, it was possible to demonstrate that the tools 
were sensitive to change and recognise important patterns in those identified as having 
pam. 
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5.5 Future research 
This study was conducted as a pilot study; therefore the findings of this research should 
encourage further study. One of the main recommendations of the current research is that 
all patients with advanced dementia need to be regularly assessed to identify if they are 
having periods of time of significant distress, and the cause of the distress needs to be 
addressed. Defining whether this practice is feasible and of benefit to patients could be 
carried out using a combination of quantitative methods (by demonstrating a change in 
scores) and qualitative (the nursing staffs opinions of the how beneficial the practice 
was). 
Additional research would help to clarify the most appropriate tools to be used to assess 
pain and distress in this population of patients. The PAINAD tool, based on a well-
validated scale, was known to be easy to use and had previously been demonstrated to 
have high levels of inter-rater reliability and moderate internal consistency. The initial 
work by Warden [3] identified that PAINAD scores changed following analgesic 
administration; this finding was also demonstrated by the current study. The concerns that 
PAINAD may not solely identify pain were confirmed by the current research, although 
the tool was demonstrated to have a sensitivity of92%. By examining the scores obtained 
from the observations, it was clear that some items on the scale were rarely used, an issue 
raised by the original research. Although the items on the scale could be modified, this 
would still not resolve the problem that behaviours that solely indicate pain have not been 
identified. Any tool that has a list of behaviours that indicate pain may also identify 
distress that is not caused by pain. The current research, therefore, has questioned the 
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ability of the PAINAD tool to differentiate between pain and distress from causes other 
than pain. It has also been suggested that there may be similar problems with other 
behavioural pain assessment tools. It has been suggested that the Pain Assessment 
Checklist for Seniors with Limited Ability to Communicate [189] is able to differentiate 
between pain and non-painful distress states [250], although prospective research has not 
been published in English to substantiate this claim. Further research using PAINAD and 
other pain assessment tools with larger numbers of participants would help to clarify 
whether these tools can differentiate between pain and non-painful distress states. This 
could be carried out using similar methods to the ones described in the current research. 
The current research identified that the DisDAT, initially designed for use in those with 
learning disabilities, could be used with elderly patients with severe dementia. At least 
one behaviour associated with distress was identified during pain observations, 
suggesting that the tool can be used to identify distress caused by pain. In addition, by 
using a PACA scoring system, a significant change was seen in the scores on treating 
pain. As the number of participants in the pain group was small, further research using 
larger numbers of participants would help to ascertain whether these findings could be 
replicated. It is difficult to demonstrate many psychometric properties of the DisDA T as 
the tool is created specifically for the individual by documenting their behaviours of 
distress and is not designed to be a scoring tool. However some aspects of the tool, such 
as inter-rater reliability could be established by further research and this would help to 
determine the utility of the tool for day-to-day usage. 
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Further work is required to help to define the optimum time used for observation. 
Although it may be helpful to have a flexible approach, understanding the differences 
between observing behaviour for a short period of time as compared with a longer time 
frame may help in selecting an appropriate length of time for observation in this group of 
patients. Although some attempt was made in the current research to quantify how 
frequently such assessments should occur, this could be more effectively addressed in a 
larger study. With a larger cohort of participants, a better assessment could also be made 
of whether changes might be seen in neuropsychiatric parameters on treating pain. 
Finally the aim of this research was to demonstrate the importance of managing pain as 
part of good quality palliative care in people with severe dementia. Several reviews have 
suggested that much needs to be done to improve the quality of care for people with 
dementia [63] and questions remain about how best to provide this care [33]. The need 
for continuing debate and research regarding the provision of palliative care for dementia 
patients remains of high importance if the WHO goal of providing palliative care to all 
those with life-threatening illness is to be achieved. 
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Chapter 6 - APPENDIX 
Clinical Dementia Rating scale 
Clifton Assessment Procedure for the Elderly - Behaviour Assessment Scale 
Cohen Mansfield Agitation Inventory 
Cornell Scale for Depression in Dementia 
Neuropsychiatric Inventory 
Pain Assessment in Advanced Dementia tool 
Disability Distress Assessment Tool (with monitoring sheet) 
Oral presentations 
Poster presentations 
Publications 
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Clinical Dementia Rating scale (CDR) [134, 135J 
None Questionable Mild Moderate Severe 
0 0.5 1 2 3 
Memory No memory loss or slight Consistent slight Moderate memory loss; Severe memory loss; only Severe memory loss; only 
inconsistent forgetfulness forgetfulness; partial more marked for recent highly learned material fragments remain 
recollection of events; events; defect interferes retained; new material 
"benign" forgetfulness with everyday activities rapidly lost 
Orientation Fully oriented Fully oriented except for Moderate difficulty with Severe difficulty with time Oriented to person only 
slight difficulty with time time relationships; oriented relationships; usually 
relationships for place at examination; disoriented to time, often 
may have geographic to place 
disorientation elsewhere 
Judgement and Solves everyday problems Slight impairment in Moderate difficulty in Severely impaired in Unable to make judgments 
problem solving & handles business & solving problems, handling problems, handling problems, or solve problems financial affairs well; similarities, and similarities, and similarities, and 
judgment good in relation differences differences; social differences; social 
to past performance judgment usually judgment usually impaired 
maintained 
Community Independent function at Slight impairment in these Unable to function No pretense of No pretense of 
Affairs usual level in job, activities independently at these independent function independent function shopping, volunteer and activities although may outside home outside home 
social groups still be engaged in some; Appears too ill to be taken 
, 
appears normal to casual Appears well enough to be 
inspection taken to functions outside a to functions outside a 
family home family home 
Home and Hobbies Life at home, hobbies, and Life at home, hobbies, and Mild but definite Only simple chores No significant function in 
intellectual interests well intellectual interests impairment of function at preserved; very restricted home 
maintained slightly impaired home; more difficult interests, poorly 
chores abandoned; more maintained 
complicated hobbies and 
interests abandoned 
Personal care Fully capable of self -care Fully capable ofself-care Needs prompting Requires assistance in Requires much help with 
dressing, hygiene, keeping personal care; frequent 
of personal effects incontinence 
Score only as decline from previous usual level due to cognitive loss, not impairment due to other factors. 
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Assignment of CDR rating 
Use all information available and make the best judgment. Score each category (M, 0, 
JPS, CA, HH, PC) as independently as possible. Mark in only one box, for each category, 
rating impairment as decline from the person's usual level due to cognitive loss alone, not 
impairment due to other factors, such as physical handicap or depression. Occasionally 
the evidence is ambiguous and the clinician's best judgment is that a category could be 
rated in either one of two adjacent boxes, such as mild (I) or moderate (2) impairment. In 
that situation the standard procedure is to check the box of greater impairment. 
Aphasia is taken into account by assessing both language and non-language function in 
each cognitive category. If aphasia is present to a greater degree than the general 
dementia, the subject is rated according to the general dementia. Supply evidence of non-
language cognitive function. 
The global CDR is derived from the scores in each of the six categories ("box scores") as 
follows. 
Memory (M) is considered the primary category and all others are secondary. CDR = M 
if at least three secondary categories are given the same score as memory. Whenever 
three or more secondary categories are given a score greater or less than the memory 
score, CDR = score of majority of secondary categories on whichever side of M has the 
greater number of secondary categories. 
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When three secondary categories are scored on one side of M and two secondary 
categories are scored on the other side ofM, CDR=M. 
When M = 0.5, CDR = I ifat least three of the other categories are scored one or greater. 
If M = 0.5, CDR cannot be 0; it can only be 0.5 or I. If M = 0, CDR = 0 unless there is 
impairment (0.5 or greater) in two or more secondary categories, in which case CDR = 
0.5. 
Although applicable to most Alzheimer's disease situations, these rules do not cover all 
possible scoring combinations. Unusual circumstances occur occasionally in Alzheimer's 
disease and may be expected in non-Alzheimer dementia as well are scored as follows: 
(1) With ties in the secondary categories on one side of M, choose the tied scores closest 
to M for CDR (e.g., M and another secondary category = 3, two secondary categories = 2, 
and two secondary categories = 1; CDR = 2). 
(2) When only one or two secondary categories are given the same score as M, CDR = M 
as long as no more than two secondary categories are on either side of M. 
(3) When M = 1 or greater, CDR cannot be 0; in this circumstance, CDR = 0.5 when the 
majority of secondary categories are O. 
317 
Clifton Assessment Procedures for the Elderly - Behaviour Rating Scale [227] 
1. When bathing or dressing, he/she requires: 
No assistance 0 
Some assistance 1 
Maximum assistance 2 
2. With regard to walking, he/she: 
Shows no signs of weakness 0 
Walks slowly without aid, or uses a stick 1 
Is unable to walk, or if able to walk, needs frame, crutches 2 
or someone by hislher side 
3. He/She is incontinent of urine and/or faeces (day or night): 
Never 0 
Sometimes (once or twice per week) I 
Frequently (3 times a week or more) 2 
4. He/She is in bed during the day (does not include couch, settee etc): 
Never 0 
Sometimes I 
Almost always 2 
5. He/She is confused (unable to find way around, loses possessions etc): 
Almost never confused 0 
Sometimes confused I 
Almost always confused 2 
6. When left to hislher own devices, his/her appearance is: 
Almost never disorderly 0 
Sometimes disorderly I 
Almost always disorderly 2 
7. If allowed outside, he/she would: 
Never need supervision 0 
Sometimes need supervision I 
Always need supervision 2 
8. He/She helps out in the home/ward: 
Often helps out 0 
Sometimes helps out I 
Never helps out 2 
9. He/She keeps him/herself occupied in a constructive or useful activity 
(works, reads, plays games, has hobbies etc) 
Almost always occupied 0 
Sometimes occupied I 
Almost never occupied 2 
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10. He/She socialises with others: 
Does establish a good relationship with others 0 
Has some difficulty establishing relationships I 
Has a great deal of difficulty establishing good relationships 2 
II. He/She is willing to do things suggested or asked of him /her: 
Often goes along 0 
Sometimes goes along I 
Almost never goes along 2 
12. He/She understands what you communicate to him/her (writing, speaking, gesturing): 
Understands almost everything you communicate 0 
Understands some of what you communicate I 
Understands almost nothing of what you communicate 2 
13. He/She communicates in any manner (writing, speaking, gesturing): 
Well enough to be understood at all times 0 
Can be understood sometimes or with some difficulty I 
Can rarely or never be understood for whatever reason 2 
14. He/She is objectionable to others during the day (Loud or constant talking, pilfering, 
soiling furniture, interfering with the affairs of others): 
Rarely or never 0 
Sometimes I 
Frequently 2 
15. He/She is objectionable to others during the night (Loud or constant talking, pilfering, 
soiling furniture, interfering with the affairs of others, wandering about): 
Rarely or never 0 
Sometimes I 
Frequently 2 
16. He/She accuses others of doing himlher bodily harm or stealing his/her personal 
possessions: 
Never 
Sometimes 
Frequently 
o 
1 
2 
17. He/She hoards apparently meaningless items (wads of paper, string, food etc): 
Never 0 
Sometimes I 
Frequently 2 
18. HislHer sleep pattern at night is: 
Almost never awake 
Sometimes awake 
Often awake 
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o 
I 
2 
Cohen-Mansfield Agitation Inventory [148] 
Behaviour as manifest during the last fortnight 
1. Pace, aimless wandering 
2. Inappropriate dress or disrobing 
3. Spitting (include at mealtimes) 
4. Curing or verbal aggression 
5. Constant unwarranted request for attention or help 
6. Repetitive sentence or questions 
7. Hitting (including self) 
8. Kicking 
9. Grabbing onto people 
10. Pushing 
II. Throwing things 
12. Strange noises (weird laughter or crying) 
13. Screaming 
14. Biting 
15. Scratching 
16. Trying to get to a different place (e.g. out of the room, building) 
17. Intentional falling 
18. Complaining 
19. Negativism 
20. Eating/drinking inappropriate substances 
21. Hurt to self or others (cigarette, hot water) 
22. Handling things inappropriately 
23. Hiding things 
24. Hoarding things 
25. Tearing things or destroying property 
26. Performing repetitive mannerisms 
27. Making verbal sexual advances 
28. Making physical sexual advances 
29. General restlessness 
Rating: 
I::::: Never 
2 = < I x week 
3= 1-2 x week 
4 ::::: Several times a week 
5 ::::: Once or twice per day 
6 ::::: Several times per day 
7 = Several times an hour 
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Cornell Scale for Depression in Dementia [226J 
Scoring System 
A = unable to evaluate 0= absent 1 = mild or intennittent 2 = severe 
Ratings should be based on symptoms and signs occurring during the week prior to 
interview. No score should be given in symptoms result from physical disability or 
illness. 
A. Mood-Related Signs 
1. Anxiety: anxious expression, ruminations, worrying a 0 2 
2. Sadness: sad expression, sad voice, tearfulness a 0 2 
3. Lack of reactivity to pleasant events a 0 2 
4. Irritability: easily annoyed, short-tempered a 0 2 
B. Behavioural Disturbance 
5. Agitation: restlessness, hand wringing, hair pulling a 0 2 
6. Retardation: slow movement, slow speech, slow reactions a 0 2 
7. Multiple physical complaints (score 0 ifGI symptoms only) a 0 2 
8. Loss of interest: less involved in usual activities a 0 2 
(score only if change occurred acutely, i.e. in less than 1 month) 
C. Physical Signs 
9. Appetite loss: eating less than usual a 0 2 
10. Weight loss (score 2 if greater than 5 lb. in 1 month) a 0 2 
11. Lack of energy: fatigues easily, unable to sustain activities a 0 2 
(score only if change occurred acutely, i.e., in less than 1 month) 
D. Cyclic Functions 
12. Diurnal variation of mood: symptoms worse in the morning a 0 2 
13. Difficulty falling asleep: later than usual for this individual a 0 2 
14. Multiple awakenings during sleep a 0 2 
15. Early morning aWakening: earlier than usual a 0 2 
(for the individual) 
E. Ideational Disturbance 
16. Suicide: feels life is not worth living, has suicidal wishes, a 0 2 
or makes suicide attempt 
17. Poor self esteem: self-blame, self-depreciation, a 0 2 
feelings offailure 
18. Pessimism: anticipation of the worst a 0 2 
19. Mood congruent delusions: delusions of poverty, illness, a 0 2 
or loss 
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Neuropsychiatric Inventory Questionnaire [228J 
Answer the following questions based on changes that have occurred since the patient 
first began to experience memory problems. 
Circle ''yes'' only if the symptom has been present in the past month. Otherwise circle 
"no" 
For each item marked ''yes'': 
Rate the frequency of the symptom 
1 = Occasionally - less than once per week 
2 = Often - about once per week 
3 = Frequently - several times per week, but less than every day 
4 = Very Frequently - daily or essentially continuously present 
Rate the severity of the symptom 
1 = Mild - produce little distress in the patient 
2 = Moderate - more disturbing to the patient but can be redirected by the care giver 
3 = Severe - very disturbing to the patient and difficult to redirect 
Delusions 
Yes No 
Hallucinations 
Yes No 
Agitation or aggression 
Yes No 
Depression or dyspboria 
Yes No 
Anxiety 
Yes No 
Does the patient believe that others are stealing from himlher, or 
planning to harm him or her in some way? 
Frequency: Severity: 
Does the patient act ifhe/she hears voices? Does he/she talk to 
people who are not there? 
Frequency: Severity: 
Is the patient stubborn and resistive to help from others? 
Frequency: Severity: 
Does the patient act ifhe/she is sad or in low spirits. Does he or 
she cry? 
Frequency: Severity: 
Is the patient nervous, worried or frightened for no apparent 
reason? 
Frequency: Severity: 
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Elation or euphoria 
Yes No 
Apathy or indifference 
Yes No 
Disinhibition 
Yes No 
Irritability or Lability 
Yes No 
Does the patient seem to be too cheerful or too happy for no 
reason? 
Frequency: Severity: 
Has the patient lost interest in the world around himlher? 
Frequency: Severity: 
Does the patient act impulsively without thinking? Do they do or 
say things that would not normally be done or said in public? 
Frequency: Severity: 
Does the patient get irritated or easily disturbed? Are his/her 
moods very changeable? 
Frequency: Severity: 
Aberrant motor behaviour Does the patient pace, do things over and over such as opening 
drawers or pick at things? 
Yes No 
Night time behaviours 
Yes No 
Appetite and eating 
Yes No 
Frequency: Severity: 
Does the patient have difficulty sleeping, wander at night or get 
dressed during the night? 
Frequency: Severity: 
Has he/she had any change in appetite, weight or eating habits? 
Frequency: Severity: 
For each domain the score is produced by mUltiplying frequency and severity scores. The 
total score is calculated by adding up the scores from each domain. 
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Pain Assessment in Advanced Dementia [3J 
0 1 2 
Breathing Normal Occasional laboured Noisy laboured 
independent of breathing. Short breathing. Long 
vocalisation period of period of 
hyperventilation hyperventilation. 
Cheyne-Stokes 
respirations 
Negative None Occasional moan or Repeated troubled 
vocalisation groan calling out. Loud 
Low-level speech moaning or 
with a negative or groaning. Crying 
dis~roving quality 
Facial expression Smiling or Sad. Frightened. Facial grimacing 
inexpressive Frown 
Body language Relaxed Tense Rigid. 
Distressed pacing. Fists clenched. 
Fidgeting Knees pulled up 
Pulling or pushing 
away. Striking out 
Consolability No need to console Distracted or Unable to console, 
reassured by voice distract or reassure 
or touch 
Item definitions 
Breathing 
1. Normal breathing is characterised by effortless, quiet, rhythmic (smooth) respirations 
2. Occasional laboured breathing is characterised by episodic burst of harsh, difficult or 
wearing respirations 
3. Short period of hyperventilation is characterised by intervals of rapid deep breaths lasting 
a short period of time 
4. Noisy laboured breathing is characterised by negative sounding respirations on 
inspiration or expiration. They may be loud, gurgling, wheezing. They appear strenuous 
or wearing 
5. Long period of hyperventilation is characterised by an excessive rate and depth of 
respirations lasting a considerable time 
6. Cheyne-Stokes respirations are characterised by rhythmic waxing and waning of 
breathing from very deep to shallow respirations with periods of apnoea (cessation of 
breathing) 
Negative Vocalisation 
1. None is characterised by speech or vocalisation that has a neutral or pleasant quality 
2. Occasional moan or groan is characterised by mournful or murmuring sounds, wails or 
laments. Groaning is characterised by louder than usual inarticulate involuntary sounds, 
often abruptly beginning and ending 
3. Low level speech with a negative or disapproving quality is characterised by muttering, 
mumbling, whining, grumbling or swearing in a low volume with a complaining, 
sarcastic or caustic tone. 
4. Repeated troubled calling out is characterised by phrases or words being used over and 
over in a tone that suggests anxiety, uneasiness or distress 
5. Loud moaning or groaning is characterised by mournful or murmuring sounds, wails or 
laments in much louder than usual volume. Loud groaning is characterised by louder than 
usual inarticulate involuntary sounds, often abruptly beginning and ending 
6. Crying is characterised by an utterance of emotion accompanied by tears. There may be 
sobbing or quiet weeping 
Facial expression 
1. Smiling or inexpressive. Smiling is characterised by upturned comers of the mouth, 
brightening of the eyes and a look of pleasure and contentment. Inexpressive refers to a 
neutral, at ease, relaxed or blank look. 
2. Sad is characterised by an unhappy, lonesome, sorrowful or dejected look. There may be 
tears in the eyes. 
3. Frightened is characterised by a look of fear, alarm or heightened anxiety. Eyes appear 
wide open 
4. Frown is characterised by a downturn of the comers of the mouth. Increased facial 
wrinkling in the forehead and around the mouth may appear 
5. Facial grimacing is characterised by a distorted distressed look. The brow is more 
wrinkled as is the area around the mouth. Eyes may be squeezed shut 
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Body language 
I. Relaxed is characterised by a calm, restful, mellow appearance. The person seems to be 
taking it easy 
2. Tense is characterised by a strained, apprehensive or worried appearance. The jaw may be 
clenched (exclude any contractures) 
3. Distressed pacing is characterised by activity that seems unsettled. There may be fearful, 
worried or disturbed element present. The rate may be faster or slower. 
4. Fidgeting is characterised by restless movement. Squirming about or wriggling in a chair 
may occur. Repetitive touching, tugging or rubbing body parts can also be observed. 
5. Rigid is characterised by stiffening of the body. The arms and/or legs are tight and 
inflexible. The trunk may appear straight and unyielding (exclude any contractures) 
6. Fists clenched is characterised by tightly closed hands. They may be open and closed 
repeatedly or held tightly shut 
7. Knees pulled up is characterised by flexing the legs and drawing the knees up towards the 
chest. An overall troubled appearance (exclude any contractures) 
8. Pulling or pushing away is characterised by resistiveness upon approach or to care. The 
person is trying to escape by yanking or wrenching him or herself free or shoving you 
away 
9. Striking out is characterised by hitting, kicking, grabbing, punching, biting or other form 
of personal assault 
Consolability 
I. No need to console is characterised by a sense of well being. The person appears content 
2. Distracted or reassured by voice or touch is characterised by a disruption in the 
behaviour when the person is spoken to or touched. The behaviour stops during the 
period of interaction with no indication that the person is at all distressed 
3. Unable to console, distract or reassure is characterised by the inability to sooth the 
person or stop the behaviour with words or actions. No amount of comforting, verbal or 
physical will alleviate the behaviour. 
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Disability 
Distress Assessment Tool 
OoB : 
Unit/ward : NHS No: 
Your name: Oate completed: 
Names of others who helped complete th is form : 
OlsOAT Is 
Intended to h Ip Kient fy distress cues in people who because 01 cogOluve impairment or physICal Illness have 5 v r y 
limited communication. 
Des igned to describe a person s usual content cues, thus enabling distress cues to be idenb ted more clean . 
NOT 0 scoring too l. It documents what many staff have done instlncltve for many years thus providIng a record 3g Inst 
which subtle changes can be compared. This IOlorma on can be transferred th the client or patient to any n Ironment 
Only t he f irs t step. Once distress has been Identifted the usual clinical decIsIOns have to b made by prof sSlonals 
Meant to help you and y our client or patient It gives you more confidence in the observatIOn skills you alre dy hay 
which III tum will help you improve the care 0 your cI ent or patient. 
INSTRUCTIONS FOR USING OlsOAT ARE ON THE BACK PAGE 
SUMMAR Y OF SIGNS AND BEHAVIOURS 
( Appearance when CONTENT Appearance when DISTRESSED 
Face Eyes Face Eyes 
~~gue/jaw Tongue/jaw 
Skin Sk tn 
--" -
-
Vocal signs when CONTENT Vocal signs when DISTRESSED 
Sounds Sounds 
SpeeCh Speech 
Habits and mannerisms when CONTENT Habits and mannerisms when DISTRESSED 
Habits HabIts 
Mannerisms Mannerisms 
Comfortable distance Comfortable d istance 
Posture & observations when CONTENT Posture & observations when DISTRESSED 
Posture Posture 
Observations Observations 
Known triggers of d istress (wnte here any actJons or sItUations that usually cause or worsen dIStress) 
Dis OAT 2006 Northumberland Tyne & Wear NHS Trust and Sl Oswai!fs HospICe 
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Disability 
Distress Assessment Tool 
Please take some time to think abou and observe your cllenrs appearance and behaviours when Ih ya re 
both content and dis ressed, and descnbe these cues In the spaces given We have listed worClS 10 eacn 
section to help you to describe your client or pallent You can CIrcle the word or words that best descnbe the 
signs and behaviours when your clien or patient is content and when tney are CllstresseCl Document me cu s 
in each ca tegory and If possible, give a tuller description in the spaces given Your d scnptions will provide 
you wi h a clearer picture 01 your client's 'language 01 distress 
COMMUNICATION LEVEL ' 
Th person is unable to show likes or dislikes 
ThIS person IS able 10 show !ha t Ihey like or don'l like something 
ThiS person IS able 10 show tha l lhey want more. or have had enough 0 something 
ThiS person is able 10 show anllcipatJon for their like or dishke of someth ing 
D 
D 
D 
D 
D 
Level 0 
Level l 
eve I 2 
Level 3 
Level 4 Th,s person is able to communlC3te detail. qualify , SpeCify and/or indicale opinions 
FACIAL SIGNS 
Appurance 
information ' instructions I Appearance when content AIloelll'ance when dIStressed 
k§ e wordS fla! best PaSSIVe LaUOh Smile Frown Passive LOOOn Smi 
describe the fadal 
aopearance Grimace Startled Frightened Gnmace Startled 
Other Other 
Jaw movement 
Informaboo I Instructions Movement when contant Movement when d IStressed 
@E§) the words IIlat best Relaxed Drooping GIindinQ Rela eel Droc:J!)tnQ 
descrl>e the jaw 
Billno RJo id Billno RJoid movement 
Otnef: Other: 
A 'ppea rance of eyes 
InformatIOn IlnstructJOOs Apj)elll'ance when content Appearance when dIStressed 
@ wordS flat best Good eye contact little eye contact Good eye contlct 
Frown 
F"Onlened 
Grinding 
eye contact 
descrl>e the Avoidino eye contac Closed eyes Avoiding eye contact Closed eyes aopeal3nce 
SUmo Sleepy eyes SUmo Sleepy eyes 
'Smillno' Wktno Vacant 'Smlll"O' W1nklno Vacant 
Tears Dilated pupils Tears Dilated pupils 
Other: Other: 
SKIN APPEARANCE 
informa tIOn 'InstnJctJOOS Appearance when content AI>Pe_arance when distressed 
~ e words fla! best Normal Pale Flushed Normal Pale FlusIled descrl>e the 
appeal3nce Sweaty Clammy Sweaty Clammy 
Other: Other 
2 DlsDAT Cl 2006 Northu01bef1and Tyne & WeiJI HS Trust nd 5t Oswald's Hos 
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VOC AL SOUNDS (NB. The sounds that a person makes are not always ~nked to \heir fee~ngs) 
InforrTlOltion ! instructions Sounds when conlant Sounds when distressed 
@ the WOItIs that best Volume high medium low Volume: hioh medIUm low 
describe the sounds 
PitCh. high medlUfll low Pilch : haoh medium low 
Write down commonly used 
Durotion: short "terminent long Durotion short ont rm,Uent SOlMS (write ft as ft SClUnds; 
'bu', 'eelOW', 1etetetete') Oescnption of sound / vocalisation. IonO 
Cry out Wall Scream laugh Oescr1plion of sound / vocal;s lion 
.. .. .. ... Cry out Wail Scream ~UOh Groan / moan shout GUI1lI8 
.. .. ... ... 
Other: 
Groan/moan shout Gulli 
... ... OIher 
SPEECH 
InforrTlOltion I instructions Words when content Words when distressed 
Wrife down commonly used 
words and phrases. If no words 
are ~en write NONE 
~the won:Is whICh best Clear Stutters Slurred Unclear Clear StutteB Slurred Unclear 
describe tile speech Mutt...-tng Fast Slow Muttering Fasl Slow 
Loud Soft Whisper Loud Soft Whisper 
Other: OIher 
HABITS & MANNERISMS 
InforrTlOltion IlflStructions Habits and mannerisms when content HIIbiIs and mannerismt when dlltr ... ed 
Write down tile habits or 
mannerisms, 
eo. "Rocks when 5itt1no" 
Write down any sPeCial 
corrtorters, possessions or toys 
this person prefers 
P1ea3e~ the statements Close with Strang81S Close with SlranQelS 
which bes descll!>e how 
Close only • known Close only W known comfortable this person is with 
other people being physicaly No one allowed Close No one allowed dose 
close by 
WIIhdraws W Iouched Withdr.rws t Iouched 
BODY POSTURE 
InforrTlOltion !lnStructions Poslure when content Posture when dlSlrHMd 
® tile words that best Normal Rigid Floppy Notmal Rigid Floppy 
describe how this 
Jerky SI~ RestleSs Jerky SkImPIICl R person sits and stands. 
Tense Stitl Able to aqust position T8Il5e StIlI Able to adlUSl POSIIIon 
Leans to side Poor head control Leans to skIe Poor head control 
Wayofwal<lng' Notmal / Abnormal Way d walklllO: Nonnal/ Abnormal 
Other: 0Iher: 
BODY OBSERVATIONS 
InforrTlOltion !InS\ructIons ObserIations when con .... t ObMrvationl when ct.atressed 
Descnbe the putse, breathing, Pulse: Pulse 
sleep, appethe and 
Breathing: BrealhlnQ: usual eating pattern, 
eo· eats very quickly, takes a Sleep: Steep 
long time with main course, eats 
PlIddinOs quickly, "picky". Appetite: Appetite 
Eating pattern' Eatino pattern 
Dis OAT C 2006 NortItumbe~and Tyne & Wear NHS TMt and SL Oswald's HospIce 3 
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Information and InstructJons 
When to UN DlsDAT 
When Ute lNm ".,leve. Ute client I. NOT 
",.".. ... ft 
The use of DIsDAT Is optional, but It can be used as 
a 
- baseline assessment document 
- transfer document for other teams 
Wh.n ,he lNm ".,leve. ,he ellen' IS fII."....ed 
n DlsDAT has already been completed It can be 
used to compare the present signs and 
behaVIoUrs with previous observations 
documented on DlsDAT. n IIlen serves as a 
baseHne to monitor change. 
If D1sDAT has not been completed: 
a) When the client Is well known OIsDAT can be 
used to document preVIoUs content signs and 
behavloln and compare these with the current 
observations 
b) When the ClIent or the cllstress Is new to the team, 
DIIDAT can be used document the present signs 
and behaVIoUrs to act a baseline to monner change. 
How to u .. E*DAT 
1. Observe .... client when content and When 
distressed- document Ills on the inside pages. 
Anyone Who cares for the patient can do this. 
2. Observe .... COrD .. In WhIch distress Is 
occurmg. 
3. Un tile ctlnlcal decision cIIs1reI. cllectUst on 
this page to assess the possible cause. 
4. T .... or MIl ..... the Iltellest cause of the 
clstress. 
5. Tile Inonlt ........... II a separate sheet, 
which may help If you _nt to see hOw the 
Clstress Changes over lime. 
Cllnlcel decIIIon d ........ checldlat 
use this to help CIedCIe the cause of the distress 
II .... new sign or llelUlVlour? 
• Repeated rapidly? 
COnSider plellttlc pain (In time with breathing) 
Consider colic (comes and goes every few minutes) 
COnslde,. repetitive movement due to bOredom or 
Ie •. 
• Associated wIIh brellthlng? 
Conslde,. infection, COPD, pleural etruslon, tumour 
• Worsened or precipitated by movement? 
ConSlCler rnovement-rel8ted pains 
• ReIIIted to eMlng? 
conSlCler: foorI refUIaIlhrough Ilness, Ie. or 
depreSSIOn 
ConSider foorI retuuI becaUSe of sW8lowtng 
problems 
conSider: upper GI problemS (orll hygiene, peptic 
&*:er, dySpepsia) or abdolnlnal problems. 
• Related to a spedftc sMuatIon? 
Con$Ider MgtIIenIng or !MIl""" slullltonS. 
• AlsocIIIIed wIIh vomiting? 
ConSlCler causes of nausea and vomlllng. 
• AIIOCIIIIed WIth elmtnaIIOn (WIne or r.ecat)? 
conSlCler umary problems (Infection, retentton) 
conSlCler GI problemS (cIIMhoea, constIpatIOn) 
• Present In a normally cornfOftable posIIIon 01 
IIluaIIOn? 
COnSlCler. anxiety, depression, pains at rest (eg. 
colIC. neuralgia), 1nI'ectIon, nausea. 
6. ,.... INIIs a recIudIon the number or severity Of "r.;;;=;;;;;;;;;~~~;;;;;;;===;1 Clstress signs and behaviours. • you ,.... .rt MIp Of furtIIr infonnMion 
• .... r.garding DilDAT .... contIIc:t: 
.. emem_r Lynn Gibeon 01670 394 260 
4 
Most Information comes tom the whole team In 00r0IIy ~ 01670". 808 
par1nersh1p will the family. Dr. Claud R..,.t 0191 2850063 Of HMiI on 
The assessment form need not be completed .. claudlJlCl!lR!Ottpawaldlldt om 
at once and may lake a period of lime. 
Reassessment Is essential as the needS of the 
client or patient may change due to Improvement 
or deterioration. 
Dlslress can be ernoIIonaI, phySical 01 
psychological. What Is a minor Issue for one 
person can be major to ~. 
If signs are recognised early then sUitable 
interventions can be put In place to avoid a 
crtsls. 
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Northgate & Prudhoe NHS Trust PlIIII8tIvt 
care Team 
and st. osw.!d's HospIce 
(wI .. ) ol,oAT Monitor Plltlent: s .. rt month: Y •• r: 
o 1 Is the sign/behaviour of distress present? H No. score 0; if Yes. go to next question 
o 2 Is it moderately affecting on 1M! day? H No. _ 1; if Ves. go to next question 
03 Isitdominali tiled HNo _2' ifVes _3 
2 
, 
o 
~IIIIIIIIIIIIIIIIIIIIIIIIIII 
Patient 'I~n or behaviour of eIIstress: 
! I [ I 111111111111111111111 III 
Patient sl~n or behmour of dlsll'ess: 
il r I I 11111111111111111111111 
Patient sl~n or behaviour of dI .... ess: 
11 t I I 11111111111111111111111 
Patient Sl~n or bellmour of dI .... ess: 
i I ( I I 111111111111 11111111 III 
...... ·r ............... -~ 
ill I III II 1111111 111111 II III 
p .. • .. ·r ........ ~' .. -' 
111 I III II I I I II II 1111 II II I I I 
Patient Sl~n or beh."lour of eIIlII'"S: 
11 t I I 11111111111111111111 III 
Patient Sl~n or behaviour of eII .... "s: 
11 ( I I 11111111111111111111111 
TOTAL score 
I I I I I I I I I I I I I I I I I I I I I I I I I I I 
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Oral presentations 
I have delivered the following oral presentations:-
"The assessment of good practice in pain management in severe dementia: a pilot study" 
DisDA T conference 
Pollock Halls, University of Edinburgh 
30th October 2006 
"Palliative care for patients with dementia" 
Current Issues in Palliative Care 
Institute of Physics, London 
3rd May 2007 
"Assessing and managing pain in dementia" 
Building Bridges conference, Supportive, Palliative and End of Life care for people with 
dementia. 
Gosforth Park Hotel, Newcastle 
5th July 2007 
"Pain and Dementia" 
Agile National Conference - Rehabilitation Perspectives in Dementia Care 
Centre for Life, Newcastle 
14th September 2007 
"Assessing pain in severe dementia" 
NHS Do Once and Share (DOAS) project 
International Conference Centre, Harrogate 
3rd October 2007 
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"Assessing Pain in Advanced Dementia" 
British Pain Society, Pain in Older Adults group 
University of Teesside 
23rd January 2008 
333 
Poster presentations 
1. Jordan A I, Hughes J C, O'Brien J T. "The assessment and management of pain in 
severe dementia". i h November 2006. UK Dementia Conference, Bournemouth 
2. Jordan A I, Hughes J C, O'Brien J T. "The assessment and management of pain in 
severe dementia". 2nd March 2007. Marie Curie Palliative Care Research 
Conference, London 
Publications 
1. Hughes J.C., Jolley D., Jordan A., Sampson E.L., Palliative care in dementia: 
issues and evidence. Advances in Psychiatric Treatment. 2007. 13: p. 251-260 
2. Jordan A.I., Regnard C .• Hughes. lC., Hidden Pain or Hidden Evidence? Journal 
of Pain and Symptom Management, 2007. 33 (6): p. 658-9 
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